Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003888	s-timotee	kU/l (u/ml)	5315	5827	0.03%
3003888	s-timotee	— (—)	4365	4542	100.00%	Distribution not available
3003888	timotei	— (—)	521	541	100.00%	Distribution not available
3003888	timotei	kU/l (u/ml)	213	221	0.00%
3003888	s-timotee	kU/l______ (u/ml)	117	119	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma and allergy

1173

1159

11.70

307.65

1.2

1.0

6.65

6.05

u/ml

0.39

933

523

Asthma, unspecified (mode), excluding more controls

1385

2568

3.98

307.65

1.1

1.0

4.49

4.57

u/ml

0.05

776

1055

Atopic dermatitis, strict definition with reimbursement

1423

3964

3.67

307.65

1.2

1.1

7.39

5.90

u/ml

2.22

1035

2082

Suggestive for eosinophilic asthma

388

406

10.47

307.65

1.3

1.0

2.92

4.50

u/ml

0.96

285

193

Asthma and allergy, excluding more controls

1174

1183

11.47

307.65

1.2

1.0

6.64

6.07

u/ml

0.38

934

540

Vasomotor and allergic rhinitis

2586

3575

7.87

307.65

1.2

1.0

7.31

5.15

u/ml

5.87

1878

1684

Chronic lower respiratory diseases

3966

6000

3.61

307.65

1.1

5.23

5.65

u/ml

0.66

2457

2933

Obesity related asthma

974

2385

4.26

307.65

1.1

4.11

4.83

u/ml

0.76

573

1093

Asthma (only as main-diagnosis), excluding more controls

2882

2835

5.93

307.65

1.1

1.0

5.12

4.96

u/ml

0.15

1868

1178

Asthma/COPD (KELA code 203)

3232

5978

3.75

307.65

1.1

4.83

5.65

u/ml

1.75

2015

2922

Asthma-related infections

2000

5028

4.05

307.65

1.2

1.1

5.28

5.58

u/ml

0.31

1359

2459

Asthma, excluding more controls

2876

2835

5.47

307.65

1.1

1.0

5.13

4.96

u/ml

0.16

1845

1178

Asthma (mode)

2924

2883

5.59

307.65

1.1

1.0

5.16

4.90

u/ml

0.27

1880

1199

Asthma, unspecified (mode)

1393

2599

3.99

307.65

1.1

1.0

4.47

4.53

u/ml

0.04

780

1069

Other diseases of upper respiratory tract

2533

4640

2.91

307.65

1.1

1.0

5.95

4.75

u/ml

2.34

1553

2112

Atopic dermatitis

2269

6016

3.13

307.65

1.1

6.68

5.20

u/ml

3.42

1470

3056

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2131

6138

3.49

307.65

1.1

6.83

4.84

u/ml

5.75

1520

2976

Allergic asthma (mode), excluding more controls

1572

1876

9.09

307.65

1.2

1.0

6.03

5.72

u/ml

0.23

1207

830

Allergic asthma (mode)

1572

1866

9.14

307.65

1.2

1.0

6.03

5.74

u/ml

0.21

1207

825

Asthma, hospital admission 2, infections

2000

5028

4.05

307.65

1.2

1.1

5.28

5.58

u/ml

0.31

1359

2459

Asthma, including avohilmo

4324

5515

4.51

307.65

1.1

5.21

5.65

u/ml

0.70

2634

2678

Dermatitis and eczema

2804

6852

2.48

307.65

1.1

5.91

4.90

u/ml

2.20

1697

3452

Chronic rhinitis, nasopharyngitis and pharyngitis

1095

2390

4.82

307.65

1.1

1.0

3.99

4.41

u/ml

0.40

666

1092

Chronic sinusitis

1229

3053

4.18

307.65

1.1

1.0

3.11

4.11

u/ml

2.09

743

1344

Conjunctivitis

2527

7156

2.95

307.65

1.1

6.57

4.89

u/ml

5.05

1743

3573

Allergic conjunctivitis

2198

6486

3.42

307.65

1.1

6.76

4.91

u/ml

5.26

1564

3165

Nasal polyp

586

883

7.02

307.65

1.2

1.0

2.97

4.35

u/ml

1.53

404

394

Asthma (diagnoses ohter than nonallergic)

3268

6752

4.09

307.65

1.2

1.1

5.08

5.55

u/ml

0.77

2191

3256

Asthma (only as main-diagnosis)

2900

2870

5.95

307.65

1.1

1.0

5.10

4.92

u/ml

0.18

1878

1194

Desensitization to allergens

634

831

9.93

307.65

1.2

1.1

9.79

6.06

u/ml

3.97

509

478

Disorders of conjunctiva

2579

7356

2.80

307.65

1.1

6.55

4.83

u/ml

5.34

1766

3665

Asthma

2906

2870

5.47

307.65

1.1

1.0

5.09

4.92

u/ml

0.16

1863

1194

Asthma, hospital admissions , main diagnosis only

3148

6916

4.15

307.65

1.1

5.16

5.47

u/ml

0.43

2088

3380

Allergic rhinitis

2482

3581

7.83

307.65

1.2

1.1

7.42

5.20

u/ml

5.95

1838

1732

1745

4232

4.31

307.65

1.2

1.1

5.38

5.84

u/ml

0.48

1193

2124

Pollen allergy

1991

2562

9.35

307.65

1.2

1.1

7.87

5.49

u/ml

5.19

1520

1320

Atopic dermatitis, strict definition

1339

4463

3.11

295.96

1.2

1.1

7.61

6.11

u/ml

2.21

983

2403

Other pulmonary diagnosis

1669

2915

2.93

285.75

1.1

1.0

5.69

4.98

u/ml

0.75

982

1218

Cough

1122

3282

3.30

278.96

1.1

4.29

5.62

u/ml

1.77

651

1700

COPD differential diagnosis

1640

2884

2.91

277.56

1.1

1.0

5.74

4.90

u/ml

0.95

967

1199

ILD differential diagnosis

1639

2883

2.91

277.22

1.1

1.0

5.75

4.90

u/ml

0.96

966

1199

Excluding asthma or asthma-COPD overlap

1645

2915

2.88

274.74

1.1

1.0

5.74

4.98

u/ml

0.81

966

1218

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1136

3544

3.17

269.07

1.1

1.0

4.81

4.29

u/ml

0.53

647

1572

Childhood asthma (age<16)

689

1241

4.65

254.94

1.2

1.0

7.54

6.89

u/ml

0.32

490

598

Childhood asthma (age<16), excluding more controls

688

1243

4.63

253.56

1.2

1.0

7.55

6.89

u/ml

0.33

489

599

Oral corticosteroids

2428

6535

2.22

250.64

1.1

4.60

5.29

u/ml

1.16

1471

3293

ILD medications: prednisolone, methylprednisolone, prednisone

2501

6619

2.14

232.65

1.1

5.11

5.46

u/ml

0.43

1504

3405

Undetermined asthma

391

635

6.47

230.68

1.2

1.0

3.70

4.66

u/ml

0.52

243

265

Asthma-related pneumonia

777

2200

3.62

229.07

1.2

1.1

5.03

5.66

u/ml

0.44

526

1076

Asthma, hospital admissions 3, pneumonia

779

2210

3.61

228.96

1.2

1.1

5.01

5.64

u/ml

0.45

528

1082

Asthma-related pneumonia or sepsis

779

2210

3.61

228.96

1.2

1.1

5.01

5.64

u/ml

0.45

528

1082

Undetermined asthma, excluding more controls

391

643

6.38

227.81

1.2

1.0

3.70

4.62

u/ml

0.49

243

268

Biological medicines for asthma

219

206

13.77

210.65

1.3

1.1

3.61

5.56

u/ml

0.82

156

116

Diseases of the respiratory system

1225

2172

2.88

204.53

1.1

1.0

5.58

4.96

u/ml

0.50

695

923

Abnormalities of breathing

2131

5858

2.12

195.39

1.1

4.96

5.86

u/ml

1.64

1231

3094

ILD medications

2497

6978

1.96

183.13

1.1

5.04

5.67

u/ml

0.99

1499

3647

Inflammatory bowel disease treatment related agents

2493

7207

1.95

181.47

1.1

4.86

5.63

u/ml

1.37

1487

3752

Childhood allergy (age < 16)

853

2465

3.07

174.48

1.2

1.1

8.68

7.85

u/ml

0.52

641

1410

Adverse effects, not elsewhere classified

716

2357

3.20

168.93

1.2

1.1

4.68

5.47

u/ml

0.74

509

1307

Deviated nasal septum

602

1770

3.48

168.16

1.1

1.0

3.64

4.33

u/ml

0.60

339

796

Conjunctivitis (acute, non atopic), including avohilmo

2000

6076

2.02

164.21

1.1

6.01

4.72

u/ml

2.32

1130

2982

First line medication for Crohn's disease

2396

6888

1.90

160.78

1.1

5.13

5.66

u/ml

0.76

1438

3594

Symptoms and signs involving the circulatory and respiratory systems

2219

5882

1.92

150.82

1.1

5.09

5.89

u/ml

1.34

1276

3105

FESS (DNB20)

420

1056

4.21

149.94

1.2

1.1

2.39

4.95

u/ml

5.07

264

552

Chronic diseases of tonsils and adenoids

1515

4512

2.15

148.82

1.1

1.0

5.57

4.83

u/ml

0.80

855

2066

Ethmoidectomy

424

1097

4.09

145.42

1.2

1.1

2.36

5.05

u/ml

5.55

267

572

Urticaria

905

3703

2.53

139.52

1.1

4.70

5.30

u/ml

0.59

578

2023

Non-allergic asthma (mode), excluding more controls

387

976

4.04

133.93

1.1

1.0

2.09

4.94

u/ml

3.47

194

426

Non-allergic asthma (mode)

387

979

4.03

133.36

1.1

1.0

2.09

4.94

u/ml

3.48

194

425

Urticaria and erythema

995

4329

2.37

133.24

1.1

4.70

5.45

u/ml

0.87

631

2349

Dermatitis due to ingested food

308

669

5.21

128.63

1.3

1.1

7.11

8.10

u/ml

0.36

259

416

Other and unspecified effects of external causes

846

3507

2.50

126.95

1.2

1.1

4.76

5.90

u/ml

1.43

577

1936

Dyspnoea

1657

6618

1.83

106.63

1.1

4.64

4.74

u/ml

0.09

967

3429

Diseases of the skin and subcutaneous tissue

1822

5177

1.79

100.04

1.1

6.02

5.08

u/ml

1.36

1091

2562

Acute sinusitis

1214

5793

1.94

96.87

1.1

4.87

5.39

u/ml

0.46

701

3031

Acute upper respiratory infections

1913

6739

1.72

96.27

1.1

5.04

5.26

u/ml

0.21

1053

3517

Personal history of allergy to analgesic agent

21.16

93.08

1.6

1.0

1.89

6.88

u/ml

1.02

Polypectomy (DHB20)

184

360

5.41

89.78

1.3

1.1

2.17

5.45

u/ml

2.59

130

183

Acute upper respiratory infections of multiple and unspecified sites

1549

6506

1.76

87.65

1.1

5.33

5.40

u/ml

0.06

884

3404

Other medical care

776

2998

2.20

86.95

1.2

1.1

9.17

4.52

u/ml

9.12

580

1530

Dermatitis

1058

5394

1.94

86.90

1.1

4.55

4.46

u/ml

0.06

586

2635

Allergic contact dermatitis

363

1212

3.11

83.44

1.1

5.58

4.46

u/ml

0.57

206

607

Diseases of the eye and adnexa

1767

5250

1.71

83.10

1.1

6.58

5.20

u/ml

2.34

1091

2685

Insomnia

1759

7459

1.66

79.97

1.1

5.48

5.40

u/ml

0.07

928

3985

Any reimbursement code in KELA

1474

4211

1.78

79.91

1.1

5.88

5.81

u/ml

0.05

885

2150

Personal history of allergy to drugs, medicaments and biological substances

107

10.85

79.81

1.5

1.1

2.42

5.13

u/ml

1.12

Other and unspecified dermatitis

886

4523

1.99

77.88

1.1

4.28

4.67

u/ml

0.33

491

2225

Sleep disorders

1751

7421

1.64

76.49

1.1

5.22

5.37

u/ml

0.14

933

3972

D07AA Corticosteroids, weak (group I)

505

2097

2.50

75.87

1.2

1.1

7.34

5.85

u/ml

1.18

374

1223

Other and unspecified urticaria

533

2309

2.38

72.73

1.1

4.72

5.51

u/ml

0.59

337

1270

Bronchitis

1990

7621

1.58

72.51

1.1

5.47

5.31

u/ml

0.14

1134

3981

Medical observation and evaluation for suspected diseases and conditions

1207

3420

1.83

71.71

1.1

5.00

5.63

u/ml

0.65

750

1706

1938

6200

1.60

71.43

1.1

4.97

5.33

u/ml

0.40

1074

3174

Sleep apnoea, including avohilmo

1661

6165

1.65

71.30

1.1

4.08

4.90

u/ml

1.47

831

3259

Asthma mixed form (mode)

129

225

5.99

71.09

1.1

1.0

3.44

4.84

u/ml

0.55

102

Asthma mixed form (mode), excluding more controls

129

226

5.96

70.75

1.1

1.0

3.44

4.79

u/ml

0.53

103

Behavioural syndromes associated with physiological disturbances and physical factors

1786

7663

1.59

68.77

1.1

5.19

5.47

u/ml

0.30

963

4149

Migraine

1243

5639

1.74

68.72

1.1

4.81

6.07

u/ml

2.09

693

3050

Pain in joint

1140

3944

1.80

67.38

1.1

5.25

5.88

u/ml

0.61

644

2181

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1860

7662

1.57

67.01

1.1

4.97

5.36

u/ml

0.48

1034

4090

Sleep disorders (combined)

1923

6515

1.56

63.61

1.1

5.23

5.65

u/ml

0.49

1002

3565

Early onset COPD, excluding more controls

220

649

3.44

61.34

1.1

1.0

4.49

3.11

u/ml

0.53

127

242

Chronic laryngitis and laryngotracheitis

219

648

3.46

61.16

1.1

1.0

4.42

3.58

u/ml

0.30

119

269

Asthma and opportunity respiratory infection

116

7.73

60.54

1.1

1.0

1.72

5.13

u/ml

1.13

Voice disturbances

475

2114

2.29

60.41

1.1

3.84

4.32

u/ml

0.32

265

1070

Special screening examination for infectious and parasitic diseases

677

2497

2.02

58.30

1.1

5.01

6.32

u/ml

1.40

422

1235

Headache

1367

6606

1.62

57.38

1.1

5.07

5.63

u/ml

0.64

727

3548

Other acute lower respiratory infections

983

5427

1.75

57.18

1.2

1.1

5.73

5.78

u/ml

0.03

621

2996

Dentofacial anomalies [including malocclusion]

1482

7434

1.58

56.23

1.1

5.75

5.23

u/ml

0.50

808

3995

Examination and observation for other reasons

1043

3412

1.74

54.81

1.1

4.86

5.59

u/ml

0.63

606

1701

Bronchiectasis

100

180

5.70

53.14

1.1

1.58

4.76

u/ml

1.82

Sleep apnoea

1446

5874

1.56

51.31

1.1

3.77

4.64

u/ml

1.60

727

3055

Dermatographic urticaria

214

706

3.19

50.82

1.1

3.12

5.03

u/ml

1.50

126

379

Recurrent or chronic depression

794

3058

1.83

50.80

1.1

5.30

5.54

u/ml

0.15

440

1637

Symptoms and signs involving speech and voice

519

2564

2.06

50.45

1.1

3.68

4.42

u/ml

0.61

286

1310

Other special examinations and investigations of persons without complaint or reported diagnosis

1118

3420

1.67

49.42

1.1

5.82

5.63

u/ml

0.12

645

1706

Idiopathic urticaria

107

232

5.09

47.20

1.1

3.95

4.26

u/ml

0.10

134

Episodal and paroxysmal disorders

1961

6935

1.45

45.58

1.1

5.06

5.85

u/ml

1.28

1058

3820

Migraine, single triptan purchase ok & required. ICD-code if available is included

1526

6954

1.50

45.30

1.1

5.72

5.68

u/ml

0.03

815

3752

Triptan medication for migraine, single purchase ok

1526

6954

1.50

45.30

1.1

5.72

5.68

u/ml

0.03

815

3752

Neurotic, stress-related and somatoform disorders

1653

7807

1.47

44.62

1.1

5.24

5.47

u/ml

0.22

974

4098

Anxiety disorders

1657

7807

1.47

44.30

1.1

5.20

5.47

u/ml

0.25

976

4099

Any death

129

2935

0.30

43.49

1.0

1.1

3.04

3.52

u/ml

0.16

1505

Acute bronchitis

665

3705

1.78

41.94

1.2

1.1

5.10

5.31

u/ml

0.13

396

2027

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

748

2124

1.79

41.76

1.1

4.99

6.44

u/ml

1.47

404

1164

Exposure to unspecified factor

1782

8533

1.43

41.60

1.1

4.63

5.50

u/ml

1.53

1059

4547

COPD/asthma related infections

1693

5883

1.45

40.37

1.1

5.14

5.32

u/ml

0.16

948

3024

COPD/asthma/ILD related infections

1693

5883

1.45

40.37

1.1

5.14

5.32

u/ml

0.16

948

3024

Intestinal infectious diseases, including avohilmo, including avohilmo

1895

7507

1.42

40.21

1.1

4.83

5.40

u/ml

0.70

1039

4000

Gastro-oesophageal reflux disease

1035

5632

1.56

38.70

1.1

4.15

4.69

u/ml

0.56

519

2956

Other inflammation of eyelid, including avohilmo

933

5929

1.59

38.57

1.1

5.57

5.46

u/ml

0.07

537

3193

Temporomandibular joint disorders, including avohilmo

1000

6248

1.57

38.57

1.1

5.09

5.73

u/ml

0.66

558

3298

Pain in throat and chest

1384

5568

1.48

38.02

1.1

4.87

5.79

u/ml

1.25

754

2904

All anxiety disorders

1330

7049

1.48

37.65

1.1

5.63

5.78

u/ml

0.11

809

3754

Irritable bowel syndrome

526

2889

1.85

37.54

1.1

4.64

5.40

u/ml

0.60

265

1505

Exposure to other specified factors

1455

8743

1.44

36.56

1.1

5.63

5.35

u/ml

0.25

874

4677

Persons encountering health services for examination and investigation

1055

3420

1.56

35.49

1.1

5.42

5.63

u/ml

0.15

611

1706

COPD

310

1150

2.20

35.41

1.1

1.0

3.74

3.18

u/ml

0.23

165

501

Anxiety (asthma-related co-morbidities)

1283

6693

1.47

35.36

1.1

5.60

5.76

u/ml

0.12

779

3547

Depression or dysthymia

989

3468

1.57

34.90

1.1

5.22

5.29

u/ml

0.05

542

1867

Triptan medication for migraine, min. 3 purchases

1248

6385

1.48

34.86

1.1

5.18

5.42

u/ml

0.19

649

3384

Other headache syndromes

727

4449

1.65

34.60

1.1

4.42

5.00

u/ml

0.49

407

2293

Mycoses, including avohilmo

1568

8524

1.41

34.55

1.1

4.56

5.51

u/ml

1.58

824

4602

Abnormalities of heart beat

516

2816

1.80

33.64

1.1

4.51

5.71

u/ml

0.97

270

1444

Other chronic obstructive pulmonary disease

290

1079

2.21

33.60

1.1

1.0

3.81

3.29

u/ml

0.20

157

459

Codes for special purposes

894

5753

1.56

33.53

1.1

4.77

5.46

u/ml

0.63

488

3133

Provisional assignment of new diseases of uncertain etiology

893

5751

1.56

33.40

1.1

4.77

5.46

u/ml

0.63

488

3132

Coxibs

430

1153

1.98

33.22

1.1

6.97

7.31

u/ml

0.12

232

664

Pain (limb, back, neck, head abdominally)

1202

4069

1.49

32.99

1.1

5.73

5.72

u/ml

0.01

663

2287

Anxiety disorders, excluding more controls

1428

6492

1.42

31.31

1.1

5.06

5.23

u/ml

0.14

838

3417

Covid-19 suspected case

490

2800

1.78

30.92

1.1

5.09

5.84

u/ml

0.40

256

1537

Atopic conjunctivitis

138

473

3.06

30.88

1.2

1.1

6.33

6.01

u/ml

0.08

264

Acetic acid derivatives and related substances

405

1076

1.97

30.71

1.1

7.09

6.68

u/ml

0.14

213

610

Other specific joint derangements/joint disorders

1444

6450

1.41

30.32

1.1

5.14

5.90

u/ml

0.99

788

3553

Depression

1612

7890

1.37

30.04

1.1

5.33

5.51

u/ml

0.16

901

4182

Other disorders of lacrimal gland

532

3131

1.72

29.92

1.1

4.12

4.61

u/ml

0.36

282

1575

Low back pain

1303

6236

1.42

29.47

1.1

4.29

5.60

u/ml

2.31

688

3342

Other anxiety disorders

1029

6013

1.47

28.96

1.1

5.13

6.01

u/ml

0.98

618

3239

Dorsalgia

1676

6541

1.37

28.82

1.1

4.87

5.87

u/ml

1.65

908

3547

Other dorsopathies, not elsewhere classified

1717

6591

1.36

28.79

1.1

4.98

5.92

u/ml

1.49

929

3584

Myalgia

437

2465

1.80

28.71

1.1

3.49

5.09

u/ml

2.28

240

1307

Other soft tissue disorders, not elsewhere classified

1609

6726

1.37

28.48

1.1

5.14

5.65

u/ml

0.57

878

3717

Bronchitis, not specified as acute or chronic

127

435

2.98

28.07

1.1

4.39

4.83

u/ml

0.14

215

Soft tissue disorders

1790

6846

1.35

27.99

1.1

5.57

5.76

u/ml

0.18

1010

3797

Eosinophilic disease (BM)

8.20

27.94

1.3

1.0

2.28

2.33

u/ml

0.01

Malignant neoplasm

666

6089

0.64

27.92

1.1

4.28

4.46

u/ml

0.12

332

3172

Tonsillectomy and adenotomy

1336

6702

1.40

27.91

1.1

6.24

5.77

u/ml

0.45

776

3758

Disorders of lacrimal system

624

3830

1.62

27.84

1.1

4.26

4.62

u/ml

0.26

324

1939

Persons encountering health services for specific procedures and health care

1837

8173

1.33

27.66

1.1

6.18

5.14

u/ml

1.74

1155

4293

Caries of enamel

1605

7787

1.36

27.51

1.1

4.89

5.21

u/ml

0.38

924

4102

Conjunctivitis (acute, non atopic)

509

3033

1.69

27.04

1.1

6.63

4.88

u/ml

1.44

306

1590

Malignant neoplasm

672

6079

0.64

26.84

1.1

4.24

4.49

u/ml

0.17

336

3165

Pain and other conditions associated with female genital organs and menstrual cycle

504

2525

1.70

26.08

1.1

4.61

6.24

u/ml

1.58

260

1381

Functional dyspepsia

405

2303

1.78

25.88

1.1

3.47

5.02

u/ml

1.50

213

1189

Mood [affective] disorders

1645

7936

1.34

25.34

1.1

5.16

5.50

u/ml

0.37

909

4209

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1502

8735

1.35

25.25

1.1

5.80

5.25

u/ml

0.61

807

4752

Lower back pain or/and sciatica

1688

7930

1.33

25.23

1.1

4.10

5.44

u/ml

3.16

889

4184

Migraine without aura

517

3176

1.66

25.07

1.1

4.88

6.13

u/ml

1.03

302

1740

Candidiasis, including avohilmo

534

3301

1.64

25.05

1.1

4.42

5.11

u/ml

0.48

284

1775

Allergic urticaria

204

932

2.26

25.01

1.1

5.38

5.43

u/ml

0.01

139

528

Speech therapy

337

1832

1.86

25.01

1.1

2.58

4.62

u/ml

2.69

158

954

Mood disorders

1644

7936

1.33

24.92

1.1

5.16

5.50

u/ml

0.38

909

4208

Solid cancers

639

5755

0.65

24.92

1.1

4.34

4.11

u/ml

0.14

316

2958

Opioids

1659

6442

1.34

24.89

1.1

5.23

5.69

u/ml

0.51

913

3430

Malignant neoplasm, wide definition

730

6344

0.66

24.71

1.1

4.45

4.52

u/ml

0.04

368

3336

Dorsopathies

1754

6740

1.33

24.61

1.1

5.39

5.89

u/ml

0.56

960

3706

Diseases of the musculoskeletal system and connective tissue

1138

4055

1.42

24.28

1.1

6.67

6.13

u/ml

0.42

654

2324

Abnormal findings on diagnostic imaging of lung

434

2419

1.71

24.18

1.1

3.41

3.55

u/ml

0.08

221

1210

Malignant neoplasm, including Hilmo

736

6355

0.67

24.05

1.1

4.20

4.56

u/ml

0.28

372

3342

Any event in cancer register

841

7098

0.69

23.98

1.1

4.94

4.67

u/ml

0.19

425

3768

Codeine

1534

6221

1.34

23.58

1.1

4.50

5.35

u/ml

1.43

828

3283

Migraine with aura

550

3483

1.60

23.42

1.1

4.72

6.07

u/ml

1.32

316

1871

Solid cancers, including Hilmo

702

6068

0.67

23.03

1.1

4.27

4.40

u/ml

0.08

350

3145

Lichen simplex chronicus and prurigo

331

3.07

22.98

1.1

4.96

4.16

u/ml

0.15

169

Codeine or tramadol medication

1717

7176

1.31

22.11

1.1

4.28

5.25

u/ml

2.06

911

3748

Certain infectious and parasitic diseases, including avohilmo

1133

4107

1.39

21.71

1.1

5.53

5.44

u/ml

0.06

618

2179

Other joint disorders

1646

6597

1.31

21.34

1.1

5.53

5.97

u/ml

0.44

915

3652

Parasetamol

1317

4960

1.35

21.09

1.1

6.15

6.33

u/ml

0.13

741

2732

Soft tissue disorders related to use, overuse and pressure

342

1976

1.75

20.75

1.1

4.35

4.28

u/ml

0.03

172

975

Abdominal and pelvic pain

1566

6027

1.31

20.53

1.1

5.17

5.59

u/ml

0.38

872

3327

Cystitis

1274

5670

1.34

20.41

1.1

4.91

5.13

u/ml

0.16

665

3012

Selective serotonin reuptake inhibitors

1511

6002

1.32

20.39

1.1

5.33

5.76

u/ml

0.39

822

3242

Migraine without aura and triptan purchases

406

2480

1.67

20.31

1.1

4.88

5.56

u/ml

0.36

228

1358

Gastrointestinal diseases

1194

4423

1.36

20.20

1.1

6.33

6.07

u/ml

0.17

661

2493

Hyperkinetic disorders, excluding more controls

437

2540

1.64

20.15

1.2

1.1

6.07

7.48

u/ml

0.95

275

1533

Diseases of middle ear and mastoid

1115

6753

1.36

20.11

1.1

6.07

5.82

u/ml

0.19

660

3763

Pruritus

182

868

2.13

19.92

1.1

5.57

4.33

u/ml

0.51

435

Neurological diseases, wide definition

705

2392

1.50

19.83

1.1

5.79

6.71

u/ml

0.69

394

1426

Diseases of oesophagus, stomach and duodenum

1604

7348

1.29

19.76

1.1

4.00

5.02

u/ml

2.10

837

3923

Nonsuppurative otitis media, including avohilmo

721

4321

1.46

19.69

1.1

6.57

6.72

u/ml

0.08

439

2470

Other antidepressants

1497

5866

1.31

19.48

1.1

5.24

5.59

u/ml

0.36

810

3127

Mood disorders, excluding more controls

1438

6483

1.31

19.33

1.1

5.12

5.22

u/ml

0.09

788

3395

Renal tubulo-interstitial diseases

712

7436

0.70

19.33

1.1

3.43

5.14

u/ml

3.74

377

3945

Migraine with aura and triptan purchases

384

2343

1.67

19.32

1.1

5.24

5.58

u/ml

0.16

224

1284

Neurological diseases

1528

5914

1.30

19.31

1.1

5.39

6.15

u/ml

0.97

838

3309

Symptoms and signs involving the digestive system and abdomen

1557

6029

1.30

19.25

1.1

5.10

5.58

u/ml

0.47

878

3329

Haemorrhage from respiratory passages

326

1671

1.74

19.19

1.1

3.56

5.42

u/ml

1.89

174

861

Depression medications

754

2616

1.47

19.14

1.1

6.25

6.98

u/ml

0.47

420

1504

COPD (mode)

174

635

2.15

18.86

1.0

4.01

2.70

u/ml

0.40

234

Propionic acid derivatives

455

1421

1.63

18.53

1.1

6.47

7.36

u/ml

0.42

254

868

Herpesviral [herpes simplex] infections, including avohilmo

489

3192

1.55

18.38

1.1

6.95

5.16

u/ml

1.43

271

1701

Fenamates

200

679

2.03

17.98

1.1

2.98

5.47

u/ml

2.53

118

385

Transport accidents

787

4694

1.41

17.64

1.1

7.64

5.23

u/ml

2.28

445

2436

Injuries to the ankle and foot

1299

8597

1.30

17.29

1.1

5.64

5.49

u/ml

0.12

758

4647

Non-allergic asthma

110

452

2.47

17.17

1.0

1.1

0.72

4.23

u/ml

5.24

202

Chronic conjunctivitis

234

3.16

17.17

1.1

4.69

5.18

u/ml

0.13

131

Follow-up examination after treatment for conditions other than malignant neoplasms

626

2861

1.47

17.16

1.1

4.96

5.27

u/ml

0.18

330

1387

Other nutritional deficiencies

1093

7575

1.33

17.15

1.1

3.91

5.22

u/ml

2.94

603

3978

Acute bronchiolitis

234

1168

1.88

16.93

1.3

1.1

7.17

7.70

u/ml

0.17

185

779

Other menopausal disorders

357

1199

1.68

16.82

1.1

2.79

4.28

u/ml

1.42

193

586

Disturbance of activity and attention

448

2875

1.56

16.60

1.2

1.1

5.85

7.51

u/ml

1.31

289

1774

All kidney diseases

964

8574

0.75

16.59

1.1

3.56

5.25

u/ml

4.35

523

4599

Inflammatory diseases of female pelvic organs

1085

5636

1.33

16.38

1.1

5.13

4.84

u/ml

0.25

566

2878

Other viral diseases, including avohilmo

793

5739

1.38

16.34

1.1

6.11

6.08

u/ml

0.02

445

3273

Hyperkinetic disorders

464

3013

1.53

16.19

1.2

1.1

6.16

7.45

u/ml

0.88

301

1858

Somatoform disorder

280

1650

1.72

16.09

1.1

4.40

4.97

u/ml

0.29

146

841

Disorders of eyelid, lacrimal system and orbit

1185

6718

1.30

15.61

1.1

4.25

4.82

u/ml

0.69

610

3509

Early onset COPD

220

1218

1.82

15.60

1.1

4.49

3.79

u/ml

0.23

127

600

Allergic colitis

121

553

2.36

15.57

1.2

7.72

7.15

u/ml

0.09

381

Diseases of the ear and mastoid process

1845

7487

1.24

15.56

1.1

5.71

5.15

u/ml

0.66

993

4024

Injuries to the wrist and hand

1605

8532

1.25

15.53

1.1

5.05

5.38

u/ml

0.36

883

4629

Mouth breathing

540

3723

1.46

15.40

1.1

4.38

4.84

u/ml

0.34

298

2080

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

700

4385

1.40

15.35

1.1

3.72

4.28

u/ml

0.58

367

2241

Other inflammation of eyelid

208

1140

1.85

15.34

1.1

4.72

4.93

u/ml

0.08

121

619

Pain in limb

1302

6479

1.28

15.30

1.1

5.35

5.52

u/ml

0.12

708

3558

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1685

7200

1.25

15.29

1.1

4.48

5.48

u/ml

1.91

998

3799

Diabetes, insulin treatment (Kela reimbursement)

871

6911

0.75

15.27

1.1

4.24

4.76

u/ml

0.50

447

3674

Schizophrenia

1697

0.37

15.21

1.0

1.1

3.00

5.87

u/ml

2.02

934

Dermatophytosis, including avohilmo

970

7235

1.32

15.07

1.1

4.30

5.46

u/ml

1.68

512

3850

Eosinophilia

4.43

15.01

1.3

1.1

2.28

5.01

u/ml

0.68

Other chronic obstructive pulmonary disease, including avohilmo

418

2246

1.54

14.97

1.0

1.1

3.17

3.28

u/ml

0.05

229

1096

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

386

2520

1.55

14.69

1.1

6.11

5.04

u/ml

0.63

202

1340

Unspecified privation

170

889

1.95

14.58

1.1

4.68

5.40

u/ml

0.25

118

479

Accidents

1263

4942

1.29

14.57

1.1

5.63

5.07

u/ml

0.54

721

2557

General symptoms and signs

1704

6917

1.24

14.34

1.1

4.81

5.61

u/ml

1.29

947

3723

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

844

6642

0.75

14.32

1.1

4.30

4.77

u/ml

0.42

440

3547

Arthropathies

1635

6673

1.24

14.26

1.1

5.68

5.92

u/ml

0.20

908

3719

Allergic contact dermatitis due to drugs in contact with skin

145

3.52

14.17

1.1

1.0

8.40

3.14

u/ml

0.84

Other external causes of accidental injury

1258

4942

1.28

14.09

1.1

5.58

5.07

u/ml

0.48

724

2557

Injuries to the knee and lower leg

1847

8186

1.22

14.07

1.1

5.43

5.37

u/ml

0.05

1022

4400

Kela-code for severe mental illness

248

4063

0.61

13.78

1.1

2.85

5.70

u/ml

6.11

137

2215

Suppurative and unspecified otitis media

792

5257

1.35

13.77

1.1

6.39

6.24

u/ml

0.09

470

3013

Schizophrenia or delusion

215

3646

0.58

13.75

1.1

3.07

5.96

u/ml

3.93

124

1998

Anti-inflammatory and antirheumatic products, non-steroids

429

1423

1.53

13.67

1.1

6.47

7.34

u/ml

0.40

249

870

Enthesopathies of lower limb, excluding foot

331

2125

1.57

13.52

1.1

4.15

4.81

u/ml

0.35

172

1082

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

646

4111

1.39

13.48

1.1

6.16

7.27

u/ml

0.91

392

2485

Heartburn

170

913

1.89

13.45

1.1

4.88

4.63

u/ml

0.06

489

External causes of morbidity and mortality

1074

4165

1.30

13.40

1.1

5.65

5.13

u/ml

0.43

603

2182

Paracetamol or NSAID medication

309

957

1.64

13.38

1.1

7.85

6.91

u/ml

0.34

191

603

Schizophrenia, schizotypal and delusional disorders

218

3650

0.59

13.28

1.1

3.05

5.95

u/ml

4.01

125

2003

Other viral diseases, not elsewhere classified, including avohilmo

552

3916

1.42

13.28

1.1

5.65

5.94

u/ml

0.13

304

2266

Sciatica+with lumbago

690

4515

1.36

13.05

1.1

3.56

4.58

u/ml

1.44

369

2335

Symptoms and signs involving the skin and subcutaneous tissue

1014

7492

1.28

12.80

1.1

4.81

4.85

u/ml

0.02

562

3931

Simple and mucopurulent chronic bronchitis

139

3.37

12.76

1.1

6.94

5.79

u/ml

0.09

Intestinal infectious diseases

1443

8718

1.24

12.68

1.1

4.91

5.46

u/ml

0.61

836

4690

Acne, including avohilmo

627

3717

1.38

12.68

1.1

7.42

7.44

u/ml

0.01

346

2214

Oxicams

229

752

1.74

12.66

1.1

4.69

5.40

u/ml

0.24

118

424

Persons encountering health services in other circumstances, wide

1702

7201

1.22

12.44

1.1

4.73

5.48

u/ml

1.18

994

3799

ILD, hospital admissions 1, main diag only

104

481

2.18

12.44

1.1

3.05

3.27

u/ml

0.07

237

Other diseases of intestines

1747

8046

1.21

12.40

1.1

4.70

5.65

u/ml

1.50

921

4452

Later onset COPD, excluding more controls

196

2.69

12.39

1.0

0.92

2.07

u/ml

0.54

Oedema, not elsewhere classified

369

2411

1.50

12.39

1.1

3.25

4.58

u/ml

1.65

210

1253

Rotator cuff syndrome

669

3396

1.36

12.38

1.1

3.86

3.85

u/ml

0.01

325

1671

Dysphagia

251

1542

1.64

12.32

1.1

4.62

4.27

u/ml

0.12

138

774

Disease of hard tissues of teeth, NOS

646

2462

1.38

12.32

1.1

4.58

5.16

u/ml

0.42

342

1231

Dislocation, sprain and strain of joints and ligaments of knee

1018

7240

1.28

12.32

1.1

5.46

5.36

u/ml

0.07

560

3812

Subjective visual disturbances

354

2356

1.52

12.31

1.1

3.65

5.27

u/ml

2.12

202

1266

Emphysema

132

3.36

12.31

1.1

1.0

1.37

3.80

u/ml

1.34

Other enthesopathies

390

2648

1.48

12.24

1.2

1.1

4.39

4.13

u/ml

0.12

190

1316

Other diseases of lip and oral mucosa

554

4010

1.39

12.23

1.1

4.12

4.93

u/ml

0.71

303

2088

Lichen simplex chronicus

180

3.02

12.20

1.0

1.1

6.01

4.17

u/ml

0.19

Acute pharyngitis

338

2214

1.53

12.19

1.1

6.69

6.67

u/ml

0.01

194

1322

Female infertility, cervical, vaginal, other or unspecified origin

480

2147

1.44

12.13

1.1

5.33

5.41

u/ml

0.04

243

1140

Other bacterial diseases

820

7048

0.77

12.07

1.1

4.61

4.79

u/ml

0.12

470

3757

Obesity

996

7383

1.28

12.03

1.1

3.63

5.23

u/ml

4.13

555

3840

Obesity and other hyperalimentation

998

7389

1.28

12.03

1.1

3.62

5.23

u/ml

4.24

557

3843

Diabetes medication

1075

7889

0.79

11.94

1.1

4.64

5.05

u/ml

0.38

559

4217

Generalized anxiety disorder

379

2583

1.49

11.78

1.1

6.85

6.84

u/ml

0.00

237

1407

Disorders of synovium and tendon

753

4857

1.32

11.72

1.1

3.92

4.82

u/ml

1.07

381

2527

Irregular menses

930

5462

1.29

11.63

1.1

4.84

5.13

u/ml

0.24

500

2813

Malignant neoplasm of breast

264

2659

0.64

11.62

1.1

3.23

3.03

u/ml

0.08

113

1246

Malignant neoplasm of breast, HER2-negative

264

2655

0.64

11.53

1.1

3.23

3.02

u/ml

0.09

113

1244

Restless leg syndrome

191

1115

1.73

11.50

1.1

6.06

4.76

u/ml

0.41

584

Cervicobrachial syndrome

296

1925

1.55

11.49

1.1

3.66

4.32

u/ml

0.43

150

949

Other noninfective gastroenteritis and colitis

375

2563

1.48

11.44

1.2

1.1

5.83

6.05

u/ml

0.08

223

1474

Prurigo nodularis

100

3.70

11.42

1.1

1.0

1.40

2.79

u/ml

0.73

Visual disturbances

641

4801

1.34

11.40

1.1

3.73

5.38

u/ml

3.09

354

2574

Peritonsillar abscess

273

1749

1.57

11.34

1.1

1.0

4.47

5.00

u/ml

0.32

139

834

Other and unspecified tonsillitis

699

4403

1.33

11.26

1.1

6.59

6.18

u/ml

0.24

391

2493

Disturbances of skin sensation

443

3137

1.43

11.23

1.1

3.91

5.13

u/ml

1.13

258

1653

Excessive, frequent and irregular menstruation

669

2662

1.35

11.20

1.1

5.03

6.27

u/ml

1.21

356

1459

Nummular dermatitis

418

2.21

11.17

1.1

2.70

3.84

u/ml

0.49

209

Female infertility

518

2231

1.40

11.16

1.1

5.22

5.49

u/ml

0.14

264

1190

Cervicocranial syndrome

148

810

1.85

11.12

1.1

5.56

4.52

u/ml

0.27

412

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

141

761

1.88

11.11

1.2

1.1

3.43

4.86

u/ml

0.84

413

Other respiratory diseases principally affecting the interstitium

129

674

1.93

11.11

1.1

2.70

3.44

u/ml

0.32

345

Diaphragmatic hernia

311

2061

1.52

11.02

1.1

3.09

3.88

u/ml

0.62

171

993

Other diseases of hard tissues of teeth

651

2506

1.35

10.95

1.1

4.74

5.02

u/ml

0.15

357

1267

Acute suppurative otitis media

631

4428

1.34

10.89

1.2

1.1

6.97

6.61

u/ml

0.20

387

2582

Dermatitis due to substances taken internally

405

2.22

10.83

1.1

10.08

4.76

u/ml

1.46

215

Disorders of skin appendages

838

6524

1.29

10.82

1.1

5.82

5.93

u/ml

0.06

462

3559

ILD, hospital admissions

111

556

2.01

10.82

1.1

3.06

3.15

u/ml

0.03

283

Excessive attrition of teeth

991

7830

1.26

10.80

1.1

4.59

5.41

u/ml

1.08

548

4179

Other interstitial pulmonary diseases

111

557

2.01

10.77

1.1

3.06

3.14

u/ml

0.02

284

Internal derangement of knee

499

3592

1.38

10.76

1.1

4.97

5.06

u/ml

0.03

259

1868

Interstitial lung disease

111

558

2.01

10.71

1.1

3.06

3.14

u/ml

0.02

284

Interstitial lung disease endpoints

111

558

2.01

10.71

1.1

3.06

3.14

u/ml

0.02

284

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1122

8279

1.24

10.62

1.1

5.59

5.63

u/ml

0.03

622

4532

Shoulder lesions

900

4226

1.28

10.61

1.1

3.78

4.43

u/ml

0.63

438

2150

Benign neoplasm: Colon

417

2765

1.42

10.50

1.1

2.75

3.24

u/ml

0.49

209

1330

Malignant neoplasm of breast, including Hilmo

283

2726

0.66

10.44

1.1

3.51

3.05

u/ml

0.21

126

1276

Malignant neoplasm of breast, HER2-negative, including Hilmo

283

2726

0.66

10.43

1.1

3.51

3.05

u/ml

0.21

126

1276

Trochanteric bursitis

162

930

1.76

10.37

1.1

3.06

3.31

u/ml

0.10

461

Acute laryngitis and tracheitis

289

1892

1.53

10.29

1.2

1.1

5.62

7.18

u/ml

0.96

181

1152

Postviral fatigue syndrome

120

3.43

10.21

1.1

2.40

6.77

u/ml

1.50

Other and unspecified nonorganic psychotic disorders

154

2620

0.58

10.20

1.1

2.99

6.83

u/ml

6.60

1484

Visual disturbances and blindness

665

5085

1.31

10.19

1.1

3.71

5.39

u/ml

3.38

371

2730

Ganglion

317

2150

1.49

10.17

1.1

4.06

5.16

u/ml

0.73

169

1109

Fibromyalgia

159

916

1.76

10.15

1.1

3.72

4.76

u/ml

0.50

463

ILD, hospital admission 2, with pulmonary infections

306

2.34

10.14

1.1

1.0

3.57

3.64

u/ml

0.01

138

Dislocation, sprain and strain of joints and ligaments at neck level

299

2009

1.51

10.13

1.1

6.91

6.17

u/ml

0.30

179

1113

Malignant neoplasm of digestive organs, including Hilmo

143

1834

0.57

10.09

1.1

5.09

3.08

u/ml

0.66

889

Schizophrenia or delusion, excluding more controls

215

3325

0.63

10.00

1.1

3.07

5.51

u/ml

2.99

124

1799

COPD, hospital admissions 1, only main diagnosis

205

1080

1.64

9.98

1.0

1.1

3.25

3.60

u/ml

0.12

108

529

Benign neoplasm: Colon, unspecified

181

1085

1.68

9.88

1.1

3.08

2.92

u/ml

0.08

516

COPD, hospital admissions

289

1618

1.51

9.88

1.1

3.81

3.25

u/ml

0.23

157

773

Other general symptoms and signs

132

721

1.86

9.87

1.2

1.1

2.27

6.08

u/ml

5.21

455

Unspecified mental disorder

333

4762

0.69

9.79

1.1

3.27

5.66

u/ml

3.82

184

2601

Injury, poisoning and certain other consequences of external causes

869

3428

1.28

9.69

1.1

5.80

4.96

u/ml

0.72

491

1802

Other contact dermatitis

114

602

1.92

9.66

1.1

5.78

3.97

u/ml

0.49

304

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

108

383

1.99

9.61

1.1

3.11

3.86

u/ml

0.24

207

Disorders of other endocrine glands

652

4942

1.31

9.59

1.1

3.88

5.68

u/ml

3.02

342

2802

COPD, early/later onset

290

1630

1.50

9.57

1.1

3.81

3.25

u/ml

0.22

157

779

1226

5883

1.22

9.56

1.1

5.24

5.32

u/ml

0.06

738

3024

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1226

5883

1.22

9.56

1.1

5.24

5.32

u/ml

0.06

738

3024

Pain in thoracic spine

222

1415

1.59

9.55

1.2

1.1

5.16

5.25

u/ml

0.03

118

737

Dental pulpitis, including avohilmo

1491

8002

1.20

9.54

1.1

5.10

5.51

u/ml

0.44

795

4249

Insulin medication

431

4891

0.73

9.52

1.1

5.68

5.19

u/ml

0.24

229

2718

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

502

3738

1.35

9.45

1.1

4.75

6.13

u/ml

1.19

294

2061

All chronic kidney diseases

336

3812

0.70

9.42

1.1

4.87

4.93

u/ml

0.02

173

2103

Diabetes, varying definitions

1105

7814

0.82

9.40

1.1

4.80

5.07

u/ml

0.23

577

4197

Infective dermatitis

128

707

1.83

9.40

1.1

4.45

4.07

u/ml

0.10

348

Alcohol dependence

115

2066

0.55

9.28

1.1

2.67

4.67

u/ml

1.50

1093

Diabetes mellitus

1116

7841

0.82

9.26

1.1

4.75

5.07

u/ml

0.29

586

4208

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1185

0.42

9.26

1.0

1.1

0.39

2.89

u/ml

10.06

554

Other diseases of oesophagus

444

2.05

9.24

1.2

1.1

5.32

4.75

u/ml

0.09

238

Other intervertebral disc disorders

1063

5156

1.23

9.12

1.1

3.64

4.75

u/ml

2.14

538

2703

Superficial injury of lower leg

406

2941

1.39

9.12

1.1

5.06

6.20

u/ml

0.82

226

1605

General examination and investigation of persons without complaint and reported diagnosis

833

3420

1.27

9.00

1.1

4.80

5.63

u/ml

0.79

459

1706

Diseases of external ear

453

3347

1.36

8.96

1.1

6.13

5.28

u/ml

0.44

256

1842

Vocal cord dysfunction

218

1233

1.57

8.91

1.2

1.1

5.03

4.70

u/ml

0.10

122

650

Seborrhoeic dermatitis

115

626

1.86

8.89

1.2

1.1

3.79

3.92

u/ml

0.04

320

Rosacea

188

1174

1.62

8.88

1.1

4.10

5.22

u/ml

0.50

598

Viral warts, including avohilmo

396

2875

1.39

8.83

1.1

6.62

6.29

u/ml

0.13

195

1641

Organic, including symptomatic, mental disorders

131

1586

0.58

8.81

1.0

1.1

4.58

3.06

u/ml

0.51

787

Inflammatory diseases of prostate (prostatitis)

113

613

1.86

8.80

1.1

5.09

5.99

u/ml

0.26

327

Panic disorder

308

2143

1.46

8.80

1.1

4.94

6.28

u/ml

1.03

187

1156

Renal failure

164

2264

0.61

8.79

1.0

1.1

4.99

4.21

u/ml

0.26

1194

Diarrhoea and gastroenteritis of presumed infectious origin

1083

7964

1.22

8.77

1.1

4.38

5.61

u/ml

2.39

639

4339

Chronic gastritis

193

1214

1.60

8.75

1.1

1.83

3.52

u/ml

2.18

105

593

Cervical disc disorders

352

2505

1.41

8.74

1.1

2.24

3.89

u/ml

3.22

168

1212

Psychiatric diseases

1356

5673

1.20

8.67

1.1

5.78

5.15

u/ml

0.62

742

3064

Exfoliative dermatitis

4.93

8.67

1.2

1.1

9.72

4.33

u/ml

0.70

Other diseases of urinary system

1369

6439

1.20

8.62

1.1

4.88

5.19

u/ml

0.28

733

3463

Genitourinary diseases

936

3784

1.25

8.57

1.1

5.37

6.34

u/ml

0.97

532

2255

Cervicalgia

244

1627

1.51

8.57

1.1

3.99

4.40

u/ml

0.21

123

825

Tramadol

1032

5069

1.23

8.56

1.1

3.78

4.73

u/ml

1.57

550

2646

Lumbar disc prolapse

807

4779

1.26

8.45

1.1

3.68

4.63

u/ml

1.33

411

2489

Hypertrophy of breast in women and men

290

2014

1.45

8.35

1.1

3.97

4.59

u/ml

0.28

142

1013

Other disorders of patella

264

1801

1.48

8.34

1.1

3.86

4.98

u/ml

0.85

138

935

Other/unspecified dorsalgia

468

3474

1.34

8.27

1.1

4.68

5.00

u/ml

0.18

274

1832

Other and unspecified drugs and medicaments

120

679

1.79

8.24

1.2

1.1

3.59

5.18

u/ml

0.79

369

Biguanides

841

6270

0.81

8.19

1.1

3.93

4.40

u/ml

0.43

421

3222

Liquid cancers, including Hilmo

148

2124

0.61

8.17

1.1

4.38

4.13

u/ml

0.06

1095

Oter anti-inflammatory and antirheumatic agents, non-steroids

156

506

1.70

8.14

1.1

2.52

4.07

u/ml

0.89

260

Other extrapyramidal and movement disorders in other diseases

254

1728

1.48

8.11

1.1

5.53

4.80

u/ml

0.26

110

897

Mental and behavioural disorders due to alcohol, excluding acute intoxication

287

4026

0.70

8.02

1.1

4.41

5.21

u/ml

0.41

164

2163

Fall on same level involving ice and snow

742

5942

1.25

7.99

1.1

5.02

5.18

u/ml

0.09

404

3144

Disorders of the thyroid gland

1297

7081

1.19

7.99

1.1

4.28

5.18

u/ml

1.45

663

3755

Striking against or struck by other objects

566

4389

1.30

7.96

1.1

5.86

6.37

u/ml

0.31

336

2559

Other disorders of urethra and urinary system

924

5250

1.23

7.92

1.1

4.57

5.02

u/ml

0.41

464

2721

Other and unspecified rosacea

131

770

1.72

7.89

1.1

4.31

4.57

u/ml

0.07

385

Infections with a predominantly sexual mode of transmission, including avohilmo

812

6020

1.24

7.88

1.1

5.45

6.30

u/ml

0.84

441

3311

Urinary track infection

1021

4202

1.22

7.87

1.1

4.16

5.03

u/ml

0.99

529

2218

Other and unspecified vaccines and biological substances

3.99

7.83

1.2

1.1

2.37

4.50

u/ml

0.42

Malignant neoplasm of digestive organs

127

1626

0.59

7.80

1.1

5.10

3.12

u/ml

0.57

784

Ovarian cyst

538

2355

1.31

7.78

1.1

4.65

5.58

u/ml

0.77

280

1261

Heart failure, not strict

431

3849

0.75

7.78

1.0

1.1

4.19

3.81

u/ml

0.18

215

1973

Other diseases of the respiratory system

151

923

1.65

7.76

1.1

4.96

3.97

u/ml

0.25

499

Other respiratory disorders and diseases

151

923

1.65

7.76

1.1

4.96

3.97

u/ml

0.25

499

Factors influencing health status and contact with health services

388

1413

1.39

7.74

1.1

5.97

5.86

u/ml

0.04

229

678

Other and unspecified nerve root and plexus disorders, also in other diseases

263

1824

1.45

7.65

1.1

3.72

4.51

u/ml

0.46

124

945

Other disorders of breast

206

1363

1.53

7.63

1.1

4.10

4.54

u/ml

0.18

121

712

Diseases of oral cavity, salivary glands and jaws

624

2507

1.29

7.62

1.1

4.24

5.02

u/ml

0.62

343

1267

482

5446

0.77

7.57

1.1

4.15

5.41

u/ml

1.13

266

2918

Substance abuse

479

5780

0.77

7.56

1.1

4.82

5.54

u/ml

0.46

278

3099

Disorders of tooth development and eruption

279

1588

1.44

7.55

1.1

5.45

5.84

u/ml

0.15

164

870

Hypothyroidism, other/unspecified

1212

6704

1.19

7.55

1.1

4.48

5.14

u/ml

0.82

623

3545

Malignant neoplasm of breast, ER-positive, including Hilmo

180

2052

0.65

7.55

1.1

2.29

2.45

u/ml

0.10

940

Tinnitus

258

1787

1.45

7.55

1.1

5.43

4.58

u/ml

0.30

124

912

Oesophagitis

276

2.21

7.50

1.2

1.1

4.08

4.27

u/ml

0.04

146

Type 2 diabetes

986

6872

0.83

7.45

1.1

4.50

4.61

u/ml

0.09

501

3590

Other (not insulin) diabetes medications

908

6464

0.82

7.43

1.1

3.95

4.38

u/ml

0.42

458

3340

Benign neoplasm of other and ill-defined parts of digestive system

159

997

1.61

7.42

1.1

2.31

3.85

u/ml

1.20

497

Other bacterial diseases, including avohilmo

1080

8038

0.84

7.41

1.1

4.94

5.02

u/ml

0.06

625

4302

COPD related to multimorbidity

217

1225

1.50

7.39

1.1

2.65

3.21

u/ml

0.28

114

572

Other diseases of intestine

134

806

1.67

7.37

1.1

3.84

3.21

u/ml

0.26

401

Alcohol use disorder, ICD-based

266

3755

0.70

7.37

1.1

4.37

5.22

u/ml

0.41

148

2023

Malignant neoplasm of breast, HER-positive

180

2042

0.65

7.35

1.1

2.29

2.44

u/ml

0.09

931

GASTRO-related operations

1397

5964

1.18

7.33

1.1

5.69

5.89

u/ml

0.16

787

3295

Any gastric operation

1397

5964

1.18

7.33

1.1

5.69

5.89

u/ml

0.16

787

3295

Nonorganic sleeping disorders, excluding more controls

359

2650

1.37

7.30

1.1

6.35

5.69

u/ml

0.28

204

1429

Hypertrophy of breast

263

1843

1.44

7.30

1.1

3.77

4.29

u/ml

0.22

127

910

All influenza

336

2453

1.38

7.28

1.1

5.28

5.57

u/ml

0.08

198

1388

Noninfective enteritis and colitis

658

5259

1.26

7.24

1.1

5.81

5.55

u/ml

0.13

359

2935

Adenomyosis (Endometriosis of uterus)

154

964

1.61

7.22

1.1

3.12

4.82

u/ml

1.11

486

Other symptoms and signs involving the circulatory and respiratory systems

417

1.94

7.16

1.1

5.13

5.57

u/ml

0.08

228

Mental and behavioural disorders due to psychoactive substance use

504

5910

0.78

7.12

1.1

4.73

5.56

u/ml

0.58

289

3175

Noninflammatory disorders of female genital tract

677

2702

1.26

7.12

1.1

6.17

6.27

u/ml

0.05

361

1493

Disorders of thyroid, IBD co-morbidities

283

1368

1.43

7.08

1.1

3.87

5.57

u/ml

1.51

157

757

Cerebrovascular diseases

383

3536

0.75

7.08

1.1

3.53

3.75

u/ml

0.11

174

1764

Otitis externa

327

2393

1.38

7.03

1.1

6.72

5.64

u/ml

0.45

185

1325

3.91

7.01

1.1

1.0

0.44

5.09

u/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1247

6941

1.18

6.95

1.1

4.42

5.04

u/ml

0.75

633

3669

Anomalies of dental arch relationship, including avohilmo

412

2827

1.33

6.93

1.1

6.40

6.58

u/ml

0.07

236

1666

Obesity, other/unspecified

523

4099

1.28

6.92

1.1

3.24

5.11

u/ml

4.13

310

2141

Fissure and fistula of anal and rectal regions

287

2063

1.40

6.87

1.1

4.06

4.86

u/ml

0.37

136

1096

Continuous positive airway pressure

229

1311

1.47

6.86

1.1

3.38

3.96

u/ml

0.36

121

771

Other disorders of eye and adnexa

220

1511

1.47

6.83

1.1

3.40

5.59

u/ml

2.25

118

840

450

5188

0.77

6.81

1.1

4.34

5.33

u/ml

0.76

253

2791

Malaise and fatigue

626

3938

1.26

6.77

1.1

3.73

5.35

u/ml

3.14

344

2121

Disorders of breast

714

5106

1.24

6.76

1.1

4.01

4.25

u/ml

0.18

378

2537

Periodontitis

927

7073

0.83

6.73

1.1

3.91

4.71

u/ml

1.07

505

3637

Type 2 diabetes, strict (exclude DM1)

902

6305

0.83

6.72

1.1

4.25

4.39

u/ml

0.11

450

3258

Chronic periodontitis, including avohilmo

925

7064

0.83

6.70

1.1

3.91

4.71

u/ml

1.04

504

3629

Immunodeficiencies

451

1.88

6.65

1.1

5.04

5.45

u/ml

0.09

270

Alcohol use disorder, Swedish definition

395

4694

0.76

6.61

1.1

4.30

5.06

u/ml

0.48

220

2494

Occupational exposure to risk-factors

188

2.39

6.61

1.1

7.85

5.17

u/ml

0.43

Insulin, combination of fast acting with intermediate-acting or long-acting

431

5053

0.77

6.60

1.1

5.68

5.02

u/ml

0.35

229

2788

Herpesviral [herpes simplex] infections

166

1084

1.55

6.60

1.1

7.83

4.85

u/ml

1.20

106

586

Any dementia

744

0.48

6.57

1.0

4.02

2.46

u/ml

0.31

355

Other disorders of eyelid

328

2285

1.36

6.57

1.1

4.46

3.36

u/ml

0.60

150

1081

Unspecified acute lower respiratory infection

202

1377

1.48

6.52

1.2

1.1

5.07

6.10

u/ml

0.41

126

754

Type 2 diabetes, definitions combined

903

6292

0.83

6.51

1.1

4.24

4.39

u/ml

0.12

451

3254

Mental and behavioural disorders due to alcohol

391

4861

0.76

6.50

1.1

4.11

5.29

u/ml

0.91

219

2611

Vasomotor rhinitis (mode)

497

1.81

6.48

1.1

4.65

4.32

u/ml

0.07

270

Xerosis cutis

3.37

6.46

1.0

7.87

5.47

u/ml

0.21

Ocular pain

138

870

1.61

6.44

1.1

2.88

5.46

u/ml

2.22

487

Dementia, including avohilmo

996

0.56

6.39

1.0

1.1

2.68

2.37

u/ml

0.09

479

Other specified disorders of external ear

154

2.51

6.38

1.0

1.1

4.93

5.70

u/ml

0.10

Hypothyroidism, strict autoimmune

1031

5706

1.19

6.37

1.1

4.46

5.00

u/ml

0.56

512

3026

Viral and other specified intestinal infections, including avohilmo

582

4494

1.25

6.36

1.1

6.25

6.96

u/ml

0.34

355

2646

Falls/tendency to fall

1675

7327

1.15

6.31

1.1

5.33

5.45

u/ml

0.10

935

3936

Otalgia

143

915

1.58

6.27

1.2

1.1

3.76

5.52

u/ml

0.91

548

Congenital malformations, deformations and chromosomal abnormalities

1001

8030

1.19

6.27

1.1

5.63

5.75

u/ml

0.08

557

4443

Spondylolisthesis/Spondylolysis

187

1265

1.49

6.27

1.1

4.66

4.22

u/ml

0.13

629

Other reaction to severe stress, and adjustment disorders

633

5131

1.24

6.27

1.1

4.78

5.57

u/ml

0.71

373

2714

Care involving use of rehabilitation procedures

808

6027

1.21

6.25

1.1

3.10

4.56

u/ml

3.29

454

3137

Other enthesopathy of foot (+metatarsalgia)

138

878

1.59

6.18

1.1

3.45

4.89

u/ml

0.65

447

Acute tubulo-interstitial nephritis

521

5511

0.79

6.18

1.1

3.30

5.16

u/ml

3.70

281

2916

Any dementia, excluding more controls

710

0.49

6.11

1.0

4.02

2.40

u/ml

0.33

334

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

861

5588

1.20

6.08

1.1

4.78

4.50

u/ml

0.24

412

2848

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1124

8289

0.85

6.08

1.1

4.75

5.20

u/ml

0.45

596

4487

Extrapyramidal and movement disorders

334

2510

1.34

6.06

1.1

4.70

4.41

u/ml

0.12

156

1294

Other immunodeficiencies

112

2.81

6.06

1.2

1.1

2.84

4.17

u/ml

0.28

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

723

5891

1.22

6.05

1.1

5.37

6.18

u/ml

0.73

426

3284

Certain disorders involving the immune mechanism

231

1639

1.42

6.05

1.1

4.25

4.84

u/ml

0.28

137

875

Other degenerative diseases of the nervous system

109

1292

0.61

6.04

1.1

3.77

4.64

u/ml

0.30

657

COPD, hospital admission 2, with asthma infections

183

1064

1.49

6.03

1.1

3.61

3.77

u/ml

0.04

105

520

Benign neoplasm of colon, rectum, anus and anal canal

492

3282

1.27

6.02

1.1

2.74

3.44

u/ml

0.89

243

1567

Infections of the skin and subcutaneous tissue

858

7080

1.20

6.00

1.1

5.64

5.49

u/ml

0.09

502

3929

Exposure to other and unspecified forces of nature

3.60

6.00

1.2

1.1

4.87

5.72

u/ml

0.12

Spondylosis

497

3067

1.27

5.99

1.1

2.78

3.68

u/ml

0.94

236

1497

Certain infectious and parasitic diseases

1490

6491

1.15

5.98

1.1

5.37

5.59

u/ml

0.20

834

3477

Pulmonary eosinophilia, not elsewhere classified

3.79

5.98

1.2

1.0

0.54

2.10

u/ml

—

Blepharochalasis

199

1376

1.45

5.96

1.1

4.08

2.52

u/ml

0.67

627

Olecranon bursitis

296

2.02

5.96

1.0

1.1

6.60

4.79

u/ml

0.27

151

ILD, hospital admissions 3, with pneumonia sepsis

262

2.08

5.94

1.1

4.26

3.24

u/ml

0.20

125

Epiphora

101

2.83

5.94

1.0

4.91

3.66

u/ml

0.13

Endometriosis of pelvic peritoneum

247

1615

1.40

5.93

1.1

4.74

5.22

u/ml

0.20

114

850

Type 2 diabetes, wide definition

561

4390

0.80

5.92

1.1

4.03

3.99

u/ml

0.02

278

2206

Degenerative diseases of the nervous system

686

0.48

5.91

1.0

1.1

2.01

2.44

u/ml

0.12

323

Other arthrosis

543

2905

1.26

5.85

1.1

2.52

4.01

u/ml

2.58

275

1427

Unspecific neurodegenerative disorder

733

0.51

5.83

1.0

1.1

1.92

1.94

u/ml

0.00

358

Stroke, including SAH

274

2664

0.74

5.83

1.0

1.1

3.05

3.44

u/ml

0.22

120

1359

Unspecified chronic bronchitis

3.03

5.81

1.1

1.0

5.84

4.10

u/ml

—

Other gastritis (incl. Duodenitis)

183

1253

1.47

5.79

1.2

1.1

2.51

4.40

u/ml

1.87

623

Pain, not elsewhere classified

383

2958

1.30

5.77

1.1

4.75

5.59

u/ml

0.47

211

1606

Haemorrhoids and perianal venous thrombosis

318

2377

1.33

5.72

1.1

4.01

4.40

u/ml

0.18

151

1224

Erosion of teeth , including avohilmo

462

3663

1.27

5.69

1.1

5.25

5.96

u/ml

0.42

272

2046

Obsessive-compulsive disorder

170

1157

1.49

5.68

1.1

4.09

6.77

u/ml

2.04

108

675

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

617

5031

1.23

5.67

1.1

4.45

4.48

u/ml

0.02

339

2562

Endometriosis

480

2201

1.27

5.67

1.1

4.52

5.32

u/ml

0.60

242

1159

Acute and transient psychotic disorders

1178

0.55

5.66

1.0

1.1

5.45

5.54

u/ml

0.01

620

Type 2 diabetes, definitions combined, including avohilmo

935

6363

0.85

5.59

1.1

4.29

4.46

u/ml

0.14

472

3292

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

398

1.85

5.55

1.1

6.33

5.40

u/ml

0.14

239

Menorrhagia

448

1958

1.28

5.53

1.1

3.50

5.14

u/ml

1.93

219

1040

Injuries to the neck

354

2724

1.31

5.53

1.1

6.60

5.98

u/ml

0.28

207

1501

Complications of medical and surgical care

867

6584

1.19

5.51

1.1

4.52

4.46

u/ml

0.03

465

3379

Appendicitis, broad definition

1015

7799

1.17

5.50

1.1

4.66

5.01

u/ml

0.31

525

4092

Substance abuse, excluding more controls

479

4991

0.80

5.48

1.1

4.82

5.40

u/ml

0.35

278

2632

Embedded and impacted teeth

647

4338

1.22

5.35

1.1

7.03

7.26

u/ml

0.10

389

2532

Diseases of appendix

1018

7814

1.17

5.35

1.1

4.66

5.01

u/ml

0.31

526

4100

Endocrine, nutritional and metabolic diseases

1413

6237

1.15

5.34

1.1

5.42

5.99

u/ml

0.65

787

3477

Injury of muscle and tendon at shoulder and upper arm level

303

2292

1.33

5.33

1.1

2.53

3.83

u/ml

1.82

141

1173

Cholinergic urticaria

4.89

5.31

1.1

1.0

3.98

6.30

u/ml

—

Stroke, excluding SAH

244

2391

0.73

5.31

1.0

1.1

3.02

3.15

u/ml

0.06

110

1206

Candidiasis

189

1328

1.44

5.30

1.1

3.68

5.28

u/ml

0.82

106

715

Dental operations

640

2694

1.23

5.30

1.1

4.16

4.56

u/ml

0.26

336

1369

Other complications of surgical and medical care, not elsewhere classified

127

824

1.56

5.29

1.2

1.1

4.29

5.09

u/ml

0.26

432

Other disorders of white blood cells

324

1.91

5.28

1.2

1.1

2.51

5.17

u/ml

1.26

175

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

969

0.52

5.28

1.1

6.39

6.81

u/ml

0.06

539

Peripheral artery disease

106

1323

0.63

5.27

1.0

1.1

3.87

3.02

u/ml

0.20

643

Other diseases of anus and rectum

282

2107

1.34

5.26

1.1

4.46

4.66

u/ml

0.09

138

1115

Other infestations, including avohilmo

2.81

5.25

1.1

4.53

3.52

u/ml

0.14

Other septicaemia, including avohilmo

196

2569

0.71

5.23

1.1

6.28

5.02

u/ml

0.39

118

1399

Mental retardation, wide definition

768

0.47

5.22

1.2

1.67

5.61

u/ml

2.30

545

Metatarsalgia

123

795

1.56

5.22

1.1

3.30

4.89

u/ml

0.65

405

Other systemic involvement of connective tissue

271

2025

1.35

5.21

1.1

4.79

4.48

u/ml

0.11

147

1045

Immunodeficiency with predominantly antibody defects

244

2.06

5.17

1.1

5.90

5.75

u/ml

0.02

148

COPD-related respiratory insufficiency

333

1.87

5.16

1.0

1.1

1.09

3.73

u/ml

3.02

157

Any operation in hilmo

211

1.84

5.11

1.1

9.65

9.09

u/ml

0.07

109

Cervical polyps

103

642

1.62

5.10

1.0

1.1

2.55

4.22

u/ml

1.11

306

Crossbite

207

1374

1.41

5.10

1.1

1.2

6.76

6.83

u/ml

0.02

145

907

Impacted teeth

514

3585

1.24

5.08

1.1

7.16

7.66

u/ml

0.19

308

2117

Covid-19 confirmed case

395

3112

1.27

5.07

1.1

4.37

5.17

u/ml

0.57

230

1692

Acute appendicitis, no complications

810

6830

1.18

5.07

1.1

4.57

5.07

u/ml

0.46

418

3619

Recurrent aphthous stomatitis , including avohilmo

202

1449

1.41

5.06

1.1

4.39

5.56

u/ml

0.61

111

828

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

750

3966

1.20

5.06

1.1

5.28

5.54

u/ml

0.18

431

2094

Other disorders of adrenal gland

440

1.76

5.03

1.1

3.78

5.88

u/ml

0.79

268

Acute appendicitis

961

7667

1.17

5.02

1.1

4.68

5.01

u/ml

0.27

498

4018

Implicit viral Sepsis, including avohilmo

317

2431

1.31

5.00

1.1

4.00

4.99

u/ml

0.72

184

1304

Condition for Implicit Sepsis (Organ dysfunction codes)

806

6573

0.85

5.00

1.1

4.57

4.96

u/ml

0.34

448

3499

Postmenopausal atrophic vaginitis

210

813

1.41

5.00

1.1

2.21

2.78

u/ml

0.37

360

Inflammatory disease of uterus

236

1742

1.37

4.99

1.1

3.34

5.11

u/ml

2.13

133

909

Liquid cancers

124

1764

0.66

4.99

1.1

5.03

4.17

u/ml

0.20

911

Pleural plaque

141

2.35

4.98

1.0

1.1

1.37

2.15

u/ml

—

Deforming dorsopathies

341

2649

1.29

4.97

1.1

6.37

5.40

u/ml

0.38

180

1415

Mental retardation

752

0.48

4.96

1.2

1.67

5.68

u/ml

2.36

537

Dementia

894

0.59

4.95

1.0

1.1

2.76

2.22

u/ml

0.15

432

Septicaemia

232

2850

0.74

4.94

1.1

5.94

5.01

u/ml

0.32

141

1551

Other functional intestinal disorders

542

4031

1.23

4.93

1.1

4.12

5.24

u/ml

0.63

289

2230

Hypermobility syndrome

115

745

1.57

4.93

1.1

5.31

5.47

u/ml

0.03

400

Other septicaemia

191

2497

0.72

4.91

1.1

6.43

5.04

u/ml

0.44

115

1356

Nonsuppurative otitis media

483

3396

1.24

4.89

1.1

7.50

7.22

u/ml

0.11

311

1998

Diseases of salivary glands

398

3160

1.27

4.89

1.2

1.1

3.62

4.99

u/ml

1.46

209

1665

Other and unspecified polyneuropathies, also in other diseases

133

887

1.51

4.88

1.1

4.58

3.99

u/ml

0.19

441

Nonorganic sleeping disorders

359

2819

1.28

4.87

1.1

6.35

5.65

u/ml

0.31

204

1536

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

908

0.53

4.85

1.0

1.1

4.26

2.97

u/ml

0.18

423

Appendectomy

927

7590

1.17

4.85

1.1

4.70

5.08

u/ml

0.32

498

3967

Obesity due to excess calories

702

5911

1.19

4.85

1.1

3.75

5.09

u/ml

2.16

378

3101

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

202

1441

1.40

4.83

1.2

1.1

5.41

5.93

u/ml

0.18

123

934

Disorders of sclera, cornea, iris and ciliary body

685

5755

1.19

4.83

1.1

6.26

4.99

u/ml

1.08

377

3067

Schizoaffective disorder

836

0.51

4.81

1.1

1.41

5.80

u/ml

6.36

457

Other systemic involvement of connective tissue (FG)

268

1988

1.33

4.79

1.1

4.72

4.54

u/ml

0.06

144

993

Other and unspecified disorders of vitreous body

317

2396

1.30

4.78

1.0

1.1

1.77

2.99

u/ml

2.21

146

1093

Other/unspecified soft tissue disorders related to use, overuse and pressure

224

2.05

4.75

1.1

1.0

6.24

6.21

u/ml

0.00

121

Dialysis, with operation codes

861

0.52

4.75

1.1

5.24

4.55

u/ml

0.12

489

All influenza (not pneumonia)

209

1526

1.38

4.74

1.2

1.1

6.39

6.02

u/ml

0.07

118

872

Other obstetric conditions, not elsewhere classified

756

4035

1.19

4.72

1.1

5.21

5.54

u/ml

0.25

434

2120

Other shoulder lesions

128

855

1.51

4.71

1.1

3.02

5.41

u/ml

1.75

435

Other otitis externa (chronic)

563

1.64

4.70

1.0

1.1

7.74

5.29

u/ml

0.47

320

Impingement syndrome of shoulder

201

1459

1.38

4.69

1.0

1.1

1.56

3.49

u/ml

2.65

701

Benign neoplasm: Liver

192

2.13

4.67

1.1

1.57

4.58

u/ml

1.70

Other spirochaetal diseases, including avohilmo

379

3009

1.27

4.67

1.1

4.02

4.77

u/ml

0.60

207

1577

Insulin, intermediate and long-acting

384

4635

0.80

4.66

1.0

1.1

6.13

5.01

u/ml

0.61

206

2563

Disorders of choroid and retina

557

4708

0.83

4.64

1.1

4.77

4.24

u/ml

0.23

288

2385

Benign neoplasm: Choroid

310

1.86

4.63

1.1

5.69

3.60

u/ml

0.43

151

Alzheimer disease, including avohilmo

577

0.51

4.60

1.0

2.38

1.52

u/ml

0.22

268

Erysipelas, including avohilmo

566

5047

0.83

4.59

1.1

5.13

4.40

u/ml

0.52

313

2578

Other/unspecified enthesopathies of lower limb, excluding foot

101

645

1.58

4.58

1.1

3.55

4.85

u/ml

0.63

334

malignant neoplasm of male genital organs

810

0.61

4.58

1.0

1.1

5.18

3.60

u/ml

0.26

404

Infections with a predominantly sexual mode of transmission

549

4540

1.21

4.56

1.1

4.72

5.61

u/ml

0.78

290

2464

Unspecified/other endometriosis

176

1233

1.41

4.55

1.1

5.66

5.68

u/ml

0.01

102

677

Selective deficiency of immunoglobulin G [IgG] subclasses

3.42

4.55

1.1

10.35

2.76

u/ml

—

Defects in the complement system

2.84

4.54

1.2

1.1

3.87

5.01

u/ml

0.16

Keratitis

447

3629

1.24

4.53

1.1

6.72

5.18

u/ml

1.00

247

1945

Benign neoplasm: Liver/bile ducts

215

2.04

4.52

1.1

1.44

4.41

u/ml

2.00

113

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

250

1.96

4.50

1.1

5.37

4.85

u/ml

0.09

130

Concussion

785

5194

1.18

4.48

1.1

5.39

6.20

u/ml

0.56

454

2910

Benign neoplasm: Sigmoid colon

124

831

1.50

4.48

1.1

2.14

3.29

u/ml

0.84

399

Gluteal tendinitis

271

1.91

4.47

1.1

3.08

4.08

u/ml

0.26

128

Drug-induced adrenocortical insufficiency

143

2.30

4.47

1.1

1.0

0.24

6.19

u/ml

3.41

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

413

3339

1.25

4.42

1.1

5.56

6.19

u/ml

0.37

227

1861

Other sleep disorders

137

941

1.47

4.41

1.1

4.17

5.55

u/ml

0.55

504

Viral pneumonia

150

1048

1.44

4.41

1.1

5.34

5.48

u/ml

0.04

102

574

Other spirochaetal diseases

370

2953

1.26

4.39

1.1

3.87

4.69

u/ml

0.69

201

1547

Hypothyroidism (congenital or acquired)

529

2436

1.22

4.39

1.1

5.71

6.31

u/ml

0.33

293

1402

Other bacterial intestinal infections, including avohilmo

249

1890

1.32

4.38

1.1

3.08

5.47

u/ml

3.07

136

1004

Polyuria

183

1325

1.39

4.37

1.1

4.40

4.29

u/ml

0.03

101

684

Benign neoplasm: Duodenum

2.69

4.34

1.4

1.0

0.84

3.75

u/ml

1.22

Benign neoplasm: Small intestine

138

2.27

4.33

1.3

1.0

0.84

3.33

u/ml

1.63

Hypothyroidism, levothyroxine purchases

524

2417

1.22

4.33

1.1

5.69

6.36

u/ml

0.37

291

1388

Hypothyroidism and >3 levothyroxin purchases

524

2417

1.22

4.33

1.1

5.69

6.36

u/ml

0.37

291

1388

Transplanted organ and tissue status

922

0.56

4.31

1.1

4.26

5.24

u/ml

0.21

550

Dysplasia of cervi uteri

363

2029

1.27

4.29

1.1

5.60

5.30

u/ml

0.13

183

1068

Benign neoplasm: Ascending colon

561

1.60

4.26

1.1

2.87

3.53

u/ml

0.24

270

Explicit Sepsis, including avohilmo

293

3385

0.78

4.20

1.1

5.57

5.08

u/ml

0.18

172

1833

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

650

5398

1.18

4.20

1.1

4.55

4.52

u/ml

0.02

357

2767

Mycoses

324

2563

1.27

4.18

1.1

4.06

5.35

u/ml

0.93

177

1382

Complications of procedures, not elsewhere classified

1005

7078

1.15

4.17

1.1

4.37

4.60

u/ml

0.20

530

3666

Lateral epicondylitis

155

1102

1.42

4.17

1.2

1.1

4.19

4.28

u/ml

0.03

544

Viral infections characterized by skin and mucous membrane lesions

546

4559

1.20

4.16

1.1

6.07

5.17

u/ml

0.59

311

2533

Primary hyperparathyroidism

510

1.62

4.16

1.1

1.0

1.04

3.12

u/ml

3.33

256

Deep bite

255

1720

1.32

4.15

1.1

6.36

6.99

u/ml

0.23

156

1091

Explicit Sepsis

283

3292

0.78

4.14

1.1

5.70

5.06

u/ml

0.24

167

1787

Polyneuropathies and other disorders of the peripheral nervous system

162

1161

1.40

4.14

1.1

4.39

3.74

u/ml

0.25

592

Endometriosis of ovary

212

1493

1.35

4.13

1.1

4.61

4.98

u/ml

0.12

774

Chondrocostal junction syndrome [Tietze]

279

1.86

4.13

1.2

1.1

2.48

4.97

u/ml

0.99

147

Disorders of ocular muscles, binocular movement, accommodation and refraction

752

6404

1.17

4.13

1.1

4.71

5.79

u/ml

1.21

422

3538

Psoas tendinitis

3.49

4.12

1.0

9.72

6.52

u/ml

—

Ischaemic Stroke, excluding all haemorrhages

220

2140

0.75

4.10

1.0

1.1

2.66

3.16

u/ml

0.27

101

1074

Complications predominantly related to the puerperium

417

3404

1.23

4.10

1.1

4.86

4.90

u/ml

0.02

219

1760

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

354

1.76

4.09

1.1

1.99

5.93

u/ml

3.31

214

Nausea and vomiting

329

2549

1.26

4.08

1.2

1.1

4.49

5.60

u/ml

0.86

195

1458

Pain associated with micturition

137

957

1.44

4.07

1.1

7.00

5.31

u/ml

0.30

525

Radiculopathy

130

899

1.45

4.06

1.2

1.1

2.67

3.96

u/ml

0.84

433

Abnormal findings in secretions and smears from cervix uteri vagina vulva

808

5130

1.16

4.05

1.1

4.73

4.56

u/ml

0.12

395

2611

Other specified/unspecified soft tissue disorders

238

1.91

4.03

1.1

1.0

5.70

4.74

u/ml

0.14

118

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

479

0.41

4.02

1.3

1.1

3.91

4.49

u/ml

0.06

266

Lyme disease, including avohilmo

361

2907

1.25

4.00

1.1

3.64

4.58

u/ml

0.89

198

1512

Lyme disease

361

2907

1.25

4.00

1.1

3.64

4.58

u/ml

0.89

198

1512

Alzheimer disease

492

0.51

3.98

1.0

3.12

1.53

u/ml

0.33

224

Colonic or urogenital fistula

291

2287

1.28

3.98

1.1

4.02

4.89

u/ml

0.43

139

1207

Stomatitis and related lesions

277

2165

1.29

3.98

1.1

5.91

5.70

u/ml

0.07

153

1207

Other predominantly sexually transmitted diseases, not elsewhere classified

313

2486

1.27

3.97

1.1

5.00

5.88

u/ml

0.49

171

1384

Myotonic disorders

2.99

3.96

1.2

1.0

8.07

5.07

u/ml

—

STROKE

405

3337

0.81

3.95

1.0

1.1

2.87

3.81

u/ml

0.99

196

1695

Sequelae of other external causes

410

1.68

3.94

1.1

4.94

4.35

u/ml

0.10

220

Acute renal failure

1038

0.60

3.93

1.0

1.1

5.21

3.95

u/ml

0.24

541

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

835

0.56

3.93

1.1

2.82

3.49

u/ml

0.18

421

malignant neoplasm of male genital organs, including Hilmo

843

0.65

3.93

1.0

1.1

4.82

3.91

u/ml

0.15

423

Diseases of tongue

350

1.73

3.91

1.1

1.0

5.06

4.69

u/ml

0.06

169

Spirochaetal infections, other/unspecified, including avohilmo

363

2934

1.24

3.90

1.1

3.64

4.64

u/ml

0.98

198

1529

Fibroblastic disorders

174

1276

1.37

3.89

1.1

2.26

3.81

u/ml

2.02

624

Dipeptidyl peptidase 4 (DPP-4) inhibitors

250

2525

0.77

3.89

1.1

2.63

3.30

u/ml

0.41

110

1259

Ulcer of vagina/vulva

293

1.81

3.88

1.1

11.86

4.07

u/ml

1.24

162

Meniscus derangement

573

3197

1.19

3.88

1.1

3.12

4.36

u/ml

2.11

286

1597

Other maternal disorders predominantly related to pregnancy

897

4890

1.15

3.86

1.1

4.39

4.92

u/ml

0.53

428

2506

Diseases of male genital organs

578

2441

1.20

3.86

1.1

5.15

6.44

u/ml

1.05

341

1483

Systemic connective tissue disorders

334

2679

1.25

3.85

1.1

4.53

4.44

u/ml

0.03

184

1381

Single spontaneous delivery

393

2546

0.81

3.84

1.1

5.01

5.74

u/ml

0.44

216

1356

Mental retardation, excluding more controls

657

0.52

3.84

1.2

1.75

5.45

u/ml

1.96

453

Nontoxic goitre/thyroid nodule

242

1867

1.30

3.83

1.1

3.27

3.74

u/ml

0.19

124

920

Persons encountering health services in circumstances related to reproduction

920

5390

1.15

3.82

1.1

5.59

5.68

u/ml

0.06

525

2992

Diseases of arteries, arterioles and capillaries

346

3142

0.81

3.82

1.1

4.29

3.83

u/ml

0.21

167

1607

N06DA Anticholinesterases

592

0.55

3.81

1.0

1.1

2.58

1.69

u/ml

0.21

274

Use of anticholinesterases

592

0.55

3.81

1.0

1.1

2.58

1.69

u/ml

0.21

274

Vulvovaginal ulceration/inflammation in other diseases

130

915

1.44

3.79

1.1

6.89

5.70

u/ml

0.29

501

Alcohol withdrawal state with delirium

365

0.35

3.76

1.1

1.62

4.62

u/ml

—

181

Primary_lymphoid and hematopoietic malignant neoplasms

1330

0.66

3.76

1.1

7.46

4.19

u/ml

0.63

721

Other viral diseases

508

4250

1.20

3.76

1.1

6.62

6.09

u/ml

0.21

278

2473

Substance use, excluding alcohol

178

2378

0.74

3.75

1.1

6.01

6.33

u/ml

0.09

106

1325

Bruxism

203

1.97

3.74

1.2

1.1

3.58

3.53

u/ml

0.01

103

Carpal tunnel syndrome

668

4960

1.17

3.74

1.1

3.69

3.99

u/ml

0.25

321

2480

Nephropathy related operations

859

0.58

3.73

1.1

5.19

4.59

u/ml

0.12

486

Sulfonylureas

786

0.60

3.72

1.0

1.1

1.70

2.81

u/ml

0.62

379

Other specified/unspecified bacterial intestinal infections

417

1.65

3.71

1.1

2.35

5.38

u/ml

1.87

233

Superficial injury of wrist and hand

350

2838

1.24

3.71

1.1

5.19

6.32

u/ml

0.75

200

1623

Subacute thyroiditis

282

1.80

3.71

1.0

1.1

3.29

3.77

u/ml

0.14

152

Bicipital tendinitis

260

1.83

3.69

1.1

5.86

4.07

u/ml

0.31

125

Sicca syndrome [Sjögren]

567

1.55

3.68

1.1

3.65

3.66

u/ml

0.00

277

Mental and behavioural disorders due to use of other stimulants, including caffeine

429

0.41

3.67

1.1

3.06

6.13

u/ml

1.14

255

Disorders of muscles

121

844

1.44

3.67

1.1

4.13

5.25

u/ml

0.37

440

Otitis media, unspecified

257

1854

1.29

3.67

1.2

1.1

6.50

7.19

u/ml

0.25

169

1138

Other and unspecified acute skin changes due to ultraviolet radiation

2.72

3.67

1.1

1.0

3.77

3.14

u/ml

—

Toxic effect of contact with venomous animals

381

1.68

3.66

1.1

3.82

6.30

u/ml

0.76

216

Premenstrual syndrome

184

2.01

3.65

1.1

5.25

6.70

u/ml

0.25

105

Acute nasopharyngitis (common cold)

152

1096

1.39

3.64

1.1

6.98

5.30

u/ml

0.55

620

Nonalcoholic fatty liver disease

128

904

1.43

3.64

1.1

4.30

4.61

u/ml

0.10

461

Polycystic ovarian syndrome, consortium definition

1114

5666

1.13

3.64

1.1

4.40

5.13

u/ml

0.95

573

2913

ILD-related respiratory insufficiency

2.49

3.64

1.0

1.1

1.40

4.32

u/ml

—

Unspecified event, undetermined intent

234

1.87

3.61

1.3

1.1

7.90

5.39

u/ml

0.39

142

Redundant prepuce, phimosis and paraphimosis

246

1889

1.29

3.60

1.1

6.19

7.09

u/ml

0.35

161

1130

Polyarthropathies

667

4976

0.86

3.60

1.1

4.12

5.25

u/ml

1.22

344

2649

Other and unspecified visual disturbances

115

798

1.45

3.59

1.1

3.61

5.30

u/ml

0.92

423

Persistent delusional disorders

511

0.47

3.59

1.1

1.38

4.25

u/ml

1.79

267

Benign neoplasm: Transverse colon

428

1.62

3.59

1.1

1.0

2.00

3.05

u/ml

0.55

211

Other and specified injuries of hip and thigh

124

2.21

3.57

1.1

1.0

2.39

7.29

u/ml

1.45

Emotional disorders starting during childhood or adolecense, excluding more controls

142

997

1.41

3.56

1.1

5.63

7.92

u/ml

0.98

661

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

544

4566

1.18

3.55

1.1

3.85

5.97

u/ml

4.00

335

2595

Abrasion of teeth

413

3420

1.21

3.55

1.1

3.03

4.48

u/ml

2.33

225

1707

Secondary uncertain malignant neoplasm

642

0.53

3.54

1.1

3.88

3.64

u/ml

0.04

330

Thyroiditis

638

1.50

3.53

1.1

2.86

4.88

u/ml

1.29

346

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

357

2916

1.23

3.53

1.1

4.19

5.64

u/ml

1.39

180

1611

Other local infections of skin and subcutaneous tissue

126

893

1.42

3.52

1.1

5.92

4.61

u/ml

0.40

496

Benign lipomatous neoplasm

268

2120

1.27

3.52

1.0

1.1

2.81

4.45

u/ml

2.65

137

1086

Uterine polyps

294

1362

1.27

3.51

1.1

2.93

4.62

u/ml

1.34

148

676

Chronic kidney disease

108

1489

0.70

3.51

1.1

5.72

4.38

u/ml

0.28

807

malignant neoplasm of female genital organs, including Hilmo

1029

0.64

3.51

1.0

1.1

3.55

2.39

u/ml

0.36

497

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.53

3.51

1.4

1.0

1.51

3.85

u/ml

0.90

Hypothyroidism, strict autoimmune, 3 medication purchases required

1091

6515

1.13

3.50

1.1

4.28

4.87

u/ml

0.68

529

3400

Mental and behavioural disorders due to opioids

503

0.47

3.50

1.1

3.37

6.64

u/ml

1.03

292

Persistent mood disorders

230

1788

1.29

3.50

1.1

4.46

5.41

u/ml

0.51

122

947

Budesonide

171

1276

1.35

3.49

1.1

6.57

5.89

u/ml

0.19

661

Patellar tendinitis

180

1.99

3.49

1.1

6.25

7.28

u/ml

0.10

109

Polyp of the female genital tract

325

1477

1.25

3.48

1.1

3.22

4.74

u/ml

1.25

161

753

Retained placenta and membranes, without haemorrhage

159

1175

1.36

3.48

1.1

3.45

4.12

u/ml

0.28

588

Coronary artery bypass grafting

542

0.56

3.45

1.0

4.35

3.11

u/ml

0.21

250

Implicit fungal Sepsis, including avohilmo

410

1.62

3.44

1.1

5.72

3.83

u/ml

0.36

209

Spinal osteochondrosis

2.57

3.42

1.1

5.25

8.35

u/ml

0.47

Unspecified fall

613

5170

1.17

3.42

1.1

5.34

5.70

u/ml

0.23

368

2876

Open wound of wrist and hand

619

5144

1.17

3.42

1.1

5.49

5.82

u/ml

0.20

331

2855

Other viral hepatitis, including avohilmo

797

0.58

3.41

1.1

3.07

6.18

u/ml

1.43

436

Carcinoma in situ of rectum

3.82

3.41

1.0

1.1

2.13

1.71

u/ml

—

Delirium, not induced by alcohol and other psychoactive substances

390

0.41

3.41

1.0

1.1

4.22

4.10

u/ml

—

186

Diabetic nephropathy, excluding more controls

694

0.60

3.40

1.1

6.68

4.44

u/ml

0.44

343

Benign neoplasm of middle ear and respiratory system

404

1.62

3.39

1.1

3.15

3.92

u/ml

0.25

218

Poor fetal growth

158

2106

0.74

3.37

1.1

5.11

5.40

u/ml

0.07

1145

L04AD Calcineurin inhibitors

1162

0.66

3.36

1.1

7.02

5.25

u/ml

0.46

695

Other and unspecified mental retardation

416

0.44

3.34

1.2

0.83

5.27

u/ml

7.23

327

Flat foot [pes planus] (acquired)

106

736

1.45

3.33

1.1

4.03

4.34

u/ml

0.10

371

Malignant neoplasm of respiratory system and intrathoracic organs

630

0.58

3.33

1.0

1.1

6.93

3.02

u/ml

0.40

299

Injury of muscle and tendon at hip and thigh level

123

878

1.41

3.33

1.2

1.1

4.68

4.88

u/ml

0.06

455

Severe mental retardation

0.00

3.33

0.0

1.2

—

6.33

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

211

1.87

3.32

1.1

3.16

4.04

u/ml

0.22

113

Disorders of refraction and accommodation

470

3952

1.19

3.32

1.1

4.37

5.91

u/ml

1.49

264

2242

Ehlers-Danlos syndrome, including avohilmo

170

2.01

3.32

1.1

8.34

4.83

u/ml

0.42

Antihypertensive medication - note that there are other indications

1258

5902

1.12

3.32

1.1

5.64

6.43

u/ml

0.90

691

3385

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

212

1.86

3.28

1.1

3.90

3.89

u/ml

0.00

112

Other skin changes

175

1323

1.33

3.28

1.1

4.39

4.87

u/ml

0.19

696

Faecal incontinence

439

1.58

3.27

1.1

1.0

1.52

2.52

u/ml

0.72

211

Other diseases of peritoneum

256

1.78

3.27

1.0

1.1

3.66

4.29

u/ml

0.10

129

Cholecystectomy

727

5383

1.15

3.27

1.1

3.50

3.98

u/ml

0.41

356

2675

Female genital prolapse

276

1218

1.26

3.26

1.1

3.46

4.36

u/ml

0.53

132

600

Adrenocortical insufficiency

294

1.73

3.26

1.1

1.70

6.11

u/ml

2.01

171

Hernia of abdominal wall

430

3606

1.20

3.26

1.1

5.07

4.30

u/ml

0.43

228

1875

Dyshidrosis [pompholyx]

143

2.08

3.26

1.1

7.02

5.00

u/ml

0.36

Disorders of vestibular function (Vertigo)

409

3324

1.20

3.25

1.1

3.94

3.95

u/ml

0.01

204

1637

Malignant neoplasm of brain, including Hilmo

352

0.39

3.24

1.3

1.1

5.11

4.58

u/ml

—

207

Persons encountering health services in other circumstances

562

4772

1.17

3.23

1.1

5.37

6.09

u/ml

0.47

289

2566

Atherosclerosis, excluding cerebral and coronary sclerosis

1079

0.69

3.23

1.1

3.89

2.63

u/ml

0.29

507

Sub-endpoint used in defining T1D endpoints

258

3166

0.80

3.22

1.1

6.04

6.03

u/ml

0.00

150

1841

Rheumatism, unspecified

120

858

1.41

3.21

1.1

1.92

3.65

u/ml

1.85

421

Non-selective monoamine reuptake inhibitors

316

2470

1.23

3.21

1.1

2.78

3.62

u/ml

0.69

179

1166

Benign paroxysmal vertigo

247

1961

1.26

3.19

1.1

3.83

4.16

u/ml

0.17

121

975

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

770

0.63

3.18

1.0

1.1

5.80

2.93

u/ml

0.40

370

Pre-eclampsia or poor fetal growth

374

4464

0.83

3.18

1.1

3.64

4.89

u/ml

1.07

191

2305

Examination and encounter for administrative purposes

372

1.62

3.18

1.1

2.76

5.47

u/ml

1.02

165

Disorders of orbit

319

1.68

3.17

1.1

1.43

4.28

u/ml

3.41

173

Presence of other functional implants

299

2519

0.81

3.16

1.1

4.41

3.48

u/ml

0.48

122

1251

Post-traumatic stress disorder

180

1378

1.32

3.16

1.2

1.1

4.09

6.26

u/ml

1.11

773

ILD medications: immunosuppressive drugs

768

6109

1.14

3.15

1.1

5.35

5.26

u/ml

0.05

408

3147

Otitis externa, unspecified

161

1213

1.34

3.14

1.1

5.91

5.68

u/ml

0.06

672

Other disorders starting during childhood or adolecense, excluding more controls

149

1063

1.36

3.11

1.1

1.2

6.08

7.56

u/ml

0.54

709

Presence of cardiac and vascular implants and grafts

152

1489

0.75

3.11

1.1

5.14

3.30

u/ml

0.53

767

Other diseases of stomach and duodenum

290

1.70

3.11

1.2

1.1

3.84

4.45

u/ml

0.12

151

Benign neoplasm: Skin of ear and external auricular canal

152

1.99

3.10

1.0

1.15

3.92

u/ml

1.38

206

1608

1.29

3.10

1.1

6.41

5.84

u/ml

0.18

124

850

Deep bite that required surgery

119

2.16

3.09

1.0

1.1

7.28

4.57

u/ml

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.42

3.09

1.1

1.0

5.20

4.31

u/ml

—

Oxycodone

190

2092

0.77

3.07

1.1

3.21

3.68

u/ml

0.26

100

1031

Contracture of joint

2.63

3.07

1.0

1.1

11.25

7.36

u/ml

—

Melanocytic naevi

409

3439

1.19

3.06

1.1

5.48

5.16

u/ml

0.16

226

1831

Coeliac disease

162

1227

1.33

3.05

1.1

5.98

5.87

u/ml

0.02

695

Other and unspecified local infections of skin and subcutaneous tissue

119

859

1.40

3.05

1.1

6.17

4.72

u/ml

0.43

478

Diagnoses used for exclusion with ILD

200

1557

1.29

3.05

1.1

2.86

4.73

u/ml

1.25

101

809

Use of disulfiram, acamprosate or naltrexone

784

0.61

3.02

1.1

0.86

4.71

u/ml

7.59

412

Erysipelas

357

3694

0.83

3.02

1.1

4.62

4.33

u/ml

0.15

200

1873

Kidney transplant status

490

0.50

3.02

1.2

1.1

5.12

5.92

u/ml

0.09

302

Other noninflammatory disorders of vulva and perineum

127

929

1.38

3.01

1.1

5.29

5.63

u/ml

0.11

494

Benign neoplasms

1476

7313

1.10

3.00

1.1

4.79

5.83

u/ml

1.87

804

4002

Viral hepatitis, including avohilmo

855

0.63

2.99

1.1

2.94

6.24

u/ml

1.70

465

Other disorders of bone

262

2114

1.25

2.99

1.1

5.34

5.66

u/ml

0.12

143

1148

Other viral hepatitis

743

0.60

2.99

1.2

1.1

3.15

6.14

u/ml

1.29

401

Exposure to other and unspecified inanimate mechanical forces

118

855

1.39

2.99

1.2

1.1

3.80

5.32

u/ml

0.84

489

Nerve, nerve root and plexus disorders

1309

7121

1.11

2.98

1.1

4.08

4.72

u/ml

0.92

639

3730

Atypical facial pain

387

1.59

2.98

1.1

1.77

4.17

u/ml

2.02

198

Haemangioma, any site

104

737

1.42

2.98

1.1

2.95

4.85

u/ml

1.01

409

Ehlers-Danlos syndrome

135

2.07

2.98

1.1

1.0

8.55

4.89

u/ml

0.39

Urethritis and urethral syndrome

141

2.02

2.98

1.1

1.0

3.42

8.16

u/ml

1.30

Viral hepatitis

804

0.62

2.97

1.1

3.05

5.99

u/ml

1.32

434

Crushed, pushed or stepped on by crowd or human stampede

148

1114

1.34

2.96

1.1

8.30

6.84

u/ml

0.42

655

Any mental disorder

1462

6664

1.10

2.96

1.1

5.99

5.13

u/ml

1.03

819

3549

Galactorrhea

2.28

2.95

1.0

1.1

5.57

5.11

u/ml

0.05

Valvular heart disease excluding rheumatic fever

276

2423

0.81

2.95

1.1

6.40

4.25

u/ml

0.93

129

1309

Localized swelling, mass and lump of skin and subcutaneous tissue

352

2930

1.21

2.95

1.1

5.89

4.96

u/ml

0.27

180

1560

Haemangioma and lymphangioma, any site

114

823

1.40

2.94

1.1

2.94

5.09

u/ml

1.32

455

Other puerperal infections

166

1272

1.32

2.94

1.1

6.13

5.61

u/ml

0.21

705

Complications associated with artificial fertilization

229

1.79

2.93

1.0

1.1

3.18

6.73

u/ml

1.04

128

Benign neoplasm of eye and adnexa

623

1.45

2.92

1.1

4.09

3.90

u/ml

0.04

322

Benign lipomatous neoplasm of other sites/unspecified

373

1.59

2.92

1.1

3.00

3.36

u/ml

0.12

185

Hyperparathyroidism

112

797

1.39

2.91

1.1

2.16

3.69

u/ml

1.05

387

Dizziness and giddiness

852

5884

1.13

2.91

1.1

4.41

4.53

u/ml

0.08

434

3050

Spirochaetal infections, other/unspecified

583

1.47

2.90

1.1

4.79

4.00

u/ml

0.22

315

Hypertrophy of tongue papillae

2.30

2.90

1.1

1.0

7.36

5.43

u/ml

—

Hypersensitivity pneumonitis due to organic dust

2.47

2.90

1.1

1.0

0.42

6.63

u/ml

—

Urticaria due to cold and heat

2.37

2.90

1.1

10.20

4.83

u/ml

0.58

Pleural plaque without asbestos

2.71

2.89

1.0

1.20

1.47

u/ml

—

Thyroiditis, ILD-related definition

163

1247

1.32

2.89

1.1

2.73

5.42

u/ml

3.01

672

Palmar fascial fibromatosis [Dupuytren]

485

1.51

2.89

1.1

1.0

1.98

3.36

u/ml

1.19

232

Acute generalized exanthematous pustulosis

375

1.59

2.88

1.1

6.50

5.73

u/ml

0.12

217

Disorders of parathyroid gland

136

1000

1.35

2.88

1.1

1.88

3.56

u/ml

1.53

504

Other erythematous conditions

222

1.78

2.87

1.2

1.1

2.45

5.04

u/ml

1.07

108

Autoimmune diseases excluding thyroid diseases, strict definition

1253

7505

0.91

2.85

1.1

6.12

5.48

u/ml

0.52

672

4145

Procedures for purposes other than remedying health state

179

1.87

2.85

1.2

1.1

3.86

3.14

u/ml

0.09

Seborrhoeic keratosis

173

1335

1.30

2.85

1.1

2.63

3.07

u/ml

0.26

634

Acute otitis externa, noninfective

103

2.17

2.83

1.2

1.0

2.14

5.20

u/ml

0.94

Oral lichen planus

123

2.06

2.83

1.0

1.1

5.10

2.06

u/ml

0.38

Idiopathic pulmonary fibrosis

186

1.84

2.83

1.1

5.08

2.89

u/ml

0.25

Gingivitis and periodontal diseases

1289

6040

1.10

2.81

1.1

5.29

5.07

u/ml

0.18

705

3198

Heart failure, strict

217

1893

0.79

2.81

1.0

1.1

4.84

2.74

u/ml

0.81

102

961

Polyarthrosis

140

944

1.34

2.81

1.1

1.0

1.11

3.20

u/ml

3.70

409

Sequelae of external causes of morbidity and mortality

237

1905

1.25

2.81

1.1

4.12

4.81

u/ml

0.34

142

1007

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

991

7434

0.90

2.81

1.1

5.04

5.16

u/ml

0.09

545

3980

Bacterial Sepsis

261

2648

0.81

2.80

1.1

3.99

4.56

u/ml

0.26

140

1404

Superficial injury of hip and thigh

137

1026

1.34

2.80

1.1

7.25

5.31

u/ml

0.48

550

Residual foreign body in soft tissue

466

1.52

2.79

1.1

4.98

5.94

u/ml

0.24

257

Superficial injury of shoulder and upper arm

150

1140

1.32

2.79

1.1

3.55

5.95

u/ml

1.25

618

Implicit Sepsis

645

5412

0.88

2.79

1.1

4.47

4.85

u/ml

0.29

364

2861

Use of biperiden

342

0.43

2.78

1.0

1.1

2.17

5.16

u/ml

—

179

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1071

7986

0.90

2.78

1.1

4.81

4.89

u/ml

0.05

615

4245

Other acute skin changes due to ultraviolet radiation

166

1.89

2.77

1.1

1.0

2.36

3.70

u/ml

0.27

All-cause Heart Failure

213

1860

0.79

2.77

1.0

1.1

4.77

2.77

u/ml

0.75

101

944

Malignant neoplasm of skin, including Hilmo

302

2449

0.82

2.77

1.1

2.98

3.27

u/ml

0.16

154

1159

Autoimmune diseases excluding thyroid diseases

1285

7647

0.91

2.77

1.1

6.01

5.47

u/ml

0.44

695

4221

Achilles tendinitis

105

756

1.40

2.76

1.1

5.24

4.23

u/ml

0.24

371

Deficiency of other B group vitamins

104

2.14

2.76

1.1

1.0

1.12

3.89

u/ml

—

Fall on and from stairs and steps

287

2361

1.22

2.75

1.1

4.50

5.41

u/ml

0.49

168

1264

Tongue abnormality

340

1.60

2.74

1.1

2.59

3.61

u/ml

0.50

175

Testicular hypofunction

294

1.65

2.74

1.0

1.1

3.18

6.60

u/ml

1.73

166

Hard cardiovascular diseases

735

4908

0.88

2.74

1.1

3.72

4.15

u/ml

0.40

348

2605

Generalized skin eruption due to drugs and medicaments

333

1.61

2.74

1.1

6.28

6.14

u/ml

0.02

197

Other mycoses, not elsewhere classified/unspecified, including avohilmo

125

2.04

2.74

1.2

1.1

12.52

6.94

u/ml

0.39

Malignant neoplasm of bronchus and lung

506

0.58

2.73

1.0

1.1

3.31

2.14

u/ml

0.17

235

Mild mental retardation

378

0.47

2.73

1.1

1.2

3.19

6.66

u/ml

—

255

Contraceptive management

633

3873

1.15

2.73

1.1

5.86

5.17

u/ml

0.45

338

2019

Major coronary heart disease event excluding revascularizations

279

2241

0.82

2.71

1.1

2.25

3.12

u/ml

0.94

126

1135

Implicit Sepsis, including avohilmo

785

6298

0.89

2.71

1.1

4.42

4.97

u/ml

0.54

438

3346

Other abnormal products of conception

631

3626

1.15

2.71

1.1

5.00

5.12

u/ml

0.07

312

1894

Delivery

415

2572

0.85

2.69

1.1

5.03

5.80

u/ml

0.47

229

1374

Other/unspecified disorders of vestibular function

212

1.76

2.68

1.1

1.0

4.65

4.28

u/ml

0.07

104

Other deformities of toe(s)

190

1.81

2.68

1.0

1.1

1.67

5.03

u/ml

1.22

Respiratory insufficiency

153

1.90

2.67

1.0

1.08

2.94

u/ml

1.05

Postmenopausal bleeding

173

697

1.30

2.65

1.1

2.06

2.66

u/ml

0.37

304

Early lumbar disc prolapse, operated

170

1326

1.29

2.65

1.1

4.68

5.66

u/ml

0.39

706

L04AA Selective immunosuppressants

180

2279

0.79

2.64

1.0

1.1

4.42

5.45

u/ml

0.54

1237

Biomechanical lesions, not elsewhere classified

289

1.64

2.64

1.2

1.1

1.79

3.87

u/ml

1.19

150

Impetigo

689

1.41

2.64

1.2

1.1

7.23

5.15

u/ml

0.47

433

Other and unspecified trigeminal disorders

2.19

2.63

1.0

1.54

4.38

u/ml

—

Noninfectious colitis NAS

170

1326

1.29

2.63

1.1

4.51

5.65

u/ml

0.45

733

Exclusions for E4_PCOS_BROAD

254

2074

1.23

2.63

1.1

3.64

5.91

u/ml

2.07

123

1228

Suppurative otitis media, unspecified

267

1.67

2.63

1.0

1.1

4.79

7.34

u/ml

0.43

166

Injury of muscle and tendon at lower leg level

157

1212

1.30

2.62

1.1

3.52

5.26

u/ml

1.03

640

Cerebrovascular diseases (FINNGEN)

261

2230

0.82

2.62

1.1

3.24

4.27

u/ml

0.62

124

1139

Pericarditis

184

1.81

2.62

1.2

1.1

3.99

6.27

u/ml

0.47

101

Zoster [herpes zoster], including avohilmo

478

3981

1.16

2.62

1.1

5.09

4.32

u/ml

0.45

250

2006

False labour

611

3321

1.15

2.61

1.1

4.97

5.21

u/ml

0.15

332

1738

Other disorders of conjunctiva

688

1.40

2.61

1.0

1.1

5.73

3.11

u/ml

0.76

322

Chalazion

134

1014

1.33

2.60

1.1

3.99

5.08

u/ml

0.58

547

Lichen ruber planus, wide definition including periferal and oral lichen planus

193

1531

1.27

2.60

1.0

1.1

4.11

3.84

u/ml

0.09

105

755

Benign neoplasm: Stomach

433

1.51

2.59

1.1

3.40

3.18

u/ml

0.05

212

Postpartum care and examination

221

1716

0.80

2.59

1.1

4.53

5.53

u/ml

0.57

118

908

Sexual dysfunction

142

1.93

2.58

1.1

3.86

6.17

u/ml

0.39

Chondropathies

202

1614

1.26

2.58

1.1

5.38

6.21

u/ml

0.31

111

874

Alzheimer disease, excluding more controls

286

0.52

2.56

1.0

4.15

1.68

u/ml

—

143

Other inflammation of vagina/vulva

477

1.49

2.55

1.1

5.09

5.17

u/ml

0.01

255

Other acquired deformities of musculoskeletal system and connective tissue

308

1.61

2.54

1.1

3.58

4.78

u/ml

0.25

168

Disorders of vitreous body and globe

384

3089

1.18

2.53

1.0

1.1

3.91

3.48

u/ml

0.13

181

1461

Nontoxic multinodular goitre

143

1096

1.31

2.53

1.1

2.91

3.61

u/ml

0.26

526

Need for other prophylactic measures

519

1.46

2.51

1.1

3.93

5.77

u/ml

0.70

317

Heart failure,strict

213

1842

0.80

2.51

1.0

1.1

4.92

2.79

u/ml

0.80

100

940

Disorders of vitreous body

374

3023

1.18

2.50

1.0

1.1

3.78

3.45

u/ml

0.10

176

1429

Trigger finger

140

1072

1.31

2.50

1.0

1.1

3.91

4.59

u/ml

0.21

527

Certain conditions originating in the perinatal period

240

1743

1.24

2.50

1.1

6.70

7.76

u/ml

0.43

158

1133

Inflammation of lacrimal passages (acute and unspecified)

102

2.09

2.49

1.1

0.75

2.08

u/ml

1.23

malignant neoplasm of female genital organs

883

0.67

2.49

1.0

1.1

3.69

2.38

u/ml

0.40

423

Acute alcohol intoxication

183

2294

0.79

2.48

1.1

3.70

5.55

u/ml

1.09

1235

Artrosis, including avohilmo

995

4918

1.11

2.48

1.1

4.60

u/ml

0.00

501

2561

Type 1 diabetes

259

3123

0.82

2.46

1.1

5.96

6.00

u/ml

0.01

152

1832

Cardiovascular diseases

1285

6238

1.10

2.46

1.1

5.99

6.09

u/ml

0.08

717

3561

Cerebral cysts

588

1.43

2.46

1.1

2.41

5.15

u/ml

2.64

343

Intracranial injury

732

6083

1.12

2.46

1.1

5.34

5.60

u/ml

0.13

424

3344

Panniculitis affecting regions of neck and back

241

1.68

2.46

1.1

2.41

4.51

u/ml

0.98

122

Spondylopathies

795

4198

1.12

2.45

1.1

3.43

4.56

u/ml

1.42

388

2148

Medicines for HER+ breast cancer

224

2555

0.81

2.44

1.1

3.45

3.39

u/ml

0.03

113

1183

Other diseases of pleura

283

2042

1.21

2.44

1.1

3.64

3.87

u/ml

0.08

139

1063

Other noninflammatory disorders of vagina

648

1.40

2.42

1.0

1.1

5.80

4.96

u/ml

0.19

330

Bacterial pneumonia (organism specified)

390

3020

1.17

2.42

1.1

4.38

5.09

u/ml

0.43

228

1601

Other bursopathies

106

784

1.36

2.41

1.0

1.1

3.34

4.22

u/ml

0.44

392

Other and unspecified injuries of lower leg

114

855

1.34

2.39

1.1

7.23

6.31

u/ml

0.18

484

Other diseases of liver

189

1514

1.25

2.38

1.1

4.01

4.64

u/ml

0.32

795

Synovial cyst of popliteal space [Baker]

361

1.53

2.38

1.1

1.0

1.70

3.92

u/ml

1.90

183

Use of pramipexole

161

1265

1.28

2.37

1.1

4.26

3.41

u/ml

0.30

634

Cluster headache, wide

370

1.53

2.37

1.1

4.86

6.14

u/ml

0.28

201

Fracture at wrist and hand level

459

3975

1.15

2.37

1.1

5.94

6.01

u/ml

0.03

258

2242

Erythema intertrigo

111

2.00

2.37

1.0

9.14

3.58

u/ml

0.72

Excessive vomiting in pregnancy

138

1066

1.31

2.37

1.1

4.90

5.91

u/ml

0.32

581

Hordeolum and other deep inflammation of eyelid

627

1.40

2.35

1.1

2.54

5.20

u/ml

1.90

358

Acne

256

2114

1.21

2.34

1.1

7.99

7.63

u/ml

0.10

153

1271

Other disorders of Eustachian tube

230

1.67

2.32

1.1

6.86

5.35

u/ml

0.17

125

Personality disorders, excluding more controls

397

3412

1.17

2.32

1.1

4.47

5.77

u/ml

1.13

231

1838

Malignant neoplasm of prostate

663

0.71

2.32

1.0

1.1

5.01

3.07

u/ml

0.31

313

Disorders of eyelid in diseases classified elsewhere

230

1.67

2.31

1.1

10.20

4.09

u/ml

0.99

129

Other factor of the environment

2.16

2.31

1.0

1.75

7.56

u/ml

—

Benign thyroid growths and nodules

275

2132

1.20

2.31

1.1

3.18

3.71

u/ml

0.24

138

1035

Pneumonia due to Streptococcus pneumoniae

261

1.62

2.30

1.0

1.1

9.98

5.26

u/ml

0.49

139

Other peripheral vertigo

495

1.44

2.30

1.1

3.69

3.84

u/ml

0.04

257

Polyarteritis nodosa and related conditions

2.10

2.30

1.4

1.1

5.82

3.29

u/ml

0.26

Monoamine oxidase A inhibitors

102

757

1.35

2.29

1.1

5.41

3.97

u/ml

0.33

381

Sacrococcygeal disorders, not elsewhere classified

262

1.62

2.28

1.1

1.59

4.96

u/ml

2.18

138

Helminthiases

127

1.92

2.28

1.2

1.1

3.25

4.44

u/ml

0.18

MS-disease / Multiple Sclerosis

848

0.68

2.28

1.0

1.1

4.42

5.04

u/ml

0.12

472

Non-seminoma of testis, including Hilmo

0.00

2.28

0.0

1.1

—

6.95

—

Exclusions for E4_PCOS_CONSORTIUM

960

6589

0.91

2.27

1.1

3.67

5.40

u/ml

3.74

471

3562

Other specified and unspecified disorders of eye and adnexa

239

1.65

2.27

1.1

0.79

6.02

u/ml

4.60

132

Amputation

328

0.49

2.27

1.1

13.23

4.44

u/ml

—

162

Female infertility, tubal origin

464

1.46

2.27

1.1

4.71

4.70

u/ml

0.00

230

Endometriosis of rectovaginal septum and vagina

572

1.41

2.26

1.1

3.57

4.92

u/ml

0.50

291

Coronary atherosclerosis

341

2524

0.85

2.26

1.1

2.86

3.18

u/ml

0.20

160

1253

Diseases of inner ear

471

3933

1.15

2.26

1.1

4.25

4.05

u/ml

0.12

239

1965

Other disorders of penis

108

810

1.34

2.26

1.2

1.1

5.07

6.64

u/ml

0.38

503

Osteopathies and chondropathies

581

4698

1.13

2.26

1.1

5.48

5.06

u/ml

0.23

316

2463

Ptosis of eyelid

505

1.43

2.26

1.1

4.51

3.27

u/ml

0.26

253

Adhesive capsulitis of shoulder

132

1019

1.30

2.25

1.1

3.92

3.65

u/ml

0.05

492

Mental and behavioural disorders due to cannabinoids

467

0.57

2.25

1.2

1.1

1.84

7.29

u/ml

6.09

286

Umbilical hernia

269

2249

1.20

2.25

1.1

5.60

4.72

u/ml

0.35

156

1192

Other infective otitis externa

473

1.45

2.25

1.1

3.90

4.32

u/ml

0.07

262

Non-rheumatic valve diseases

274

2332

0.84

2.24

1.1

6.45

4.02

u/ml

1.10

128

1240

Female infertility, associated with anovulation

159

1261

1.27

2.24

1.0

1.1

5.50

5.63

u/ml

0.04

692

Malignant neoplasm of bronchus and lung, including Hilmo

608

0.66

2.23

1.0

1.1

3.29

2.36

u/ml

0.18

284

Event of undetermined intent

719

1.36

2.23

1.2

1.1

6.18

5.39

u/ml

0.16

403

Varicose veins

377

3306

0.86

2.23

1.1

2.68

3.17

u/ml

0.29

154

1540

Spinal instabilities

187

1.73

2.22

1.0

0.83

4.29

u/ml

2.47

Short Achilles tendon (acquired)

172

1.76

2.22

1.1

1.0

3.67

4.75

u/ml

0.20

Background retinopathy and retinal vascular changes

100

2.02

2.22

1.1

5.34

5.78

u/ml

0.03

Other neurological diseases

511

4501

0.88

2.21

1.1

3.37

4.41

u/ml

1.07

271

2319

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

129

1.90

2.20

1.0

6.49

5.89

u/ml

0.05

Bulimia nervosa (incl. atypical)

569

1.41

2.20

1.2

1.1

3.55

6.53

u/ml

1.44

326

Drug-induced cataract

158

1.80

2.19

1.3

1.1

5.43

6.10

u/ml

0.07

Acute inflammation of orbit

2.37

2.19

1.1

0.74

6.67

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

175

1405

1.25

2.18

1.1

5.98

5.17

u/ml

0.16

111

778

KRA_PSY_EATING, excluding more controls

184

1475

1.25

2.18

1.1

5.23

6.82

u/ml

0.66

111

858

Metabolic disorders

1004

6596

0.91

2.17

1.1

4.25

4.82

u/ml

0.63

553

3490

Viral pneumonia (unknown virus, not influenza)

560

1.40

2.17

1.1

6.87

5.62

u/ml

0.22

316

Malignant neoplasm of skin

277

2228

0.84

2.17

1.1

3.13

3.11

u/ml

0.01

145

1059

Other and unspecified erythematous conditions

204

1.68

2.16

1.1

2.72

5.25

u/ml

0.92

102

Acute lymphadenitis

681

1.36

2.15

1.1

4.45

5.63

u/ml

0.39

390

Cluster headache, strict

363

1.50

2.14

1.1

4.86

6.26

u/ml

0.31

197

Acute alcohol intoxication, ICD10

164

2040

0.80

2.14

1.1

3.84

5.75

u/ml

1.02

1115

Insulin, fast-acting or short human

307

3598

0.85

2.13

1.1

6.21

5.58

u/ml

0.25

168

2051

Insulin, fast-acting

307

3597

0.85

2.13

1.1

6.21

5.58

u/ml

0.25

168

2052

Disorders of iron metabolism

102

1.99

2.12

1.1

1.0

0.79

5.14

u/ml

—

Oral lichen planus, including avohilmo , including avohilmo

429

1.45

2.12

1.0

1.1

3.06

3.73

u/ml

0.19

215

Peroneal tendinitis

138

1.84

2.11

1.1

6.50

4.98

u/ml

0.10

Viral meningitis, including avohilmo

422

1.46

2.11

1.1

7.49

4.94

u/ml

0.52

241

Drug-induced headache, not elsewhere classified

2.64

2.11

1.3

1.0

3.09

2.38

u/ml

—

Other specified disorders of muscle

175

1.73

2.11

1.0

1.1

6.19

5.45

u/ml

0.06

Emotional disorders and disorders of social functioning with onset specific to childhood

157

1230

1.27

2.10

1.1

5.22

7.41

u/ml

1.04

805

Bacterial infection, other or unspecified

355

3471

0.86

2.10

1.1

4.23

4.53

u/ml

0.16

197

1847

Anogenital herpesviral [herpes simplex] infection, including avohilmo

208

1713

1.22

2.09

1.1

5.05

6.00

u/ml

0.42

108

969

Viral pneumonia (known virus, not influenza)

183

1.71

2.09

1.2

1.1

2.34

6.38

u/ml

1.26

111

Type 1 diabetes, wide definition

237

2830

0.83

2.09

1.1

6.65

6.13

u/ml

0.17

144

1662

Implicit bacterial Sepsis

204

2123

0.82

2.07

1.1

3.16

4.04

u/ml

0.44

109

1084

Scleritis and episcleritis

557

1.39

2.07

1.1

3.85

4.70

u/ml

0.22

291

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

366

1.49

2.07

1.1

5.19

5.59

u/ml

0.08

199

Secondary and unspecified malignant neoplasm of lymph nodes

470

0.59

2.07

1.1

4.15

4.18

u/ml

0.00

254

Chronic viral hepatitis

627

0.65

2.06

1.1

3.25

6.08

u/ml

1.13

340

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

192

1569

1.23

2.06

1.1

5.59

5.28

u/ml

0.06

120

877

Testicular dysfunction

342

1.51

2.06

1.0

1.1

3.18

6.45

u/ml

1.79

193

Abnormal findings on examination of blood, without diagnosis

393

3088

1.15

2.05

1.1

3.82

4.99

u/ml

0.92

193

1668

Iron deficiency

492

1.42

2.05

1.1

3.17

6.00

u/ml

1.39

279

Impacted maxillary canine

194

1.71

2.04

1.0

1.1

3.61

7.69

u/ml

1.68

132

Separation of retinal layers (serosa)

270

1.57

2.04

1.1

5.00

4.81

u/ml

0.03

139

Congenital malformations of trachea and bronchus

2.05

2.04

1.3

1.1

8.04

5.87

u/ml

0.15

Pediculosis, acariasis and other infestations, including avohilmo

296

2523

1.18

2.04

1.1

5.65

6.49

u/ml

0.32

163

1449

Influenza and pneumonia

1516

8696

1.08

2.04

1.1

5.37

5.38

u/ml

0.00

906

4652

Sequelae of cerebrovascular disease

124

1355

0.78

2.04

1.0

1.1

4.23

3.00

u/ml

0.42

659

Other retinal disorders

403

3510

0.87

2.03

1.0

1.1

4.14

4.50

u/ml

0.21

216

1816

Impacted cerumen

695

1.34

2.03

1.1

3.80

4.66

u/ml

0.26

408

Atrial septal defect

619

0.65

2.03

1.0

1.2

2.49

5.56

u/ml

1.36

442

Abnormal results of function studies

101

765

1.33

2.03

1.0

1.1

4.28

4.82

u/ml

0.18

423

Benign neoplasm: Rectum

105

799

1.32

2.02

1.1

2.48

3.64

u/ml

0.62

393

Benign neoplasm: Oesophagus

2.54

2.02

1.3

1.0

2.27

1.70

u/ml

—

Ischemic heart diseases

690

4563

0.90

2.02

1.1

3.82

4.04

u/ml

0.16

321

2400

Other epidermal thickening

311

1.52

2.01

1.1

4.54

5.90

u/ml

0.26

174

Speech and linguistic disorders, excluding more controls

184

1410

1.23

2.01

1.2

1.1

5.99

7.62

u/ml

0.60

121

922

Single ventricle heart

0.00

2.01

0.0

1.2

—

6.08

—

Pleural plaque with presence of asbestos

104

1.93

2.00

1.0

1.1

1.93

1.59

u/ml

—

Malignant neoplasm of prostate, including Hilmo

697

0.74

2.00

1.0

1.1

4.64

3.04

u/ml

0.27

330

Type 1 diabetes, strict (exclude DM2)

135

1692

0.79

1.99

1.1

5.86

7.19

u/ml

0.42

1056

Viral meningitis

386

1.47

1.99

1.0

1.1

6.33

5.11

u/ml

0.26

216

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

132

1039

1.28

1.99

1.0

1.1

3.17

4.10

u/ml

0.65

525

Other specified/unspecified hearing loss

443

1.43

1.99

1.1

5.56

4.48

u/ml

0.15

243

Type1 diabetes, definitions combined, early onset

105

1353

0.76

1.98

1.1

6.52

7.19

u/ml

0.16

861

Lifestyle-related condition

2.06

1.98

1.0

1.75

6.58

u/ml

—

Open wound of lower leg

173

1406

1.24

1.98

1.1

5.85

6.54

u/ml

0.22

114

783

Lesion of ulnar nerve

138

1093

1.27

1.98

1.1

2.12

4.64

u/ml

2.89

564

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

494

1.40

1.98

1.1

1.03

3.95

u/ml

4.22

247

Other disorders of cornea

665

1.35

1.97

1.1

7.14

4.79

u/ml

0.50

338

LeFortI or BSSO operation

496

1.41

1.96

1.1

4.24

5.14

u/ml

0.22

265

Dental caries, including avohilmo

830

3855

1.10

1.95

1.1

4.57

5.27

u/ml

0.62

452

2007

Benign neoplasm: Rectum, anus and anal canal

116

900

1.29

1.95

1.1

2.53

3.42

u/ml

0.47

442

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

305

1.52

1.95

1.0

3.88

4.08

u/ml

0.03

146

Chronic periodontitis, complicated

385

4293

0.87

1.95

1.1

3.63

3.99

u/ml

0.20

207

2118

Other/unspecified enthesopathies, not elsewhere classified

504

1.40

1.94

1.3

1.1

5.93

3.96

u/ml

0.39

247

Whooping cough, including avohilmo

243

1.60

1.94

1.2

1.1

7.33

5.58

u/ml

0.24

142

Benign neoplasm: Other and unspecified parts of small intestine

2.47

1.94

1.1

1.0

0.66

2.98

u/ml

—

Androgenic alopecia

2.10

1.94

1.1

1.0

1.25

1.87

u/ml

—

Congenital malformations of the respiratory system, including avohilmo

251

1.58

1.93

1.2

5.52

5.69

u/ml

0.02

175

Collagenous colitis

685

1.34

1.92

1.1

5.77

4.36

u/ml

0.36

373

Horner syndrome

2.28

1.92

1.1

1.0

3.41

5.78

u/ml

—

Ventral hernia

191

1573

1.22

1.92

1.1

3.33

4.45

u/ml

0.67

799

Car occupant injured in other and unspecified transport accidents

270

2297

1.18

1.92

1.1

9.20

6.06

u/ml

0.94

143

1260

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

923

6367

0.91

1.92

1.1

3.90

4.36

u/ml

0.43

476

3236

Single delivery by forceps and vacuum extractor

259

1822

0.84

1.91

1.1

4.87

5.59

u/ml

0.36

127

1014

Diabetic nephropathy

739

0.69

1.91

1.1

6.68

4.58

u/ml

0.40

372

Polyarthritis, unspecified

235

1.59

1.91

1.1

5.26

5.45

u/ml

0.03

122

Mental and behavioural disorders due to sedatives or hypnotics

723

0.69

1.91

1.1

5.98

5.75

u/ml

0.04

405

Oligomenorrhoea

398

1.45

1.91

1.0

1.1

3.70

5.59

u/ml

0.94

225

Otorrhagia

0.00

1.90

0.0

1.1

—

7.20

—

Contact with machinery

712

1.33

1.90

1.1

3.33

5.33

u/ml

0.77

380

Inflammatory disorders of breast

106

818

1.31

1.90

1.1

5.53

5.73

u/ml

0.06

444

Enlarged lymph nodes

177

1449

1.23

1.90

1.1

6.06

5.92

u/ml

0.04

110

800

Autonomic disorders

181

1.68

1.90

1.1

4.14

6.73

u/ml

0.63

Other symptoms and signs involving the digestive system and abdomen

169

1377

1.23

1.90

1.1

5.56

4.24

u/ml

0.38

731

Peripheral arterial reconstruction

434

0.60

1.90

1.2

1.0

1.61

3.10

u/ml

0.66

202

conjunctival haemorrhage

332

1.48

1.89

1.0

1.1

8.80

3.34

u/ml

0.89

161

Type 1 diabetes, wide definition, subgroup 1

232

2746

0.84

1.89

1.1

6.44

6.19

u/ml

0.08

140

1609

Anosmia

144

1.74

1.89

1.1

0.90

2.66

u/ml

—

Tic and related disorders

286

1.55

1.88

1.1

1.2

4.69

6.50

u/ml

0.53

210

Osteoporosis

149

1099

1.25

1.88

1.1

4.27

3.64

u/ml

0.16

550

Maternal care for other known or suspected fetal problems

411

2933

0.87

1.88

1.1

4.78

5.31

u/ml

0.29

205

1570

Malignant neoplasm of pancreas, including Hilmo

266

0.49

1.88

1.0

1.1

0.12

3.21

u/ml

—

127

Other abnormal uterine and vaginal bleeding

231

1390

1.20

1.88

1.1

3.01

5.00

u/ml

1.88

125

729

Pulmonary embolism

192

1586

1.21

1.87

1.1

4.33

3.77

u/ml

0.19

102

793

Other orthopaedic follow-up care

374

1.45

1.87

1.1

3.14

3.60

u/ml

0.09

188

Malignant neoplasm of corpus uteri, including Hilmo

369

0.57

1.87

1.1

1.47

1.60

u/ml

—

174

Care involving dialysis

493

0.63

1.87

1.1

4.51

4.03

u/ml

0.07

272

Ménière disease

466

1.40

1.86

1.0

1.1

4.09

3.11

u/ml

0.32

233

Abnormal blood-pressure reading, without diagnosis

317

1.49

1.86

1.1

1.55

6.85

u/ml

3.40

183

Ulcerative colitis (strict definition, all Crohn cases excluded)

129

1617

0.79

1.86

1.1

6.30

6.39

u/ml

0.02

895

Overexertion and strenuous or repetitive movements

118

926

1.28

1.86

1.1

4.11

5.09

u/ml

0.39

501

Pulmonary heart disease

192

1588

1.21

1.85

1.1

4.33

3.75

u/ml

0.19

102

796

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

417

1.43

1.85

1.1

3.00

5.46

u/ml

0.77

222

Type 1 diabetes, definitions combined

137

1697

0.80

1.85

1.1

6.43

7.13

u/ml

0.18

1059

Injuries to the abdomen, lower back, lumbar spine and pelvis

427

3711

1.14

1.85

1.1

6.02

5.49

u/ml

0.26

254

2004

Cardiac murmurs and other cardiac sounds

135

1065

1.26

1.85

1.1

9.27

7.07

u/ml

0.59

624

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

392

3440

1.14

1.84

1.1

3.60

5.04

u/ml

1.52

222

1854

Malignant neoplasm of breast, HER-negative

1230

0.77

1.84

1.1

4.75

2.60

u/ml

0.42

580

Lichen planus

716

1.32

1.84

1.0

1.1

6.10

3.47

u/ml

0.60

354

Haemorrhage in early pregnancy

413

3534

1.14

1.83

1.1

4.15

4.76

u/ml

0.43

192

1846

Lichen planus, including avohilmo

155

1257

1.24

1.83

1.0

1.1

4.69

3.77

u/ml

0.28

625

Atrial fibrillation and flutter

238

1817

0.84

1.83

1.0

1.1

2.97

4.40

u/ml

1.51

124

928

Other prurigo

2.30

1.82

1.2

1.0

9.64

5.54

u/ml

—

Other bursitis of knee

1.98

1.81

1.1

1.0

1.01

8.92

u/ml

—

Nontoxic single thyroid nodule

503

1.38

1.81

1.0

1.1

4.76

4.21

u/ml

0.08

258

Type 1 diabetes, strict definition

124

1547

0.79

1.80

1.1

6.80

7.24

u/ml

0.10

975

Lactose intolerance

312

1.49

1.80

1.0

1.1

4.75

5.24

u/ml

0.06

193

Bleeding

692

5344

0.91

1.80

1.1

4.93

4.71

u/ml

0.10

361

2839

Disturbances of smell and taste

255

1.54

1.79

1.1

0.85

3.39

u/ml

3.55

124

Peripheral artery operations in Hilmo

389

0.59

1.79

1.2

1.1

9.15

4.06

u/ml

0.43

187

Calculus of kidney and ureter

235

1989

1.18

1.79

1.1

4.39

4.75

u/ml

0.14

138

1034

Other female pelvic inflammatory diseases

166

1361

1.22

1.78

1.1

3.13

4.55

u/ml

1.12

678

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.19

1.78

1.0

0.76

3.11

u/ml

—

Spinal stenosis

311

1977

1.16

1.78

1.1

1.81

3.02

u/ml

1.90

149

902

Atrial septal defect, secundum type

494

0.64

1.78

1.0

1.2

2.39

4.92

u/ml

0.88

358

Retinal breaks without detachment

117

922

1.27

1.78

1.1

3.96

3.89

u/ml

0.02

450

179

1327

1.21

1.78

1.1

2.12

2.74

u/ml

0.33

622

Oesophageal obstruction

109

1.85

1.77

1.1

6.81

4.78

u/ml

0.13

Pedestrian injured in collision with pedal cycle

224

1.58

1.77

1.1

2.97

5.38

u/ml

0.86

124

L02BG Aromatase inhibitors

155

1871

0.82

1.77

1.1

2.98

3.27

u/ml

0.13

868

Other superficial mycoses, including avohilmo

172

1418

1.22

1.77

1.1

5.40

6.13

u/ml

0.22

795

Special screening examination for neoplasms

329

1.47

1.76

1.1

1.0

4.99

3.95

u/ml

0.15

131

Extracorporeal dialysis

349

0.57

1.76

1.2

1.1

6.05

5.59

u/ml

0.05

194

Campylobacter enteritis

193

1.62

1.76

1.1

1.26

5.93

u/ml

2.83

192

1602

1.21

1.76

1.1

3.45

5.29

u/ml

1.61

139

857

Gastric ulcer

660

1.32

1.75

1.1

1.87

3.51

u/ml

1.41

329

Ulcerative colitis (strict definition, require KELA)

157

1913

0.82

1.75

1.1

6.34

6.35

u/ml

0.00

1073

Disorders of lacrimal system and orbit in diseases classified elsewhere

170

1.67

1.75

1.0

1.1

1.82

2.40

u/ml

0.35

Cholecystitis

678

1.32

1.75

1.1

5.05

3.81

u/ml

0.23

334

Excessive earwax

621

5085

1.11

1.75

1.1

5.99

4.98

u/ml

0.64

320

2722

Suicide or other Intentional self-harm

254

2965

0.85

1.75

1.1

3.76

5.79

u/ml

1.74

131

1614

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

258

1.54

1.74

1.1

8.06

5.14

u/ml

0.40

157

Other sexually transmitted chlamydial diseases, including avohilmo

229

1943

1.19

1.74

1.1

5.55

7.57

u/ml

1.15

136

1147

Misadventures to patients during surgical and medical care

130

1041

1.25

1.74

1.1

4.10

4.61

u/ml

0.13

541

Alcoholic liver disease

484

0.64

1.74

1.0

1.1

2.11

4.03

u/ml

0.71

238

Benign mammary dysplasia

114

899

1.27

1.74

1.1

4.27

3.66

u/ml

0.15

443

Lymphoid leukaemia

296

0.54

1.73

1.3

1.1

4.72

6.70

u/ml

—

191

Demyelinating diseases of the central nervous system

973

0.75

1.73

1.1

4.35

5.33

u/ml

0.26

534

Hypertensive diseases

897

5502

0.92

1.73

1.1

4.49

4.64

u/ml

0.10

460

2905

Caries of dentine, including avohilmo

948

4455

1.09

1.72

1.1

4.93

5.37

u/ml

0.35

528

2365

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

184

2202

0.83

1.71

1.1

4.24

6.05

u/ml

0.98

1229

Localized skin eruption due to drugs and medicaments

2.03

1.71

1.1

2.97

6.93

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

111

874

1.27

1.71

1.1

5.31

4.08

u/ml

0.31

428

Degenerative macular diseases

381

1.42

1.71

1.0

1.1

2.36

3.01

u/ml

0.23

187

Major anomalies of jaw size

275

1.51

1.71

1.1

7.77

6.98

u/ml

0.07

164

Benign neoplasm of other and unspecified endocrine glands

115

910

1.27

1.71

1.0

1.1

4.27

4.26

u/ml

0.00

473

Other/unspecified synovitis and tenosynovitis

116

919

1.27

1.71

1.0

1.1

3.89

4.97

u/ml

0.44

463

Other and/or unspecified nontoxic goitre

483

1.37

1.70

1.1

1.80

3.60

u/ml

1.49

240

Superficial injury of thorax

154

1260

1.23

1.70

1.1

6.31

5.53

u/ml

0.21

677

Heart failure and coronary heart disease

137

1186

0.81

1.70

1.0

1.1

4.90

2.88

u/ml

0.49

602

Other disorders of prostate

1.92

1.70

1.1

1.0

0.68

6.23

u/ml

2.19

Other protozoal intestinal diseases, including avohilmo

235

1.55

1.70

1.1

3.40

6.82

u/ml

1.21

135

Implicit bacterial Sepsis, including avohilmo

248

2410

0.85

1.70

1.1

3.20

4.21

u/ml

0.64

133

1244

Habitual aborter

284

1.50

1.69

1.0

1.1

6.81

5.84

u/ml

0.11

156

Other viral diseases, not elsewhere classified

288

2484

1.16

1.69

1.1

6.26

6.07

u/ml

0.04

148

1471

Fall on and from ladder

399

1.41

1.69

1.1

6.24

5.34

u/ml

0.14

213

Tic and related disorders

293

1.50

1.69

1.1

1.2

4.69

4.81

u/ml

0.03

208

Fracture of femur

1009

0.77

1.69

1.0

1.1

2.62

4.14

u/ml

1.09

542

Sequelae of injuries of lower limb

105

824

1.28

1.68

1.1

4.83

4.56

u/ml

0.07

429

COPD, hospital admissions 3, with asthma pneumonia sepsis

112

756

1.27

1.68

1.1

2.73

3.85

u/ml

0.40

371

Infections, IBD-co-morbidities

175

1016

1.21

1.68

1.1

3.69

5.94

u/ml

1.56

576

Chronic iridocyclitis

405

0.61

1.67

1.1

3.30

5.91

u/ml

0.59

236

Fall on same level

1677

8404

1.06

1.67

1.1

5.18

5.45

u/ml

0.28

951

4539

Effects of air pressure and water pressure

2.32

1.66

1.0

1.1

2.07

6.02

u/ml

—

Dermatitis herpetiformis

1.91

1.66

1.0

6.84

4.75

u/ml

—

Reimbursement for rheumatic diseases

509

5623

0.90

1.66

1.1

4.16

4.79

u/ml

0.38

250

2945

Cluster headache, wide,, including avohilmo

581

1.34

1.66

1.1

5.70

5.40

u/ml

0.06

310

Other demyelinating diseases of the central nervous system

440

0.63

1.66

1.1

2.92

5.73

u/ml

1.05

240

Inflammatory disease of cervix uteri

376

1.42

1.65

1.1

2.70

2.45

u/ml

0.09

181

Diverticular disease of intestine

578

3243

1.11

1.65

1.1

2.06

3.31

u/ml

3.51

264

1578

Chronic apical periodontitis

1338

8018

0.93

1.65

1.1

4.28

5.46

u/ml

1.89

724

4221

Neuralgia and neuritis, unspecified

368

1.42

1.65

1.1

2.62

5.55

u/ml

1.24

189

Poisoning by medicine

243

2830

0.86

1.65

1.1

4.79

5.99

u/ml

0.68

133

1569

Disorder of lipoprotein metabolism, unspecified

486

1.36

1.64

1.0

1.1

1.46

3.41

u/ml

1.74

249

Diseases of the digestive system

407

3583

1.13

1.64

1.1

4.88

5.01

u/ml

0.05

221

1948

Hypersomnia

1.87

1.63

1.2

1.0

4.90

2.75

u/ml

—

Other and unspecified cicatricial alopecia

3.69

1.63

1.0

1.1

—

2.65

—

Contusion of toe(s) with damage to nail

113

1.80

1.63

1.2

1.1

11.74

5.67

u/ml

—

Maternal care for other conditions predominantly related to pregnancy

383

3305

1.13

1.63

1.1

3.33

5.46

u/ml

3.69

199

1752

Myocarditis

394

1.41

1.63

1.1

6.96

4.99

u/ml

0.45

219

Perforation of tympanic membrane

107

846

1.27

1.62

1.1

4.41

5.58

u/ml

0.39

472

Other bursitis of hip

1.85

1.62

1.1

1.0

0.81

4.43

u/ml

1.27

Myocardial infarction

209

1725

0.84

1.62

1.1

2.48

2.93

u/ml

0.30

850

Retention of urine

144

1421

0.82

1.62

1.1

4.44

3.78

u/ml

0.17

729

Alzheimer’s disease, strict definition

385

0.65

1.62

1.0

3.11

1.76

u/ml

0.27

168

Hypertension

898

5488

0.92

1.62

1.1

4.49

4.65

u/ml

0.11

460

2898

Viral infections of the central nervous system, including avohilmo

732

1.29

1.61

1.1

8.27

4.84

u/ml

1.06

407

Dronedarone medication

2.16

1.61

1.1

0.88

2.14

u/ml

—

Hallux rigidus

679

1.30

1.61

1.1

2.10

2.77

u/ml

0.28

312

Procreative management

557

4145

1.11

1.61

1.1

5.62

5.76

u/ml

0.07

335

2357

Type 1 diabetes, strict definition, subgroup 1

119

1469

0.80

1.60

1.1

6.36

7.29

u/ml

0.24

925

Vascular disorders of the intestines

174

1.61

1.60

1.1

1.0

4.36

4.38

u/ml

0.00

Poisoning by drugs, medicaments and biological substances

271

3123

0.86

1.60

1.1

4.50

5.99

u/ml

1.04

147

1738

Hypogonadotropic hypogonadism

271

1.49

1.60

1.1

4.07

6.57

u/ml

0.80

159

Congenital malformations of the musculoskeletal system, not elsewhere classified

207

1.58

1.60

1.1

8.21

4.81

u/ml

0.44

131

Pacemaker

112

1301

0.80

1.60

1.0

1.1

3.13

3.48

u/ml

0.16

670

severe traumatic brain injury, does not include concussion

1131

0.78

1.60

1.1

3.88

4.45

u/ml

0.23

603

Decubitus ulcer and pressure area

210

0.47

1.60

1.0

1.1

0.16

4.94

u/ml

—

Benign neoplasm of other and unspecified female genital organs

271

1.49

1.59

1.1

7.51

2.65

u/ml

1.03

141

Insulin, fast-acting (human)

133

1628

0.81

1.59

1.0

1.1

5.43

6.27

u/ml

0.30

925

Pneumonia due to other infectious organisms, not elsewhere classified

167

1.63

1.59

1.2

1.1

4.87

6.36

u/ml

0.26

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

220

1867

1.18

1.58

1.1

6.03

6.65

u/ml

0.23

140

1159

Cluster headache, strict, including avohilmo

569

1.33

1.58

1.1

5.70

5.46

u/ml

0.05

305

Benign neoplasm: Parotid gland

405

1.39

1.57

1.1

2.09

4.29

u/ml

1.67

207

Stenosis and insufficiency of lacrimal passages

603

1.32

1.57

1.1

4.53

4.72

u/ml

0.03

324

Cleft lip, lip and palate or palate

233

0.51

1.57

1.1

8.63

7.11

u/ml

—

144

Other endocrine disorders

123

953

1.25

1.57

1.2

5.10

6.29

u/ml

0.42

667

Medial epicondylitis

264

1.49

1.56

1.3

1.0

5.53

4.15

u/ml

0.24

129

Superficial injury of ankle and foot

212

1808

1.18

1.54

1.1

8.72

6.48

u/ml

0.66

136

1036

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

170

2026

0.84

1.54

1.1

6.57

6.24

u/ml

0.09

1135

Other congenital malformations of skin, including avohilmo

118

952

1.25

1.53

1.1

5.71

5.03

u/ml

0.16

539

Other disorders of male genital organs

315

1.44

1.53

1.1

4.32

7.57

u/ml

1.23

191

Aplastic and other anaemias

239

2536

0.86

1.53

1.1

3.87

4.26

u/ml

0.17

125

1328

Hernia of abdominal wall, postoperative

164

1357

1.20

1.53

1.1

4.17

4.41

u/ml

0.08

676

Crowding of teeth, including avohilmo

247

1766

1.17

1.53

1.2

1.1

8.03

7.09

u/ml

0.35

177

1126

Major coronary heart disease event

667

4365

0.91

1.53

1.1

3.60

3.96

u/ml

0.30

306

2292

Other specified/unspecified dorsopathies

209

1.54

1.52

1.2

1.1

4.50

3.15

u/ml

0.20

102

Dislocation, sprain and strain of joint and ligaments of hip

185

1.58

1.52

1.2

1.0

10.60

6.43

u/ml

0.46

100

Sarcoidosis

118

953

1.24

1.51

1.1

3.18

3.90

u/ml

0.27

477

Acute gastritis

366

1.40

1.51

1.1

1.52

4.25

u/ml

1.99

184

Burn and corrosion confined to eye and adnexa

202

1.55

1.50

1.1

10.83

6.28

u/ml

0.32

112

Other neurotic disorders

242

1.50

1.3

1.1

1.50

4.59

u/ml

2.47

120

Use of donepezil

341

0.61

1.50

1.0

4.14

1.89

u/ml

—

146

Corneal degeneration

1.96

1.49

1.1

1.0

2.13

3.10

u/ml

—

Benign neoplasm of mouth and pharynx

696

1.28

1.49

1.1

6.22

4.18

u/ml

0.62

362

Erythema nodosum

202

1.55

1.49

1.1

4.35

3.30

u/ml

0.27

102

Malignant neoplasm of head and neck

307

0.58

1.49

1.0

1.1

2.70

3.61

u/ml

—

143

Ectropion of eyelid

2.08

1.49

1.1

1.0

3.66

4.65

u/ml

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

156

1866

0.83

1.49

1.1

6.34

6.36

u/ml

0.01

1044

Non-Hodgkin lymphoma, all, including Hilmo

571

0.70

1.48

1.0

1.1

6.73

4.03

u/ml

0.35

295

Heterophoria

123

1002

1.24

1.47

1.1

6.56

6.33

u/ml

0.05

596

Benign intracranial hypertension

156

1.64

1.47

1.1

2.47

5.25

u/ml

1.14

Graves ophthalmopathy

171

1.60

1.47

1.0

1.1

1.82

2.58

u/ml

0.46

Diplopia

114

921

1.24

1.46

1.1

3.24

5.09

u/ml

0.82

483

Congenital malformations of the respiratory system

228

1.52

1.46

1.2

5.67

6.00

u/ml

0.03

161

Dystonia

420

1.37

1.46

1.1

3.67

4.14

u/ml

0.15

230

Melanocytic naevi of eyelid, including canthus

2.15

1.46

1.2

1.0

4.86

2.63

u/ml

—

Symptoms and signs involving the nervous and musculoskeletal systems

632

5782

1.09

1.46

1.1

3.94

4.89

u/ml

1.19

340

3118

Barrett oesophagus

187

1.56

1.46

1.1

1.0

0.36

4.25

u/ml

3.65

Other congenital malformations of the digestive system, including avohilmo

102

810

1.26

1.45

1.2

3.16

5.82

u/ml

2.37

549

Diffuse brain injury

279

0.57

1.45

1.1

3.42

4.76

u/ml

—

162

Fever of other and unknown origin

689

5478

1.09

1.45

1.1

4.16

5.69

u/ml

2.49

399

2968

Other congenital malformations, including avohilmo

219

1883

1.17

1.45

1.1

5.07

6.14

u/ml

0.46

136

1125

Neuromuscular dysfunction of bladder

541

1.32

1.45

1.1

3.82

5.11

u/ml

0.22

292

Abnormal findings on diagnostic imaging of other body structures

119

967

1.23

1.45

1.1

3.65

4.00

u/ml

0.15

497

Other disorders of the musculoskeletal system and connective tissue

117

949

1.24

1.45

1.1

2.98

4.15

u/ml

0.52

480

Emotional disorders starting during childhood or adolescence

143

1177

1.22

1.44

1.2

1.1

5.64

7.56

u/ml

0.78

771

Bacterial infection, other or unspecified, including avohilmo

444

4039

0.90

1.44

1.1

4.39

4.67

u/ml

0.17

250

2137

Malignant neoplasm of breast, ER-negative, including Hilmo

120

1373

0.82

1.44

1.1

4.96

2.81

u/ml

0.54

640

Mixed conductive and sensorineural hearing loss

594

1.30

1.44

1.1

1.0

1.67

3.68

u/ml

1.79

312

Carcinoma in situ of other and unspecified digestive organs

156

1.61

1.44

1.1

1.0

3.02

2.92

u/ml

0.02

Conotruncal defects

324

0.60

1.43

1.2

6.22

6.49

u/ml

0.03

242

Spermatocele

261

1.46

1.43

1.1

4.86

5.76

u/ml

0.14

134

Bicornuate uterus

1.90

1.43

1.1

4.10

2.45

u/ml

—

Other arrhythmias

774

5331

1.09

1.43

1.1

4.80

4.62

u/ml

0.12

388

2774

Abnormal serum enzyme levels

188

1541

1.18

1.43

1.1

2.96

4.08

u/ml

0.75

808

Alcohol abuse, main dg

131

1585

0.82

1.42

1.1

4.15

6.13

u/ml

0.89

870

Focal epilepsy

176

2073

0.85

1.42

1.1

3.79

5.98

u/ml

1.71

1191

Other and unspecified mood [affective] disorders

125

1025

1.23

1.42

1.1

6.37

6.71

u/ml

0.07

574

Scabies, including avohilmo

260

2269

1.15

1.42

1.1

5.90

6.61

u/ml

0.24

145

1311

Pulmonary heart disease, diseases of pulmonary circulation

205

1755

1.17

1.42

1.0

1.1

4.07

3.93

u/ml

0.04

110

895

Autoimmune thyroiditis

197

1.54

1.42

1.1

1.84

4.88

u/ml

1.47

116

Anomalies of pupillary function

205

1.53

1.42

1.1

8.35

6.88

u/ml

0.21

120

Rash and other nonspecific skin eruption

782

1.26

1.42

1.1

5.97

4.61

u/ml

0.32

438

Glucosamine medication

211

1442

1.17

1.42

1.1

2.60

2.11

u/ml

0.20

655

Fatigue fracture of vertebra

2.14

1.41

1.2

1.1

1.67

6.64

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

363

1.38

1.41

1.0

1.1

2.49

4.46

u/ml

1.01

180

Bacterial pneumonia, not elsewhere classified

344

2681

1.13

1.40

1.1

3.76

5.12

u/ml

1.17

204

1419

Other and unspecified follicular disorders

372

1.38

1.40

1.2

1.1

3.10

4.85

u/ml

0.65

204

Diseases of arteries, arterioles and capillaries (FINNGEN)

158

1298

0.84

1.40

1.1

5.60

3.69

u/ml

0.62

679

Episcleritis

484

1.33

1.40

1.1

3.46

4.47

u/ml

0.27

257

Injury of muscle and tendon at ankle and foot level

222

1.50

1.40

1.1

3.69

5.48

u/ml

0.47

121

Hyperplasia of prostate

195

932

1.18

1.39

1.1

2.24

3.52

u/ml

1.26

489

Contact with other hot fluids

356

1.39

1.1

5.85

6.41

u/ml

0.09

219

Bitten or struck by other mammals

172

1457

1.19

1.39

1.1

4.59

5.74

u/ml

0.55

105

794

Infective bursitis

142

1.63

1.39

1.0

1.1

5.88

6.25

u/ml

—

Cardiomyopathy (excluding other)

633

0.72

1.39

1.1

6.84

4.31

u/ml

0.41

339

Endometriosis ASRM stages 1,2

249

2171

1.15

1.39

1.1

4.70

4.96

u/ml

0.10

115

1148

Fasciculation

1.83

1.39

1.1

2.97

5.09

u/ml

—

Benign neoplasm of major salivary glands

494

1.32

1.37

1.1

1.89

4.26

u/ml

2.13

257

Convergence insufficiency and excess

159

1.60

1.37

1.2

1.1

3.58

5.87

u/ml

0.33

Persons encountering health services for specific procedures, not carried out

109

885

1.24

1.37

1.1

4.32

4.54

u/ml

0.06

465

Myocardial infarction, strict

190

1573

0.85

1.37

1.1

2.53

2.82

u/ml

0.16

778

Caries of dentine

223

1860

1.16

1.36

1.2

1.1

5.61

5.37

u/ml

0.08

146

974

Other benign neoplasms of skin

315

2791

1.13

1.36

1.1

4.18

4.67

u/ml

0.23

157

1427

Contact with heat and hot substances

592

1.29

1.36

1.1

5.83

5.69

u/ml

0.03

350

Other bacterial intestinal infections

146

1221

1.20

1.35

1.1

2.71

4.93

u/ml

2.23

642

Burns and corrosions confined to eye and internal organs

232

1.48

1.35

1.1

9.82

5.97

u/ml

0.29

124

Heart failure and antihypertensive medication

142

1105

0.83

1.35

1.0

1.1

6.41

3.87

u/ml

0.68

591

Sequelae with surgical and medical care as external cause

161

1359

1.19

1.35

1.1

3.67

4.24

u/ml

0.27

705

Acquired absence of limb

0.00

1.35

0.0

1.0

—

5.42

—

Viral Sepsis

184

1571

1.17

1.35

1.2

1.1

4.58

4.98

u/ml

0.16

114

856

Chronic myeloproliferative disease

0.00

1.35

0.0

1.1

—

3.42

—

Other and unspecified hypertrophic disorders of skin

2.08

1.35

1.0

1.1

3.05

5.82

u/ml

—

Amblyopia ex anopsia

567

1.30

1.34

1.1

4.58

7.10

u/ml

0.98

360

Pedestrian injured in other and unspecified transport accidents

1.94

1.34

1.2

1.0

1.00

4.90

u/ml

—

Other abnormal immunological findings in serum

208

1.51

1.34

1.1

1.10

5.26

u/ml

3.04

123

Right ventricular outflow tract obstruction

218

0.53

1.34

1.2

10.23

6.23

u/ml

—

170

Other articular cartilage disorders

105

1.73

1.34

1.2

1.0

2.74

6.56

u/ml

—

Other and unspecified injuries of ankle and foot

550

1.30

1.33

1.1

4.82

5.41

u/ml

0.10

310

Schizotypal disorder

233

0.55

1.33

1.1

5.46

5.41

u/ml

—

127

Caught, crushed, jammed or pinched in or between objects

594

1.29

1.33

1.1

7.23

5.84

u/ml

0.26

339

Other retinal artery occlusion

2.05

1.33

1.0

1.1

0.29

3.75

u/ml

—

Tic disorders

293

1.43

1.33

1.1

1.2

4.82

6.08

u/ml

0.33

209

Agranulocytosis

809

0.76

1.32

1.2

1.1

3.02

4.25

u/ml

0.46

439

Delivery, wide proxy

369

2188

0.89

1.32

1.1

5.22

6.26

u/ml

0.65

198

1188

Injury of nerves and spinal cord at thorax level

2.55

1.31

1.0

2.10

4.51

u/ml

—

Psychotic depression

498

1.31

1.1

3.88

5.67

u/ml

0.53

278

Other diseases caused by chlamydiae, including avohilmo

185

1.54

1.31

1.1

1.0

9.89

5.63

u/ml

0.36

Other symptoms and signs involving the nervous and musculoskeletal systems

471

4279

1.10

1.31

1.1

3.57

4.99

u/ml

2.24

251

2302

Other disorders starting during childhood or adolescence

153

1281

1.19

1.30

1.1

1.2

5.85

6.97

u/ml

0.41

869

Later onset COPD

433

1.30

1.0

0.92

2.19

u/ml

1.15

202

Other diseases of gallbladder

209

1.49

1.30

1.2

1.1

3.61

4.22

u/ml

0.12

Right bundle-branch block

129

1.64

1.30

1.0

1.1

3.31

6.47

u/ml

—

Other sexually transmitted chlamydial diseases

137

1147

1.20

1.30

1.1

4.50

6.65

u/ml

1.05

677

Phobic anxiety disorders

244

2132

1.15

1.30

1.1

4.94

6.86

u/ml

1.32

150

1180

Implicit viral Sepsis

183

1568

1.17

1.29

1.2

1.1

4.13

4.98

u/ml

0.44

113

854

Other specified/unspecified disorders of bone/cartilage

169

1.55

1.29

1.1

1.0

5.80

5.42

u/ml

0.05

Disorders of continuity of bone

117

964

1.22

1.29

1.1

4.75

5.48

u/ml

0.20

514

Other specified/unspecified systemic involvement of connective tissue

430

1.33

1.29

1.1

4.82

3.84

u/ml

0.18

217

Other disorders of veins

384

3400

1.11

1.28

1.1

3.47

3.68

u/ml

0.11

204

1630

Other noninflammatory disorders of uterus, except cervix

143

797

1.20

1.28

1.1

1.71

3.86

u/ml

2.46

370

Intestinal adhesions without obstruction

378

1.35

1.28

1.0

1.1

3.77

3.42

u/ml

0.05

201

Diseases caused by chlamydiae, including avohilmo

178

1.54

1.28

1.1

1.0

9.89

5.85

u/ml

0.33

Sequelae of injuries, of poisoning and of other consequences of external causes

254

2232

1.14

1.28

1.1

3.67

5.07

u/ml

1.01

142

1196

Injuries to the thorax

414

3739

1.11

1.28

1.1

5.30

4.97

u/ml

0.15

229

1988

Macular pucker

491

1.31

1.27

1.0

1.1

1.28

2.55

u/ml

1.03

228

Benign neoplasm of bone and articular cartilage

794

1.24

1.27

1.1

7.87

5.42

u/ml

0.67

437

Dislocation, sprain and strain of joints and ligaments of thorax

277

1.42

1.27

1.1

7.23

5.09

u/ml

0.22

155

Malignant neoplasm of corpus uteri

317

0.63

1.27

1.1

1.47

1.40

u/ml

—

151

Plantar fascial fibromatosis

767

1.24

1.27

1.1

2.58

4.06

u/ml

1.07

379

Abnormal involuntary movements

130

1084

1.20

1.27

1.1

4.12

4.82

u/ml

0.29

583

Benign neoplasm: Scapula and long bones of upper limb

1.85

1.27

1.1

1.0

7.22

6.20

u/ml

—

Other and unspecified iridocyclitis

388

1.35

1.27

1.1

11.39

5.86

u/ml

0.80

224

Benign neoplasm: salivary glands, exclude unknown (D119)

457

1.32

1.27

1.1

2.02

4.16

u/ml

1.82

237

Bilateral sagittal split ramus osteotomy operation

406

1.34

1.26

1.0

1.1

4.27

5.24

u/ml

0.19

220

Colorectal neuroendocrine tumor and carcinoma

1.84

1.26

1.0

19.35

6.03

u/ml

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

154

1281

1.19

1.26

1.1

1.2

5.91

6.96

u/ml

0.37

837

Status post-ami

611

0.77

1.26

1.0

2.12

2.62

u/ml

0.24

285

Alzheimer’s disease (Late onset)

311

0.66

1.26

1.0

1.40

1.65

u/ml

—

134

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

449

1.33

1.26

1.2

3.53

6.70

u/ml

2.04

335

Intracranial trauma

843

5301

1.08

1.26

1.1

5.29

6.19

u/ml

0.71

486

2969

Pregnancy, childbirth and the puerperium

330

1930

0.89

1.25

1.1

5.45

6.50

u/ml

0.57

175

1068

Diseases of pulp and periapical tissues and dental caries

734

3482

1.08

1.25

1.1

4.45

5.45

u/ml

0.96

402

1810

Generalized epilepsy, strict definition

313

1.39

1.24

1.1

1.2

4.19

7.14

u/ml

0.63

200

Puerperal sepsis

123

1023

1.21

1.24

1.1

2.75

4.18

u/ml

1.28

503

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

756

0.77

1.24

1.0

1.1

3.54

3.88

u/ml

0.09

388

Bacterial pneumoniae

369

2913

1.11

1.24

1.1

4.28

5.13

u/ml

0.53

218

1549

Juvenile arthritis (FINNGEN)

787

0.77

1.24

1.1

4.54

7.27

u/ml

0.60

472

Short stature, not elsewhere classified

693

1.26

1.23

1.1

1.2

5.67

6.00

u/ml

0.08

526

Colorectal cancer, including Hilmo

100

1139

0.82

1.23

1.1

5.44

3.00

u/ml

0.63

524

Pterygium

1.77

1.23

1.1

1.0

1.39

1.98

u/ml

—

Melanoma in situ

163

1.54

1.23

1.1

1.0

2.38

3.56

u/ml

0.34

Congenital malformations and deformations of the musculoskeletal system

180

1542

1.17

1.23

1.1

6.22

6.18

u/ml

0.01

120

976

Thyroiditis, unspecified

116

1.66

1.22

1.1

5.00

4.01

u/ml

—

Myopia

211

1840

1.15

1.22

1.1

4.95

6.28

u/ml

0.55

114

1028

Ulcer of oesophagus

229

1.45

1.21

1.2

1.1

3.30

4.69

u/ml

0.37

117

Keratoconus

213

1.47

1.21

1.1

12.11

6.14

u/ml

0.68

123

Juvenile osteochondrosis

444

1.32

1.21

1.1

8.70

6.40

u/ml

0.31

268

Dental caries

254

2113

1.14

1.21

1.2

1.1

5.07

5.28

u/ml

0.07

164

1106

712

0.76

1.21

1.1

1.2

4.89

5.98

u/ml

0.29

521

Bacterial intestinal infections, IBD co-morbidities

145

1227

1.18

1.21

1.1

2.60

4.87

u/ml

2.28

646

Combinations of oral blood glucose lowering drugs

129

1535

0.84

1.21

1.0

1.1

3.80

3.55

u/ml

0.06

773

Benign neoplasm: Larynx

132

1.60

1.21

1.1

3.33

4.43

u/ml

—

Astigmatism

106

872

1.22

1.20

1.1

4.67

6.03

u/ml

0.50

558

Muscle strain

289

1.39

1.20

1.1

4.76

5.88

u/ml

0.20

162

Syncope and collapse

430

3260

1.10

1.20

1.1

4.57

5.60

u/ml

0.77

238

1739

Coronary revascularization (ANGIO or CABG)

639

4198

0.92

1.20

1.1

3.62

3.99

u/ml

0.29

287

2205

Mixed specific developmental disorders

637

0.75

1.20

1.1

1.2

3.55

6.94

u/ml

1.02

481

Basal cell carcinoma

216

1686

0.87

1.20

1.1

2.13

2.51

u/ml

0.29

114

785

Cardiac arrest

255

0.63

1.20

1.0

1.1

7.48

4.71

u/ml

—

131

Lactose intolerance, other/unspecified

264

1.41

1.20

1.0

1.1

5.28

5.90

u/ml

0.07

164

Follicular cysts of skin and subcutaneous tissue

183

1581

1.16

1.19

1.1

4.97

5.08

u/ml

0.03

827

Emergency coronary revascularization (for ACS)

659

4297

0.92

1.19

1.1

3.59

3.96

u/ml

0.30

290

2256

Benign neoplasm: Bones of skull and face

1.90

1.19

1.0

14.61

7.10

u/ml

—

Urolithiasis

240

2113

1.14

1.19

1.1

4.36

4.68

u/ml

0.12

139

1098

Early lumbar disc prolapse operation

173

1490

1.17

1.19

1.1

4.66

5.66

u/ml

0.41

802

Other and unspecified myopathies

430

0.70

1.19

1.0

1.1

1.73

4.51

u/ml

2.07

229

Disorders of gallbladder, biliary tract and pancreas

979

6484

0.94

1.18

1.1

3.21

4.45

u/ml

2.44

483

3347

Early syphilis, including avohilmo

102

1.69

1.17

1.1

1.0

2.70

8.51

u/ml

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

516

1.28

1.17

1.1

6.35

4.11

u/ml

0.38

271

Generalized epilepsy, mode (most common among epilepsy diagnosis)

403

1.33

1.17

1.1

5.85

6.32

u/ml

0.07

251

Melanocytic naevi of other and unspecified parts of face

543

1.28

1.17

1.2

1.1

5.81

4.93

u/ml

0.19

294

Complications of labour and delivery

847

4392

1.07

1.17

1.1

5.33

4.77

u/ml

0.45

430

2239

Carcinoma in situ of breast, other/unspecified

2.02

1.17

1.1

1.0

4.77

1.01

u/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

700

4581

0.93

1.17

1.1

4.00

4.08

u/ml

0.05

376

2310

Other disorders of electrolyte and fluid balance, not elsewhere classified

0.00

1.16

0.0

1.1

—

3.90

—

Mucosal proctocolitis

120

1429

0.84

1.16

1.1

6.02

6.56

u/ml

0.14

780

Struck by thrown, projected or falling objec

544

1.28

1.16

1.2

1.1

4.86

6.07

u/ml

0.28

324

Congenital malformations of great arteries

529

0.73

1.16

1.0

1.2

6.09

5.78

u/ml

0.04

401

DVT of lower extremities and pulmonary embolism

273

2417

1.13

1.16

1.1

3.70

3.97

u/ml

0.12

145

1208

Leiomyoma of uterus

625

3790

0.92

1.15

1.1

2.39

3.67

u/ml

2.66

269

1845

Percutaneous Coronary Intervention

639

4195

0.92

1.15

1.1

3.58

3.99

u/ml

0.34

288

2203

Lung cancer and mesothelioma

311

1.34

1.15

1.0

3.15

2.09

u/ml

0.21

117

Family history of malignant neoplasm

103

1243

0.83

1.15

1.1

1.95

5.07

u/ml

5.02

648

Focal epilepsy, strict definition

154

1794

0.86

1.15

1.1

3.45

5.99

u/ml

2.20

1035

Cardiomyopathies, Primary/intrinsic

599

0.75

1.14

1.1

6.84

4.33

u/ml

0.41

321

Congenital malformations of the nervous system

389

0.68

1.14

1.1

1.2

5.65

5.69

u/ml

0.00

262

Actinic keratosis

136

1046

1.18

1.14

1.1

2.61

2.23

u/ml

0.14

480

Chromosomal abnormalities, not elsewhere classified

468

0.71

1.14

1.1

1.2

3.88

5.37

u/ml

0.39

337

Tooth agenesis EXCLUDE clefts and syndromes

100

825

1.22

1.14

1.1

9.08

7.64

u/ml

0.28

520

Skin changes due to chronic exposure to nonionizing radiation

147

1133

1.18

1.14

1.1

2.56

2.21

u/ml

0.14

521

Corneal ulcer

213

1871

1.14

1.12

1.1

6.93

5.39

u/ml

0.56

111

993

Malignant neoplasm of head and neck, including Hilmo

401

0.70

1.12

1.1

3.82

3.55

u/ml

0.05

190

Nonspecific lymphadenitis

538

1.27

1.12

1.1

4.89

5.16

u/ml

0.05

271

Trigeminal neuralgia

423

1.31

1.12

1.1

2.00

3.51

u/ml

0.68

212

Abnormal findings on diagnostic imaging of central nervous system

432

1.30

1.12

1.1

6.04

4.18

u/ml

0.48

241

Meralgia paraesthetica

234

1.42

1.11

1.1

1.29

4.21

u/ml

2.18

122

Unspecified kidney failure

365

0.68

1.11

1.2

1.1

6.32

5.19

u/ml

0.16

195

Crohn disease (strict definition, all UC cases excluded)

593

1.26

1.10

1.1

8.59

5.45

u/ml

0.58

336

Use of memantine

407

0.73

1.10

1.0

1.15

1.57

u/ml

0.19

184

Use of other anti-dementia drugs

407

0.73

1.10

1.0

1.15

1.57

u/ml

0.19

184

Retinal detachment with retinal break

583

1.26

1.10

1.1

11.76

3.62

u/ml

0.69

288

Macular cyst

1.68

1.10

1.0

1.1

1.35

2.87

u/ml

—

Anogenital herpesviral [herpes simplex] infection

107

892

1.21

1.10

1.1

2.81

5.87

u/ml

4.00

506

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

376

0.69

1.10

1.1

2.73

3.32

u/ml

0.23

175

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

169

1.51

1.10

1.1

1.2

14.61

7.63

u/ml

0.70

121

Dilated cardiomyopathy

515

0.74

1.10

1.1

8.04

3.93

u/ml

0.64

262

Sudden idiopathic hearing loss

557

1.26

1.09

1.1

4.77

4.21

u/ml

0.09

284

Benign neoplasm: Vulva

120

1.60

1.09

1.1

9.77

1.68

u/ml

—

Atrophic disorders of skin

155

1334

1.17

1.09

1.1

5.47

4.42

u/ml

0.35

690

Chronic ulcer of skin, not elsewhere classified

304

0.66

1.09

1.1

1.16

5.20

u/ml

2.68

152

Benign neoplasm: Adrenal gland

381

1.32

1.09

1.0

1.1

4.85

3.16

u/ml

0.23

188

Intestinal malabsorption

364

1.33

1.09

1.1

3.13

5.29

u/ml

0.70

209

Benign neoplasm: Caecum

416

1.30

1.08

1.0

1.1

2.27

3.20

u/ml

0.26

198

Viral infections of the central nervous system

657

1.24

1.08

1.0

1.1

7.29

4.52

u/ml

0.85

364

Injuries to unspecified part of trunk, limb or body region

109

911

1.20

1.08

1.1

5.12

5.62

u/ml

0.15

505

Dialysis

303

0.66

1.08

1.2

1.1

3.27

6.11

u/ml

0.50

186

Infections of breast associated with childbirth

515

1.27

1.08

1.1

4.21

4.99

u/ml

0.21

273

Other disorders of breast and lactation associated with childbirth

262

1.39

1.08

1.0

1.1

7.84

5.29

u/ml

0.31

143

Mandibular retrognathia AND surgery (BSSO)

296

1.37

1.07

1.1

4.82

5.20

u/ml

0.05

156

Other specified and unspecified strabismus

121

1.59

1.07

1.1

3.85

6.68

u/ml

0.59

Familial hypercholesterolemia

541

1.26

1.07

1.0

1.1

3.51

3.98

u/ml

0.13

286

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

301

0.66

1.06

1.0

1.1

0.76

4.13

u/ml

—

162

Glomerular diseases

116

1373

0.84

1.06

1.1

4.64

5.21

u/ml

0.15

752

Papulosquamous disorders

372

3385

1.10

1.06

1.1

3.43

4.82

u/ml

1.18

188

1744

Drug-induced neutropenia

408

0.71

1.06

1.1

3.67

3.64

u/ml

0.00

210

Coxarthrosis [arthrosis of hip](FG)

332

2526

0.90

1.06

1.1

2.46

3.25

u/ml

0.57

153

1178

Benign neoplasm: Cerebral meninges

453

1.28

1.06

1.1

2.09

2.98

u/ml

0.51

226

Non-follicular lymphoma

373

0.70

1.06

1.0

1.1

8.77

4.20

u/ml

—

198

Postdysenteric arthropathy

1.82

1.06

1.1

1.0

2.35

6.07

u/ml

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

150

1736

0.86

1.05

1.1

3.20

5.90

u/ml

2.61

988

Bullous disorders

271

1.37

1.05

1.0

1.1

5.99

3.84

u/ml

0.29

139

Graves ophthalmopathy, strict

154

1.51

1.04

1.0

1.83

2.90

u/ml

0.61

Scleritis

1.65

1.04

1.1

1.0

4.82

5.19

u/ml

—

Sacroiliitis, not elsewhere classified

589

1.25

1.04

1.0

1.1

6.93

5.50

u/ml

0.20

321

Delayed milestone in childhood

613

0.77

1.04

1.1

1.2

5.03

6.47

u/ml

0.33

480

Leiomyosarcoma

2.30

1.04

1.0

—

1.80

—

Diabetic maculopathy, excluding more controls

845

0.80

1.03

1.0

1.1

6.22

5.75

u/ml

0.07

463

Superficial injury of forearm

143

1230

1.17

1.03

1.1

6.24

6.15

u/ml

0.02

706

Complications of surgical and medical care, not elsewhere classified

1198

7580

1.05

1.03

1.1

4.72

4.89

u/ml

0.13

636

3953

Right hemicolectomy

178

0.56

1.03

1.0

0.28

3.25

u/ml

—

Acne vulgaris

186

1630

1.15

1.03

1.1

8.96

7.89

u/ml

0.29

114

976

Other/unspecified rheumatoid arthritis

588

0.76

1.03

1.1

0.94

3.34

u/ml

4.35

288

Other hearing loss

152

1271

1.16

1.03

1.1

4.57

3.83

u/ml

0.18

629

Postpartum hemorraghe, parous women as controls

430

3300

1.09

1.02

1.1

5.76

4.71

u/ml

0.71

204

1694

Vitamin deficiency, wide

359

1.32

1.02

1.1

6.73

5.39

u/ml

0.29

205

Vitamin deficiency

359

1.32

1.02

1.1

6.73

5.39

u/ml

0.29

205

Early syphilis

1.71

1.02

1.1

1.0

1.86

8.25

u/ml

—

Hirsprung

0.00

1.02

0.0

1.1

—

4.14

—

Prolonged pregnancy

262

2490

0.89

1.01

1.1

6.82

5.41

u/ml

0.74

147

1358

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

827

1.20

1.01

1.1

6.93

6.10

u/ml

0.16

471

Other protozoal intestinal diseases

139

1.53

1.01

1.0

1.1

3.02

6.18

u/ml

0.76

Viral warts

130

1112

1.17

1.01

1.1

5.73

5.84

u/ml

0.02

630

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

557

3782

0.93

1.00

1.1

3.79

4.60

u/ml

0.70

283

1953

Spontaneous abortion

655

4090

1.07

1.00

1.1

3.78

4.87

u/ml

1.31

311

2114

Venous thromboembolism

392

3453

1.09

1.00

1.1

3.59

3.84

u/ml

0.14

209

1722

Symptoms and signs concerning food and fluid intake

108

908

1.19

1.00

1.1

2.79

5.70

u/ml

2.74

545

Other and unspecified injuries of neck

1.74

1.00

1.1

4.65

4.62

u/ml

—

5-aminosalicylic acid

240

2143

1.12

1.00

1.1

7.21

6.06

u/ml

0.46

118

1136

Cellulitis

246

2200

1.12

1.00

1.1

4.63

5.52

u/ml

0.48

137

1220

Sulfasalazine

264

2370

1.12

1.00

1.1

5.26

5.07

u/ml

0.06

121

1185

Vascular diseases of the intestine

1.62

1.00

1.1

1.0

7.01

4.44

u/ml

—

Diabetic retinopathy, excluding more controls

150

971

0.86

0.99

1.1

5.71

4.09

u/ml

0.52

471

Congenital malformations of pulmonary and tricuspid valves

198

0.59

0.99

1.2

10.23

6.22

u/ml

—

152

Noonan syndrome

0.00

0.99

0.0

1.0

—

5.82

—

Tobacco use

467

1.27

0.99

1.1

8.70

5.85

u/ml

0.50

249

Spina bifida

0.00

0.99

0.0

1.1

—

2.77

—

Arteriovenous malformation of cerebral vessels

1.83

0.99

1.0

7.68

6.09

u/ml

—

Colorectal adenocarcinoma

775

0.80

0.99

1.1

2.34

2.53

u/ml

0.07

356

Malignant neoplasm of rectum

379

0.71

0.99

1.1

5.71

3.48

u/ml

0.31

182

Foreign object accidentally left in body during surgical and medical care

0.00

0.99

0.0

1.0

—

2.81

—

Hypertensive diseases (excluding secondary)

714

4434

0.93

0.99

1.1

4.56

4.94

u/ml

0.27

381

2384

Labyrinthitis

0.00

0.99

0.0

1.0

—

6.51

—

Congenital ichthyosis

2.01

0.99

1.3

1.0

3.59

9.15

u/ml

—

Pilonidal cyst

1143

0.84

0.98

1.1

5.99

6.19

u/ml

0.03

621

Obstructed labour due to maternal pelvic abnormality

137

1181

1.16

0.97

1.1

2.34

3.54

u/ml

0.70

547

Exophthalmic conditions

1.87

0.97

1.0

1.43

2.88

u/ml

—

Hydronephrosis

705

0.79

0.97

1.0

1.1

3.29

4.54

u/ml

0.50

374

Other abnormalities of plasma proteins

1.75

0.97

1.1

1.36

2.74

u/ml

—

Valvular operations

716

0.79

0.97

1.1

6.01

4.57

u/ml

0.26

404

Ovarian hyperstimulation (induction)

285

1.35

0.97

1.0

1.1

3.30

4.64

u/ml

0.32

149

Alcohol abuse, main dg, excluding more controls

131

1520

0.86

0.97

1.1

4.15

5.65

u/ml

0.61

826

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.96

0.0

1.1

—

3.92

—

Presbyopia

622

1.23

0.96

1.1

4.33

3.41

u/ml

0.24

294

Entropion and trichiasis of eyelid

207

1.40

0.96

1.0

1.08

3.05

u/ml

1.67

104

802

0.81

0.96

1.1

1.2

5.53

6.95

u/ml

0.38

585

Other and unspecified mononeuropathies, also in other diseases

149

1.49

0.96

1.1

1.0

2.95

3.61

u/ml

—

Cerebral palsy

269

0.66

0.95

1.2

7.88

5.38

u/ml

0.14

183

Other malignant neoplasms of skin (=non-melanoma skin cancer)

235

1783

0.89

0.95

1.1

2.75

2.77

u/ml

0.01

124

835

Ingrowing nail

516

1.25

0.94

1.1

5.47

5.57

u/ml

0.02

299

Speech and linguistic disorders

202

1721

1.13

0.94

1.2

5.58

7.40

u/ml

0.79

133

1136

Other hammer toe(s) (acquired)

682

1.20

0.94

1.1

2.95

3.30

u/ml

0.07

306

Other and unspecified injuries of shoulder and upper arm

260

1.36

0.93

1.1

6.04

5.24

u/ml

0.09

145

Alzheimer’s disease (Late onset), excluding more controls

176

0.66

0.93

1.1

1.0

2.09

1.33

u/ml

—

Cysts of oral region, not elsewhere classified

463

1.26

0.93

1.1

3.47

5.64

u/ml

1.18

267

Malignant neoplasm of urinary organs, including Hilmo

431

0.74

0.92

1.1

4.52

3.17

u/ml

0.24

212

Unknown and unspecified causes of morbidity

517

1.24

0.92

1.2

1.1

5.33

5.78

u/ml

0.08

275

Diabetic retinopathy

166

1174

0.88

0.92

1.0

1.1

5.34

3.85

u/ml

0.53

560

Injuries to the head

1525

8660

1.04

0.92

1.1

6.02

5.21

u/ml

0.89

871

4650

Certain zoonotic bacterial diseases, including avohilmo

184

1.42

0.92

1.2

1.1

6.76

6.48

u/ml

0.03

105

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

126

1.52

0.92

1.1

11.32

3.78

u/ml

0.73

Other congenital malformations of the digestive system

713

1.21

0.92

1.2

3.41

6.17

u/ml

2.15

486

Other bullous disorders

159

1.46

0.91

1.0

6.23

4.26

u/ml

—

Symptoms and signs involving emotional state

349

1.30

0.91

1.2

1.1

9.28

4.66

u/ml

0.78

208

Benign neoplasm: Long bones of lower limb

305

1.32

0.91

1.0

1.1

4.82

5.82

u/ml

0.20

175

Periapical abscess

452

4878

0.93

0.91

1.1

5.21

4.89

u/ml

0.17

257

2580

Non-ischemic cardiomyopathy

122

1124

0.86

0.91

1.0

1.1

4.17

2.98

u/ml

0.35

585

Abnormalities of forces of labour

143

1246

1.15

0.90

1.1

4.02

4.33

u/ml

0.11

612

Congenital malformations of breast, including avohilmo

271

1.34

0.90

1.1

2.61

5.31

u/ml

1.19

146

Superficial injury of abdomen, lower back and pelvis

189

1677

1.13

0.90

1.1

7.29

5.99

u/ml

0.39

106

942

Varicella [chickenpox]

528

1.24

0.90

1.1

4.52

6.16

u/ml

0.45

313

Burns and corrosions

179

1584

1.13

0.90

1.1

7.30

6.07

u/ml

0.33

103

900

Erectile dysfunction

243

0.66

0.90

1.0

1.1

0.23

6.15

u/ml

—

128

Seronegative juvenile rheumatoid arthritis

312

0.70

0.90

1.0

1.1

1.70

7.21

u/ml

—

192

Left bundle-branch block

279

1.33

0.90

1.1

2.33

3.70

u/ml

0.60

134

Maternal care related to the fetus and amniotic cavity and possible delivery problems

718

3955

1.07

0.90

1.1

5.20

5.17

u/ml

0.02

367

2021

Lesion of plantar nerve

323

1.31

0.90

1.1

1.0

2.84

3.16

u/ml

0.10

153

Infectious mononucleosis

169

1492

1.14

0.89

1.1

8.37

7.00

u/ml

0.42

103

868

Infectious mononucleosis, including avohilmo

169

1492

1.14

0.89

1.1

8.37

7.00

u/ml

0.42

103

868

Superficial injury of head

266

2405

1.11

0.89

1.1

5.16

5.44

u/ml

0.10

157

1352

Other and unspecified injuries of abdomen, lower back and pelvis

127

1.51

0.89

1.2

1.1

1.07

8.26

u/ml

3.91

Adenocarcinoma and papilloma adenocarcinoma of rectum

359

0.72

0.89

1.1

2.73

3.30

u/ml

0.22

167

Autoimmune diseases related-to ILD

1067

8476

1.05

0.88

1.1

4.71

5.31

u/ml

0.62

534

4547

Maternal care for known or suspected disproportion

548

1.23

0.88

1.0

1.1

2.92

4.40

u/ml

0.48

275

Eustachian salpingitis and obstruction

129

1119

1.16

0.88

1.1

7.70

6.00

u/ml

0.46

654

Heart failure and bmi 25plus

136

1043

0.87

0.88

1.0

1.1

5.89

2.73

u/ml

0.93

496

Basal cell carcinoma, including Hilmo

239

1797

0.90

0.88

1.1

1.98

2.54

u/ml

0.53

125

838

Other specified/unspecified arthritis

274

2487

1.10

0.88

1.1

5.37

u/ml

0.00

142

1306

Benign neoplasm: Pituitary gland, craniopharyngeal duct

431

1.26

0.88

1.0

1.1

4.24

5.40

u/ml

0.17

241

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

2.03

0.87

1.2

1.0

0.64

7.99

u/ml

—

Unstable angina pectoris

122

1109

0.86

0.87

1.1

1.0

2.02

2.60

u/ml

0.32

529

IgA nephropathy (IgA glomerulonephritis)

161

1.44

0.87

1.0

6.63

7.62

u/ml

0.09

Other congenital malformations, not elsewhere classified

162

1.45

0.87

1.1

4.35

5.26

u/ml

0.12

123

Other or ill-defined heart diseases

369

1.28

0.87

1.2

1.1

8.78

5.51

u/ml

0.68

206

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

255

1902

0.90

0.86

1.1

2.62

2.82

u/ml

0.10

132

893

Unspecified misadventure during surgical and medical care

343

1.29

0.86

1.1

1.02

4.19

u/ml

3.62

186

Other keratitis

133

1158

1.15

0.86

1.1

8.31

5.53

u/ml

0.70

623

Crohn's disease of small intestine

797

1.19

0.85

1.1

7.14

6.04

u/ml

0.22

443

Benign neoplasm: Other and unspecified parts of mouth

170

1.42

0.85

1.0

7.95

4.56

u/ml

0.43

Venous complications and haemorrhoids in the puerperium

1.65

0.85

1.1

1.28

1.81

u/ml

—

Pure hypercholesterolaemia

584

3958

0.94

0.85

1.1

4.10

4.02

u/ml

0.05

325

1967

Chronic suppurative otitis media, including avohilmo

797

1.18

0.85

1.1

4.70

5.57

u/ml

0.27

481

Malignant neoplasm of bladder

128

1.49

0.85

1.2

1.0

2.32

3.14

u/ml

0.14

Calcific aortic valvular stenosis, diagnosis (helper)

801

1.18

0.85

1.0

1.1

4.00

3.43

u/ml

0.10

400

Operations 2 for CAVS

801

1.18

0.85

1.0

1.1

4.00

3.43

u/ml

0.10

400

6-mercaptopurine

457

0.76

0.85

1.0

1.1

6.08

4.99

u/ml

0.19

274

Hypoplasia of dental enamel

382

0.73

0.85

1.2

1.3

0.50

6.70

u/ml

11.78

314

Thyrotoxicosis

246

2226

1.11

0.85

1.1

3.54

4.39

u/ml

0.58

140

1153

Benign neoplasm of meninges

514

1.23

0.84

1.0

1.1

2.28

3.40

u/ml

0.67

250

Hyperlipidaemia, other/unspecified

223

1803

1.11

0.84

1.1

2.93

3.29

u/ml

0.17

891

Other and unspecified epidermal thickening

188

1.39

0.83

1.2

1.1

3.28

6.56

u/ml

0.73

109

Malignant melanoma of skin, including Hilmo

712

0.81

0.83

1.1

3.78

3.27

u/ml

0.11

337

Malignant neoplasm of ovary, including Hilmo

331

0.72

0.83

1.0

1.1

2.29

2.76

u/ml

—

166

Myocardial infarction, unclassifiable

468

0.78

0.82

1.0

1.1

2.92

3.66

u/ml

0.19

218

Melanocytic naevi of lower limb, including hip

417

1.25

0.82

1.1

3.96

5.57

u/ml

0.39

232

Other metabolic disorders

150

1322

1.14

0.82

1.0

1.1

4.53

4.79

u/ml

0.08

708

274

1.31

0.82

1.1

5.39

6.54

u/ml

0.24

145

Carcinoma in situ of skin of other and unspecified parts of face

146

1.44

0.82

1.0

3.64

2.24

u/ml

0.18

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

1.62

0.82

1.2

1.0

3.06

9.48

u/ml

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

596

0.80

0.82

1.1

1.2

3.47

6.24

u/ml

0.92

404

Colorectal cancer

994

0.85

0.81

1.1

5.08

2.88

u/ml

0.53

458

Sequelae of injuries of upper limb

847

1.17

0.81

1.1

2.11

4.60

u/ml

1.96

451

Cramp and spasm

400

1.26

0.81

1.1

6.86

4.86

u/ml

0.51

231

Alport

0.00

0.81

0.0

1.2

—

6.09

—

Fentanyl

386

0.75

0.81

1.1

1.0

6.86

3.94

u/ml

0.24

184

Other salmonella infections, including avohilmo

338

1.28

0.80

1.1

1.78

4.45

u/ml

1.70

178

Exposure to other and unspecified animate mechanical forces

419

1.25

0.80

1.1

4.71

5.83

u/ml

0.30

254

Other leukaemias of specified cell type

0.00

0.80

0.0

1.1

—

9.19

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.80

0.0

1.0

—

1.16

—

Cerebral oedema

0.00

0.80

0.0

1.0

—

5.57

—

Internuclear ophthalmoplegia

0.00

0.80

0.0

1.0

—

2.08

—

Calcific aortic valvular stenosis, including rheumatic fever

806

1.17

0.80

1.0

1.1

4.00

3.41

u/ml

0.11

402

Contusion of other and unspecified parts of foot

739

1.18

0.79

1.1

11.06

6.04

u/ml

0.82

424

Neuromyelitis optica

0.00

0.79

0.0

1.0

—

2.88

—

Other congenital malformations of ear

234

1.34

0.79

1.1

2.32

5.78

u/ml

1.89

154

Other disorders of bone density and structure

223

0.67

0.79

1.1

8.68

5.69

u/ml

—

118

Pre-eclampsia

223

2461

0.90

0.79

1.1

3.27

4.82

u/ml

1.54

108

1291

Other congenital malformations of tongue, mouth and pharynx

375

1.27

0.78

1.2

3.82

6.72

u/ml

1.53

284

Diseases of peritoneum

592

1.20

0.78

1.1

2.21

4.26

u/ml

0.85

305

Malignant neoplasm of gum, including Hilmo

0.00

0.78

0.0

1.0

—

2.74

—

Foreign body in alimentary tract

447

1.24

0.78

1.2

1.1

5.67

u/ml

0.00

275

Delayed puberty

183

1.40

0.78

1.1

8.36

9.63

u/ml

0.13

138

Elevated blood glucose level

675

1.19

0.78

1.1

7.12

5.28

u/ml

0.35

397

Injuries to the hip and thigh

405

3371

1.08

0.78

1.1

5.50

5.29

u/ml

0.09

220

1809

Anaemias

404

2401

1.08

0.78

1.1

6.46

5.97

u/ml

0.19

235

1407

Malignant melanoma, including Hilmo

880

0.84

0.78

1.1

3.26

3.39

u/ml

0.03

424

Viral encephalitis, not elsewhere classified/unspecified

123

1.47

0.78

1.1

11.95

3.83

u/ml

0.72

Maternal care for known or suspected abnormality of pelvic organs

457

2876

1.07

0.78

1.1

4.98

4.92

u/ml

0.03

242

1516

Finngen Rheumatological endpoints

1259

7449

0.96

0.78

1.1

4.55

5.37

u/ml

1.06

671

3990

Hypoplasia of dental enamel, prenatal , including avohilmo

195

0.64

0.78

1.2

1.3

1.63

5.26

u/ml

1.88

153

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.78

0.0

1.0

—

6.91

—

Injury of unspecified body region

648

1.19

0.78

1.0

1.1

5.32

5.11

u/ml

0.05

364

Rare circulating lymphoid malignancy, including Hilmo

222

0.67

0.78

1.1

1.2

3.23

7.58

u/ml

—

155

Myositis

123

1.47

0.78

1.2

1.0

1.22

5.46

u/ml

—

Pedestrian injured in transport accident

584

1.20

0.78

1.1

4.87

5.22

u/ml

0.07

320

Non-small cell lung cancer

266

0.70

0.77

1.0

1.1

0.59

2.32

u/ml

—

118

Convergent concomitant strabismus

769

0.83

0.77

1.0

1.1

5.80

6.10

u/ml

0.06

452

Intracerebral haemorrhage

417

0.77

1.1

5.27

4.16

u/ml

0.13

210

Specific personality disorders

351

3248

1.08

0.77

1.1

4.67

5.98

u/ml

0.98

204

1772

Caries in Clefts patients

161

0.61

0.77

1.0

1.1

10.05

7.00

u/ml

—

Malignant neoplasm of oral cavity, including Hilmo

186

0.64

0.77

1.1

0.23

5.15

u/ml

—

Alcohol-induced chronic pancreatitis

360

0.75

0.77

1.0

1.1

2.22

4.66

u/ml

1.13

179

Blindness or visual impairment, binocular

0.00

0.76

0.0

1.0

—

6.42

—

Other and unspecified coagulation defects

549

1.21

0.76

1.2

1.1

4.45

4.94

u/ml

0.11

311

Unattended death

0.00

0.76

0.0

1.1

—

3.92

—

Other congenital malformations of circulatory system

183

1.38

0.76

1.2

1.1

7.66

4.80

u/ml

0.37

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.76

0.0

1.0

—

6.74

—

Other abnormal findings of blood chemistry

332

1.27

0.76

1.1

2.80

4.98

u/ml

1.00

192

Other osteochondrodysplasias, including avohilmo

124

1.47

0.76

1.1

1.2

2.49

4.16

u/ml

—

Artificial opening status

348

0.74

0.76

1.1

7.90

4.72

u/ml

0.20

210

Other juvenile arthritis

669

0.82

0.76

1.1

4.48

7.51

u/ml

0.61

410

Other follicular disorders

835

1.17

0.76

1.1

5.70

5.75

u/ml

0.01

449

Constipation

991

6404

1.05

0.76

1.1

3.32

4.79

u/ml

2.09

504

3454

Prepatellar bursitis

279

1.30

0.76

1.0

1.1

6.31

6.01

u/ml

0.03

139

Malignant neoplasm of cervix uteri, including Hilmo

197

0.66

0.76

1.0

1.1

6.75

3.24

u/ml

—

113

Other other unspecified disorders of the circulatory system

209

0.67

0.76

1.1

0.61

5.15

u/ml

—

112

Acute pancreatitis (for exclusion)

113

1295

0.87

0.75

1.1

6.00

4.08

u/ml

0.42

661

Crohn's disease of large intestine

559

1.20

0.75

1.1

5.93

6.09

u/ml

0.03

319

Exposure to other and unspecified man-made environmental factors

175

1.38

0.75

1.1

2.15

7.05

u/ml

2.28

104

Encephalitis

232

0.69

0.75

1.1

10.36

3.94

u/ml

—

134

Lichen sclerosus et atrophicus

789

1.17

0.75

1.1

4.59

4.18

u/ml

0.13

390

Atrial fibrillation and flutter with reimbursement

158

1119

0.89

0.75

1.1

2.48

3.26

u/ml

0.51

565

Sleep disorders, other/unspecified

432

1.23

0.75

1.2

1.1

6.46

6.18

u/ml

0.03

247

Amenorrhoea

117

1023

1.15

0.75

1.1

3.84

6.19

u/ml

1.93

576

Additional codes for the location of defect, injury or illness

468

1.22

0.75

1.1

7.24

5.50

u/ml

0.27

276

Invasive ventilation

548

0.80

0.75

1.1

1.2

0.92

4.44

u/ml

5.62

335

Congenital malformations of cardiac septa

1106

0.86

0.75

1.1

1.2

6.27

5.93

u/ml

0.08

744

Non-small cell lung cancer, including Hilmo

431

0.78

0.74

1.0

1.1

3.31

2.04

u/ml

0.17

201

Calcific aortic valvular stenosis, operated

813

1.16

0.74

1.0

1.1

4.00

3.42

u/ml

0.11

406

Calcific aortic valvular stenosis

813

1.16

0.74

1.0

1.1

4.00

3.42

u/ml

0.11

406

Helminthiases, including avohilmo

579

1.20

0.74

1.1

5.29

5.06

u/ml

0.05

350

Other appendicitis

698

1.18

0.74

1.1

4.35

4.44

u/ml

0.02

364

Loose body in joint

133

1.44

0.74

1.2

1.1

8.11

7.84

u/ml

—

Other and unspecified mononeuropathies of lower limb

167

1.39

0.74

1.0

4.76

4.22

u/ml

—

Personality disorders

397

3699

1.08

0.74

1.1

4.47

5.85

u/ml

1.24

231

2019

Disorders of psychological development

268

2279

1.09

0.73

1.1

6.13

7.78

u/ml

0.80

168

1474

Hyperhidrosis

352

1.26

0.73

1.1

3.20

5.23

u/ml

0.86

191

Hyperkinetic disorders (excl. ADHD)

491

1.22

0.73

1.2

6.37

7.15

u/ml

0.12

360

Respiratory and cardiovascular disorders specific to the perinatal period

718

1.17

0.73

1.2

7.01

6.30

u/ml

0.16

538

Unspecified maternal hypertension

185

1.37

0.73

1.1

0.61

4.36

u/ml

3.07

Laparoscopic right hemicolectomy

167

1.38

0.73

1.0

3.09

3.88

u/ml

—

Arthropathic psoriasis

927

0.85

0.73

1.1

3.35

4.51

u/ml

0.22

482

Psoriasis (vulgaris), strict definition

272

1.29

0.73

1.1

1.09

5.17

u/ml

3.43

147

Retinal detachments and breaks

213

1932

1.10

0.73

1.1

7.31

3.43

u/ml

0.97

104

944

Acute pancreatitis

113

1291

0.87

0.73

1.1

6.00

4.26

u/ml

0.37

667

Hypertrichosis

317

1.27

0.73

1.0

1.1

4.61

4.43

u/ml

0.04

169

Contact with and exposure to communicable diseases

519

5488

0.94

0.73

1.1

6.21

6.13

u/ml

0.04

284

3129

Other congenital malformations

149

1326

1.13

0.73

1.1

4.16

5.96

u/ml

0.92

818

Other disorders involving the immune mechanism, not elsewhere classified

290

1.28

0.73

1.1

5.04

6.04

u/ml

0.18

169

Transient ischemic attack

246

2143

0.91

0.72

1.1

1.98

3.26

u/ml

1.57

122

1049

Disorder of the sleep-wake schedule

229

1.32

0.72

1.1

7.43

4.79

u/ml

0.31

151

Crohn disease (strict definition, require KELA, min 2 HDR)

784

1.17

0.72

1.1

6.77

6.13

u/ml

0.11

443

Herpesviral keratitis and keratoconjunctivitis

264

1.29

0.71

1.0

1.1

9.61

5.01

u/ml

0.57

140

Crohn disease (strict definition, require KELA)

794

1.16

0.71

1.1

6.98

6.08

u/ml

0.16

449

Malignant neoplasm of cervix uteri

158

0.63

0.71

1.0

1.1

8.09

2.37

u/ml

—

Other and unspecified abdominal hernia

203

1.34

0.71

1.1

1.50

3.39

u/ml

0.85

108

Guttate psoriasis

101

1.50

0.70

1.1

1.0

10.57

5.89

u/ml

—

Other symptoms and signs involving the urinary system

655

1.18

0.70

1.0

1.1

2.07

4.65

u/ml

2.67

345

Pre-eclampsia or eclampsia

236

2579

0.91

0.70

1.1

3.03

4.76

u/ml

2.02

117

1342

Traumatic subdural haemorrhage

426

0.79

0.70

1.1

4.18

3.79

u/ml

0.07

224

Chronic nephritic syndrome

217

0.69

0.70

1.0

1.1

6.94

6.17

u/ml

—

113

Other conjunctival vascular disorders and cysts

101

1.49

0.70

1.1

2.97

1.29

u/ml

—

Small fibre neuropathy

143

1.41

0.70

1.4

1.0

2.34

4.10

u/ml

0.51

Septal defects

1059

0.86

0.70

1.1

1.2

6.70

5.55

u/ml

0.28

723

Congenital malformations of breast

248

1.30

0.70

1.1

2.86

5.22

u/ml

0.78

132

Periodontal disease, other/unspecified

195

1.34

0.70

1.0

1.1

1.76

4.88

u/ml

2.17

112

Other lesions of median nerve

1.51

0.69

1.1

1.0

3.74

3.26

u/ml

—

Burn and corrosion of wrist and hand

464

1.21

0.69

1.1

9.72

4.95

u/ml

0.94

279

Hypertension, essential

856

5070

0.95

0.69

1.1

4.36

4.49

u/ml

0.09

432

2607

Malignant neoplasm of urinary organs

365

0.77

0.69

1.1

5.26

3.34

u/ml

—

183

Other noninflammatory disorders of cervix uteri

230

1.31

0.69

1.1

4.38

3.17

u/ml

0.24

109

Other specified and unspecified personality disorders

117

1030

1.14

0.69

1.1

4.22

5.87

u/ml

0.60

558

Parkinson's disease, including avohilmo

443

0.79

0.69

1.0

1.1

0.78

2.56

u/ml

2.61

208

Benign neoplasm: Other/unspecified site

1.57

0.69

1.1

1.0

6.24

4.37

u/ml

—

Other pleural conditions

310

1.26

0.69

1.1

0.92

3.78

u/ml

3.31

154

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

179

1.36

0.68

1.0

1.1

8.44

6.42

u/ml

0.22

125

Syphilis

161

1.37

0.68

1.1

2.33

6.61

u/ml

1.98

Syphilis, including avohilmo

161

1.37

0.68

1.1

2.33

6.61

u/ml

1.98

Thrombocytopenia, unspecified

486

0.80

0.68

1.1

1.89

4.66

u/ml

2.53

278

Rheumatic fever incl heart disease

110

1.46

0.68

1.1

1.0

2.15

6.55

u/ml

—

Diseases of liver

293

2708

1.08

0.68

1.1

4.05

4.56

u/ml

0.32

150

1394

Other and unspecified iron deficiency

307

2838

1.08

0.68

1.1

6.48

4.63

u/ml

0.80

167

1543

Other (seronegative) rheumatoid arthritis, wide

103

1176

0.87

0.68

1.1

1.94

4.17

u/ml

2.58

599

Pedal cyclist injured in transport accident

279

2576

1.09

0.67

1.1

6.33

6.16

u/ml

0.05

171

1450

Single delivery by caesarean section

325

1998

0.93

0.67

1.1

5.35

5.49

u/ml

0.05

173

1085

Other problems related to primary support group, including family circumstances

223

1984

1.10

0.67

1.1

2.80

6.25

u/ml

6.47

125

1240

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

276

1.28

0.67

1.1

5.15

6.27

u/ml

0.19

160

Secondary polycythaemia

119

1.44

0.67

1.0

1.1

3.72

6.25

u/ml

—

Hodgkin lymphoma, hilmo

214

0.70

0.66

1.2

1.1

17.08

5.29

u/ml

—

130

Other aneurysm

188

1.33

0.66

1.1

1.0

1.24

3.49

u/ml

1.39

Use of levodopa decarboxylase inhibitor

362

0.77

0.66

1.0

1.14

2.57

u/ml

1.38

171

Glaucoma-related operations

162

1.36

0.66

1.1

1.0

3.11

2.78

u/ml

0.06

Thyrotoxicosis, other and/or unspecified

204

1860

1.10

0.66

1.1

3.63

4.54

u/ml

0.55

119

980

Other, unspecified and serous retinal detachments

145

1.39

0.66

1.1

1.0

33.35

4.77

u/ml

—

Visual impairment including blindness (binocular or monocular)

417

0.79

0.66

1.1

4.57

5.55

u/ml

0.19

245

Other specified/unspecified spondylopathies

1.54

0.65

1.1

1.0

1.38

5.61

u/ml

—

L02BA Anti-estrogens

106

1204

0.88

0.65

1.1

3.34

2.97

u/ml

0.17

573

Other complications of labour and delivery, not elsewhere classified

215

2080

0.91

0.65

1.1

7.09

5.74

u/ml

0.58

118

1127

Benign neoplasm: Tonsil

1.63

0.65

1.0

4.62

5.34

u/ml

—

Varicose veins of other sites

449

1.21

0.65

1.1

2.82

5.89

u/ml

1.61

240

Other localized connective tissue disorders

120

1.43

0.65

1.1

1.0

3.53

5.39

u/ml

0.20

Other anaemias

229

2334

0.92

0.65

1.1

3.99

4.05

u/ml

0.02

120

1221

Other diseases of arteries and capillaries

523

1.19

0.64

1.1

1.91

4.33

u/ml

1.73

265

Alopecia areata

296

1.26

0.64

1.1

10.35

4.70

u/ml

0.72

171

Other heart diseases

689

4702

0.95

0.64

1.1

6.19

5.40

u/ml

0.55

367

2623

424

1.22

0.64

1.1

1.2

5.06

8.18

u/ml

0.99

274

Mumps

172

1.35

0.64

1.2

1.1

0.82

5.57

u/ml

—

Postpartum haemorrhage due to anatomy

190

1732

1.10

0.63

1.1

6.79

5.84

u/ml

0.36

944

Impotence

235

0.72

0.63

1.1

5.52

6.30

u/ml

—

115

Retinoblastoma

0.00

0.63

0.0

1.0

—

7.59

—

Macular hole

155

1.36

0.63

1.0

1.1

1.28

1.58

u/ml

0.16

Viral conjunctivitis, including avohilmo

470

1.20

0.62

1.1

6.11

5.54

u/ml

0.08

267

Retinoblastoma, including Hilmo

0.00

0.62

0.0

1.0

—

7.54

—

Social disorders starting during childhood or adolecense, excluding more controls

174

1.35

0.62

1.0

1.1

1.37

6.04

u/ml

3.67

130

Ascites

324

0.77

0.61

1.0

1.1

4.01

3.43

u/ml

0.11

168

Reactive arthropathies

721

1.15

0.61

1.0

1.1

7.61

5.39

u/ml

0.41

375

Parkinson's disease

424

0.80

0.61

1.0

1.1

0.78

2.60

u/ml

2.61

200

Ulcerative ileocolitis

390

0.79

0.61

1.1

7.31

4.79

u/ml

0.32

216

Lung diseases due to external agents

572

1.17

0.61

1.1

2.89

4.70

u/ml

0.41

300

Dislocation, sprain and strain of joints and ligaments of head

536

1.18

0.61

1.1

4.47

4.56

u/ml

0.02

306

Malignant neoplasm of kidney, except renal pelvis

346

0.78

0.61

1.1

5.26

3.31

u/ml

—

175

Arthrosis

748

3910

1.05

0.61

1.1

3.39

4.45

u/ml

1.46

376

1980

Carcinoma in situ of breast, intraductal

467

0.81

0.61

1.0

1.1

8.12

2.18

u/ml

0.64

208

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.60

0.0

1.3

—

2.97

—

Endometroid carcinoma of ovary

0.00

0.60

0.0

1.0

—

1.07

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

0.60

0.0

1.0

—

12.78

—

Malignant neoplasm of rectum, including Hilmo

467

0.81

0.60

1.1

6.67

3.38

u/ml

0.53

223

Eating disorder

186

1696

1.10

0.60

1.1

5.19

6.70

u/ml

0.63

112

1014

Malignant neoplasm of ureter, including Hilmo

0.00

0.60

0.0

1.1

—

2.75

—

Vitreous haemorrhage

565

0.83

0.60

1.0

1.1

15.52

4.23

u/ml

0.72

297

Dextrocardia

0.00

0.60

0.0

1.3

—

2.07

—

Congenital malformations of eye, ear, face and neck

113

1005

1.13

0.60

1.1

6.16

6.15

u/ml

0.00

612

Intentional self-harm by smoke, fire and flames

0.00

0.60

0.0

1.0

—

5.55

—

Personal history of other diseases and conditions

216

1977

1.09

0.60

1.1

6.05

6.27

u/ml

0.07

126

1213

Complications peculiar to reattachment and amputation

0.00

0.60

0.0

1.0

—

5.54

—

Iliotibial band syndrome

1.51

0.60

1.0

1.17

5.74

u/ml

—

Subarachnoid haemorrhage

444

1.20

0.60

1.0

1.1

2.56

2.78

u/ml

0.07

226

Injuries to the shoulder and upper arm

985

7302

1.04

0.60

1.1

4.44

5.47

u/ml

1.29

510

3946

Exposure to sunlight

0.00

0.60

0.0

1.1

—

12.68

—

Non-seminoma of testis

0.00

0.60

0.0

1.1

—

10.72

—

Tooth eruption problems

330

2980

1.07

0.60

1.1

6.85

7.47

u/ml

0.28

216

1822

Benign neoplasm: Skin of lower limb, including hip

186

0.70

0.60

1.0

1.33

4.34

u/ml

—

Disorders of purine and pyrimidine metabolism

0.00

0.59

0.0

1.2

—

2.97

—

Prominent ears

175

1.33

0.59

1.0

1.1

3.45

6.27

u/ml

0.86

113

Scabies

519

1.18

0.59

1.1

2.96

5.39

u/ml

0.70

295

Congenital malformations of aortic and mitral valves

465

0.81

0.59

1.1

1.2

7.08

6.92

u/ml

0.02

297

Congenital deformities of hip, including avohilmo

363

1.22

0.59

1.2

1.86

6.58

u/ml

3.46

233

Benign neoplasm: Tongue

131

1.38

0.59

1.1

1.0

9.47

4.94

u/ml

—

Burns and corrosions of external body surface, specified by site

138

1243

1.11

0.59

1.1

7.19

6.10

u/ml

0.29

707

Injury of eye and orbit

176

1605

1.10

0.59

1.1

9.12

5.66

u/ml

0.76

108

888

Burns and corrosions of multiple and unspecified body regions

197

0.71

0.59

1.1

5.77

7.44

u/ml

—

122

Polyglandular dysfunction

0.00

0.59

0.0

1.0

—

6.41

—

Chronic mastoiditis

1.45

0.59

1.0

1.1

1.92

6.02

u/ml

—

Iron deficiency anaemia secondary to blood loss (chronic)

102

902

1.13

0.59

1.1

4.58

4.33

u/ml

0.06

466

Other superficial mycoses

228

1.28

0.59

1.2

1.1

1.75

5.66

u/ml

1.83

130

Seropositive rheumatoid arthritis, strict definition

1013

0.88

0.59

1.0

1.1

3.76

4.17

u/ml

0.11

510

Pathological resorption of teeth

309

1.24

0.58

1.1

1.69

5.36

u/ml

3.09

174

Isolated growth hormone deficiency

251

0.74

0.58

1.2

1.3

5.45

6.60

u/ml

0.20

201

Qualitative platelet defects

1.75

0.58

1.2

1.1

7.21

4.01

u/ml

—

Varicella [chickenpox], including avohilmo

734

1.15

0.58

1.1

3.40

6.72

u/ml

1.86

460

Haemolytic anaemias

246

1.27

0.58

1.1

8.89

4.94

u/ml

0.48

149

Hypocalcemia

150

0.66

0.58

1.2

1.0

7.38

5.48

u/ml

—

Vertical strabismus

273

1.25

0.58

1.1

3.38

4.78

u/ml

0.37

155

Other adrenocortical overactivity

115

1.42

0.58

1.1

6.62

6.47

u/ml

—

Statin medication

949

5132

1.04

0.58

1.1

4.36

5.18

u/ml

1.05

509

2779

Assault by sharp object

173

0.69

0.58

1.0

1.1

2.52

7.25

u/ml

—

106

Thoracic aortic aneurysm

622

1.16

0.58

1.1

5.97

3.99

u/ml

0.33

315

Bursitis of shoulder

149

1.35

0.58

1.2

1.0

3.98

6.33

u/ml

0.35

Melanocytic naevi of upper limb, including shoulder

193

1.30

0.58

1.1

9.39

3.69

u/ml

0.80

Venous complications and haemorrhoids in pregnancy

275

0.76

0.58

1.0

1.1

2.24

4.74

u/ml

—

144

Glomerular disorders in diseases classified elsewhere

777

0.86

0.58

1.0

1.1

6.91

4.36

u/ml

0.56

423

Chorioretinal inflammation

173

0.69

0.58

1.1

1.15

5.43

u/ml

—

Other and unspecified anaemias

228

2315

0.92

0.57

1.1

4.02

4.06

u/ml

0.01

119

1212

Diffuse large B-cell lymphoma

173

0.69

0.57

1.0

1.1

11.67

4.71

u/ml

—

Diffuse large B-cell lymphoma, helper endpoint

173

0.69

0.57

1.0

1.1

11.67

4.71

u/ml

—

Diffuse large B-cell lymphoma, including Hilmo

173

0.69

0.57

1.0

1.1

11.67

4.71

u/ml

—

Other and unspecified disorders of skin and subcutaneous tissue

410

1.20

0.57

1.1

2.52

4.00

u/ml

0.68

213

Embolic stroke

106

1.42

0.57

1.0

2.87

2.46

u/ml

—

Special screening examination for other diseases and disorders

114

1017

1.12

0.57

1.1

7.03

6.35

u/ml

0.13

518

Erosion and ectropion of cervix uteri

132

1.37

0.57

1.1

5.80

1.89

u/ml

0.49

Iron deficiency anaemia

372

3431

1.06

0.57

1.1

6.11

4.51

u/ml

0.79

197

1813

Pyoderma

115

1.40

0.57

1.1

1.0

0.47

4.90

u/ml

—

Vitamin D deficiency

176

1.32

0.57

1.1

10.05

5.47

u/ml

0.85

108

Anorexia (incl.atypical)

870

0.87

0.57

1.1

9.05

6.01

u/ml

0.63

513

Supplementary factors related to causes of morbidity and mortality classified elsewhere

358

3365

1.07

0.56

1.1

6.26

5.74

u/ml

0.17

196

1868

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

386

0.80

0.56

1.1

4.52

3.28

u/ml

0.22

193

Maxillary retrognathism

293

1.24

0.56

1.1

1.2

4.68

7.38

u/ml

0.46

198

Habit and impulse disorders

206

0.72

0.56

1.1

8.25

7.52

u/ml

—

125

Intussusception

124

1.38

0.56

1.1

1.0

0.60

3.70

u/ml

—

Other ulcerative colitis

613

0.85

0.56

1.1

7.41

5.27

u/ml

0.35

344

Pyogenic arthritis

393

1.20

0.56

1.2

1.1

5.66

5.59

u/ml

0.01

217

Shoulder region

107

1.41

0.56

1.1

2.35

4.76

u/ml

—

Viral and other specified intestinal infections

380

3495

1.06

0.55

1.1

6.69

7.55

u/ml

0.30

231

2121

Other disorders of pigmentation

302

1.23

0.55

1.3

1.1

5.59

5.41

u/ml

0.03

165

Other salmonella infections

221

1.27

0.55

1.1

1.62

4.32

u/ml

1.05

113

Maternal care for cervical incompetence

357

1.21

0.55

1.0

1.1

3.90

4.15

u/ml

0.04

183

Autoimmune hyperthyroidism

588

1.16

0.55

1.1

1.79

4.91

u/ml

4.01

301

Use of ropinirole

107

1.41

0.55

1.1

1.0

14.63

2.48

u/ml

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

206

0.73

0.55

1.0

1.1

3.66

4.52

u/ml

—

103

Familial hypercholesterolemia, with ischemic heart disease

221

1.27

0.55

1.0

2.71

3.33

u/ml

—

106

Mumps, including avohilmo

177

1.31

0.55

1.2

1.1

0.82

5.57

u/ml

—

Hydrocephalus

351

0.80

0.55

1.0

1.1

9.15

4.79

u/ml

0.30

205

Cerebral palsy and other paralytic syndromes

985

0.88

0.54

1.1

3.00

4.91

u/ml

0.58

550

Fracture of foot, except ankle

317

2973

1.07

0.54

1.1

4.54

5.71

u/ml

0.82

182

1627

Achalasia of cardia

1.47

0.54

1.0

2.37

5.26

u/ml

—

Benign neoplasm of urinary organs

205

0.73

0.54

1.0

1.1

4.91

3.46

u/ml

—

Complications following abortion and ectopic and molar pregnancy

204

1.28

0.54

1.1

0.89

2.01

u/ml

—

101

Toxic effects of substances chiefly nonmedicinal as to source

136

1232

1.11

0.54

1.1

4.64

6.19

u/ml

0.58

693

Glomerulonephritis

761

0.87

0.54

1.1

2.29

4.93

u/ml

1.09

445

Radial styloid tenosynovitis [de Quervain]

543

1.16

0.54

1.1

1.82

5.01

u/ml

3.06

273

Postprocedural musculoskeletal disorders, not elsewhere classified

317

0.79

0.54

1.0

4.34

3.70

u/ml

0.06

151

Open wound of ankle and foot

118

1061

1.11

0.54

1.0

1.1

7.59

6.07

u/ml

0.38

591

Ankyloglossia

460

1.18

0.53

1.2

3.35

6.88

u/ml

2.35

337

Hypotension

580

1.16

0.53

1.1

2.64

3.66

u/ml

0.42

290

Left ventricular outflow tract obstruction (LVOTO), broad definition

983

0.88

0.53

1.1

6.16

4.76

u/ml

0.34

587

Hypertensive Renal Disease

1.49

0.53

1.0

1.1

1.83

3.33

u/ml

—

Abscess of anal and rectal regions

778

1.13

0.53

1.1

7.52

5.36

u/ml

0.48

428

Hyperkalaemia

169

1.30

0.53

1.0

3.53

3.46

u/ml

0.01

Other specified and unspecified retinal disorders

178

1.30

0.53

1.0

1.48

5.72

u/ml

2.41

Viral agents as the cause of diseases classified to other chapters, including avohilmo

250

1.25

0.53

1.1

2.82

4.37

u/ml

0.35

147

Other and unspecified mononeuropathies of upper limb

215

0.74

0.52

1.1

0.37

5.23

u/ml

—

119

Rheumatoid arthritis

221

2109

0.93

0.52

1.1

2.58

4.32

u/ml

1.85

112

1012

Bipolar affective disorders

256

2388

1.07

0.52

1.1

4.11

5.91

u/ml

1.35

140

1281

Recurrent dislocation of patella

789

1.13

0.52

1.1

4.05

6.77

u/ml

1.39

437

Malignant neoplasm of colon, including Hilmo

724

0.87

0.52

1.1

4.82

3.18

u/ml

0.25

340

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

403

3766

1.06

0.52

1.1

4.98

5.68

u/ml

0.42

210

2013

Ulcerative colitis

249

2670

0.93

0.52

1.1

5.52

6.04

u/ml

0.22

125

1479

Xanthelasma of eyelid

1.51

0.52

1.2

1.1

—

3.67

—

Oral leukoplakia, including avohilmo

126

1.35

0.51

1.1

1.0

0.24

5.95

u/ml

—

Congenital deformities of hip

342

1.21

0.51

1.2

1.86

6.66

u/ml

3.49

227

Endometriosis ASRM stages 3,4

258

2410

1.07

0.51

1.1

4.91

4.56

u/ml

0.14

128

1248

Other facial nerve disorders

188

1.28

0.51

1.3

1.1

9.22

3.87

u/ml

0.43

Chondromalacia

206

1.27

0.51

1.2

1.1

3.88

4.56

u/ml

0.09

102

Fracture of neck

270

0.78

0.51

1.2

1.1

3.59

5.25

u/ml

—

141

Personal history of medical treatment

1.43

0.51

1.1

3.10

6.22

u/ml

—

Acute peritonitis

325

0.80

0.51

1.1

0.46

3.98

u/ml

5.81

173

Viral hepatitis, IBD co-morbidity

542

0.85

0.50

1.2

1.1

3.14

7.22

u/ml

1.90

314

Open wound of forearm

102

914

1.12

0.50

1.1

2.26

6.22

u/ml

4.35

490

Other/unspecified reactive arthropathies

556

1.15

0.50

1.0

1.1

8.27

4.43

u/ml

0.70

308

Congenital malformations of the urinary system

702

0.87

0.50

1.1

4.97

6.03

u/ml

0.24

442

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

681

0.86

0.50

1.1

4.29

4.75

u/ml

0.08

354

Whooping cough

1.45

0.50

1.2

1.0

0.14

6.70

u/ml

—

Ischaemic heart disease, wide definition

511

3299

0.95

0.50

1.1

3.67

3.30

u/ml

0.22

235

1630

Bell's palsy

105

943

1.12

0.50

1.1

5.43

5.09

u/ml

0.08

497

Pedal cyclist injured in other and unspecified transport accidents

127

1153

1.10

0.50

1.1

6.02

5.84

u/ml

0.04

629

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

101

1.40

0.50

1.0

1.1

7.60

5.17

u/ml

—

Secondary hypertension

670

0.87

0.50

1.0

1.1

4.22

5.18

u/ml

0.20

398

Injuries to the elbow and forearm

922

7626

1.04

0.50

1.1

5.44

5.66

u/ml

0.15

515

4129

All dysplastic lesions of the vagina

235

0.76

0.50

1.0

1.1

4.93

2.99

u/ml

—

119

Other strabismus

305

2858

1.06

0.49

1.1

5.11

5.89

u/ml

0.41

182

1654

Use of rivastigmine

257

0.78

0.49

1.1

1.0

0.02

1.69

u/ml

—

109

Hirsutism in women

289

1.22

0.49

1.0

1.1

4.78

3.96

u/ml

0.18

155

Other arthritis (FG)

320

3015

1.06

0.49

1.1

5.24

5.20

u/ml

0.01

170

1580

Chronic suppurative otitis media

614

1.14

0.49

1.1

5.09

6.10

u/ml

0.24

357

Other and unspecified injuries of forearm

1.46

0.48

1.4

1.1

5.64

7.46

u/ml

—

Disorders of lens

471

3067

0.95

0.48

1.1

4.35

3.50

u/ml

0.33

232

1486

Congenital malformations of ovaries, fallopian tubes and broad ligaments

709

1.13

0.48

1.1

7.22

5.02

u/ml

0.39

377

Blood alcohol or alcohol intoxication level

245

0.77

0.48

1.1

7.69

7.05

u/ml

0.04

146

Carrier of infectious disease

235

1.24

0.48

1.2

1.1

4.82

7.75

u/ml

0.61

129

Disorders of adult personality and behaviour

426

4052

1.05

0.48

1.1

4.97

6.01

u/ml

0.73

251

2223

Crohn disease

163

1501

1.09

0.48

1.1

6.23

6.42

u/ml

0.05

824

Autoimmune diseases

1480

7718

0.97

0.48

1.1

6.00

5.46

u/ml

0.48

814

4268

608

1.13

0.48

1.1

1.06

1.56

u/ml

0.62

278

Fracture of lower leg, including ankle

579

5443

1.04

0.48

1.1

5.21

5.29

u/ml

0.03

327

2856

Other and unspecified diseases of blood and blood-forming organs

128

1.33

0.48

1.1

1.0

3.17

4.54

u/ml

0.22

Contact with other hot metals

137

1.32

0.47

1.2

1.1

8.22

5.51

u/ml

0.28

Sequelae of injuries of head

409

0.83

0.47

1.1

2.51

5.76

u/ml

1.50

232

Glaucoma

303

2730

0.94

0.47

1.1

2.87

3.60

u/ml

0.50

145

1327

Molar incisor enamel hypoplasia, with caries

359

0.81

0.47

1.2

1.3

0.46

7.30

u/ml

11.12

288

Phlebitis and thrombophlebitis (not including DVT)

178

1646

1.08

0.47

1.1

3.32

4.41

u/ml

0.53

838

Rheumatoid arthritis, including avohilmo

264

2812

0.94

0.47

1.1

3.06

4.33

u/ml

1.09

138

1393

Gonarthrosis,primary

647

4062

0.96

0.47

1.1

2.49

3.08

u/ml

0.86

303

1915

Premature rupture of membranes

366

2747

0.95

0.47

1.1

5.03

5.15

u/ml

0.06

180

1482

Contact with sharp glass

462

0.84

0.47

1.1

6.84

5.53

u/ml

0.13

264

Effects of other external causes

337

1.19

0.47

1.1

9.85

5.56

u/ml

0.44

203

Other symptoms and signs involving general sensations and perceptions

299

0.80

0.47

1.3

1.1

3.18

6.31

u/ml

1.03

178

Bacterial, viral and other infectious agents, including avohilmo

106

958

1.11

0.46

1.1

3.52

5.33

u/ml

1.12

536

Other vitreous opacities

209

1.25

0.46

1.1

0.86

4.41

u/ml

—

107

Implicit fungal Sepsis

191

1.26

0.46

1.1

1.0

5.59

4.03

u/ml

0.13

Social disorders starting during childhood or adolescence

183

1.28

0.46

1.0

1.2

1.37

5.50

u/ml

2.96

134

Eating disorders

196

1820

1.08

0.46

1.1

5.35

6.50

u/ml

0.45

117

1075

444

1.16

0.46

1.1

0.86

1.60

u/ml

1.01

202

Other diseases of pancreas

402

1.17

0.46

1.1

2.55

3.63

u/ml

0.29

204

Synovial hypertrophy, not elsewhere classified

1.44

0.46

1.1

4.81

7.01

u/ml

—

Wet age-related macular degeneration

307

1.19

0.46

1.0

0.93

1.49

u/ml

0.52

137

Autism spe, excluding more controls

533

1.15

0.46

1.1

4.07

6.52

u/ml

0.71

341

Congenital malformations of the urinary system, including avohilmo

738

0.88

0.46

1.1

4.87

6.03

u/ml

0.27

459

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

812

0.88

0.45

1.2

1.1

3.19

5.97

u/ml

1.17

460

Use of glatiramer acetate

209

0.76

0.45

1.0

1.1

2.03

4.68

u/ml

—

105

Volume depletion

461

0.84

0.45

1.1

10.70

4.83

u/ml

1.05

265

Coxarthrosis, primary, with hip surgery

188

1876

0.93

0.45

1.1

2.90

2.57

u/ml

0.11

879

Torsion of ovary, ovarian pedicle and fallopian tube

228

1.23

0.45

1.1

4.63

4.33

u/ml

0.05

124

Unspecified urinary incontinence

524

1.15

0.45

1.0

1.1

4.12

4.23

u/ml

0.03

272

Liveborn infants according to place of birth

255

1.22

0.45

1.1

1.2

0.86

5.84

u/ml

5.42

182

Rubella [German measles], including avohilmo

198

0.75

0.45

1.2

1.0

0.74

2.83

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

115

1046

1.10

0.45

1.1

3.35

5.35

u/ml

0.98

551

Vitiligo

112

1.35

0.45

1.0

1.1

2.39

3.23

u/ml

—

Haemorrhage, not elsewhere classified

156

1.29

0.45

1.1

1.0

4.05

4.90

u/ml

0.11

Deep endometriosis

105

951

1.11

0.45

1.1

5.29

4.96

u/ml

0.08

519

Male infertility

497

1.15

0.45

1.1

8.98

8.23

u/ml

0.08

293

Convalescence

385

1.17

0.44

1.2

1.1

3.96

3.44

u/ml

0.15

198

Specific development disorders of scholastic skills

113

1008

1.10

0.44

1.2

7.53

7.35

u/ml

0.03

689

Disorders in reading

349

1.19

0.44

1.2

7.60

7.49

u/ml

0.01

242

Nontraumatic intracranial haemmorrhage

821

0.89

0.44

1.1

3.94

3.45

u/ml

0.10

415

Gastroduodenal ulcer

114

1034

1.10

0.44

1.1

1.0

2.39

3.30

u/ml

0.53

507

Biological medication for rheuma

217

2318

0.93

0.44

1.1

4.10

6.19

u/ml

1.32

113

1292

Other encephalitis

208

0.77

0.44

1.1

10.36

4.47

u/ml

—

120

Disorders of puberty, all

434

1.16

0.43

1.1

1.2

6.35

7.76

u/ml

0.26

309

Other disorders of skin and subcutaneous tissue

706

5743

1.04

0.43

1.1

4.39

4.44

u/ml

0.03

371

2955

Other congenital malformations of skin

480

1.15

0.43

1.2

1.1

3.81

5.13

u/ml

0.30

294

Open bite that required surgery (Lefort1 or BSSO)

113

1.34

0.43

1.0

1.1

2.52

7.05

u/ml

—

Tumor necrosis factor alpha inhibitors

196

2099

0.93

0.43

1.1

4.03

6.05

u/ml

1.07

1166

Other diseases caused by chlamydiae

113

1.34

0.43

1.1

1.0

3.03

4.78

u/ml

—

Benign neoplasm of breast

102

925

1.10

0.43

1.1

5.46

4.21

u/ml

0.25

463

Ulcerative rectosigmoiditis

787

0.89

0.43

1.1

5.96

5.32

u/ml

0.11

423

Rubella [German measles]

196

0.76

0.43

1.2

1.0

0.74

2.86

u/ml

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

151

0.73

0.42

1.0

1.1

4.12

5.64

u/ml

—

Pectus excavatum, including avohilmo

1.38

0.42

1.2

1.1

7.09

8.89

u/ml

—

Ulcer of lower limb, not elsewhere classified

596

0.87

0.42

1.0

1.1

6.52

3.84

u/ml

0.42

294

Enterocolitis due to Clostridium difficile

532

0.86

0.42

1.1

5.23

4.37

u/ml

0.21

284

Asymmetry of jaw

176

1.26

0.42

1.1

10.01

6.62

u/ml

0.31

107

Parkinson's disease, strict definition

371

0.83

0.42

1.0

0.83

2.55

u/ml

2.22

175

Other disorders of amniotic fluid and membranes

223

2292

0.94

0.42

1.1

4.85

5.26

u/ml

0.15

102

1231

Lesion of radial nerve

212

1.23

0.42

1.1

1.0

1.06

3.82

u/ml

2.08

108

Other meningitis

131

1.30

0.42

1.0

10.50

6.46

u/ml

—

Acquired haemolytic anaemia

131

1.30

0.42

1.2

1.1

14.32

3.63

u/ml

—

Undescended testicle

281

0.80

0.42

1.2

6.76

7.21

u/ml

0.05

219

Disorders of optic nerve and visual pathways

985

0.90

0.42

1.1

6.27

5.72

u/ml

0.09

566

Hypoparathyroidism

194

1.24

0.42

1.1

0.20

4.32

u/ml

—

109

Wide developmental disorders, excluding more controls

766

1.11

0.42

1.1

1.2

3.88

6.90

u/ml

1.30

521

Burn and corrosion of head and neck

195

0.77

0.42

1.0

1.1

5.83

6.93

u/ml

—

121

Other disorders of fluid, electrolyte and acid-base balance

171

1731

0.93

0.42

1.1

2.57

3.96

u/ml

1.12

899

Polycystic ovarian syndrome, broad definition

212

1988

1.07

0.41

1.1

4.89

5.74

u/ml

0.46

105

1109

Streptococcal septicaemia

563

0.87

0.41

1.0

1.1

4.48

5.34

u/ml

0.18

324

Intentional self-harm by drowning and submersion

0.00

0.41

0.0

1.0

—

6.22

—

Disorders of globe

1.36

0.41

1.0

6.15

u/ml

—

Hip and thigh

0.00

0.41

0.0

1.1

—

1.88

—

Lumbosacral spina bifida and hydrocephalus

0.00

0.41

0.0

1.1

—

3.08

—

Use of riluzole

0.00

0.41

0.0

1.1

—

5.78

—

Benign neoplasm: Eye, unspecified

0.00

0.41

0.0

1.1

—

1.66

—

Assault by drugs, medicaments and biological substances

0.00

0.41

0.0

1.1

—

4.19

—

Postinflammatory hyperpigmentation

0.00

0.41

0.0

1.1

—

1.53

—

Burkitt lymphoma, helper endpoint

0.00

0.41

0.0

1.1

—

8.38

—

Burkitt lymphoma, including Hilmo

0.00

0.41

0.0

1.1

—

8.38

—

Burkitt lymphoma

0.00

0.41

0.0

1.1

—

8.38

—

Aortic aneurysm

825

1.11

0.41

1.1

5.44

3.40

u/ml

0.49

407

Use of hypnotics and sedatives

1206

7076

0.97

0.41

1.1

4.00

4.71

u/ml

0.94

616

3729

Fitting and adjustment of external prosthetic device

0.00

0.41

0.0

1.1

—

8.05

—

Thromboangiitis obliterans

0.00

0.41

0.0

1.1

—

5.60

—

Benign neoplasm: Scrotum

0.00

0.41

0.0

1.0

—

8.79

—

Cerebral amyloid angiopathy

0.00

0.41

0.0

1.1

—

2.81

—

Other secondary gonarthrosis

268

1.20

0.41

1.0

1.1

1.98

4.02

u/ml

1.07

128

Scissor bite

647

1.12

0.41

1.1

1.2

11.82

8.88

u/ml

0.48

443

Exposure to smoke, fire and flames

183

0.76

0.40

1.1

4.79

5.51

u/ml

—

113

Chronic Coagulation defects

260

0.80

0.40

1.1

1.57

6.23

u/ml

3.21

154

Hyposplenism

0.00

0.40

0.0

1.0

—

2.86

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

108

987

1.10

0.40

1.1

3.54

5.48

u/ml

0.88

523

Acute alcohol intoxication ICD-9

132

1.29

0.40

1.1

1.72

4.58

u/ml

—

Squamous cell neoplasms and carcinomas of the skin

204

1.23

0.40

1.0

6.58

2.81

u/ml

0.32

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.40

0.0

1.0

—

5.69

—

Erectile dysfunction, exclusion

0.00

0.40

0.0

1.1

—

4.38

—

Other and unspecified injuries of wrist and hand

446

1.15

0.40

1.2

1.1

8.59

5.62

u/ml

0.35

261

Agoraphobia

496

0.86

0.40

1.0

1.1

2.21

6.76

u/ml

2.59

284

Hypertrophic disorders of skin

673

1.12

0.40

1.1

7.08

5.80

u/ml

0.21

377

Failed attempted abortion

187

1.24

0.39

1.1

1.36

5.27

u/ml

—

Diseases caused by chlamydiae

106

1.33

0.39

1.1

1.0

3.03

3.46

u/ml

—

Multiple delivery

949

0.90

0.39

1.1

2.20

4.17

u/ml

1.61

496

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

346

0.84

0.39

1.0

1.1

0.62

3.62

u/ml

—

179

Eccrine sweat disorders

0.00

0.39

0.0

1.1

—

4.66

—

Generalized epilepsy

579

1.13

0.39

1.1

4.88

6.27

u/ml

0.31

356

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.39

0.0

1.1

—

3.21

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

160

1.26

0.39

1.1

5.48

4.18

u/ml

—

Progressive systemic sclerosis

0.00

0.39

0.0

1.0

—

1.72

—

Fracture of shoulder and upper arm

305

3204

0.95

0.39

1.1

6.14

5.99

u/ml

0.04

168

1787

Disorders of calcium metabolism

378

0.84

0.39

1.1

2.75

4.13

u/ml

0.37

210

Carcinoma in situ of cervix uteri, endocervix

142

1.28

0.39

1.0

1.1

8.97

2.90

u/ml

—

Cardiomyopathy

948

0.91

0.39

1.1

6.01

4.20

u/ml

0.49

507

Open wound of abdomen, lower back and pelvis

307

1.18

0.39

1.1

5.01

6.24

u/ml

0.19

183

Other and unspecified vasculitis limited to skin

133

1.28

0.38

1.2

1.1

8.96

3.67

u/ml

—

Other disorders of choroid

1.37

0.38

1.2

1.0

29.76

4.97

u/ml

—

Abdominal aortic aneurysm (AAA)

141

1.27

0.38

1.1

1.04

2.88

u/ml

0.93

Follow-up care involving plastic surgery

252

1.19

0.38

1.1

3.06

3.22

u/ml

0.03

123

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

234

1.21

0.38

1.1

4.96

6.22

u/ml

0.14

154

Benign neoplasm: other/unspecified salivary gland

1.35

0.38

1.2

1.0

0.46

3.46

u/ml

—

Contact with nonpowered hand tool

317

1.17

0.38

1.1

9.41

5.82

u/ml

0.32

175

Polymyalgia rheumatica

366

0.85

0.38

1.0

1.1

1.55

2.20

u/ml

0.39

171

Nonischemic cardiomyopathy

483

0.87

0.38

1.0

1.1

3.55

4.17

u/ml

0.14

247

Mandibular prognathia

225

1.21

0.37

1.1

1.2

14.41

7.26

u/ml

0.84

158

Gonarthrosis, primary, with knee surgery

285

2335

0.95

0.37

1.0

1.1

2.10

2.58

u/ml

0.44

127

1037

Monoarthritis, not elsewhere classified

308

1.17

0.37

1.1

4.32

6.18

u/ml

0.38

159

Postpartum haemorrhage

430

3402

1.04

0.37

1.1

5.76

5.04

u/ml

0.42

204

1780

Cystic kidney disease

268

0.82

0.37

1.0

1.1

4.08

6.37

u/ml

0.43

162

Algoneurodystrophy

327

1.17

0.37

1.1

5.53

4.60

u/ml

0.10

179

Other disorders of optic [2nd] nerve and visual pathways

599

0.88

0.37

1.1

7.34

5.36

u/ml

0.24

361

SLE, strict definition

257

0.81

0.37

1.1

5.32

3.98

u/ml

0.17

140

SLE, ICD10

257

0.81

0.37

1.1

5.32

3.98

u/ml

0.17

140

LSIL lesion of the cervix uteri, vagina or vulva

177

1888

0.94

0.37

1.1

4.99

4.77

u/ml

0.08

982

Benign neoplasm: Brain, supratentorial

134

1.28

0.37

1.0

1.1

1.27

4.78

u/ml

—

Erythema multiforme

152

1.26

0.37

1.2

1.1

4.59

4.49

u/ml

—

Vasculitis limited to skin, not elsewhere classified

152

1.25

0.37

1.2

1.0

7.16

3.94

u/ml

—

Other misadventures during surgical and medical care

125

1.28

0.37

1.3

1.0

0.48

3.89

u/ml

—

Psoriatic arthropathies, ICD10

830

0.90

0.37

1.1

3.37

4.18

u/ml

0.15

429

Intermittent heterotropia

963

0.91

0.37

1.1

1.2

4.56

6.23

u/ml

0.55

628

Postprocedural endocrine and metabolic disorders, not elsewhere classified

130

1205

1.08

0.36

1.0

1.1

3.30

4.91

u/ml

1.04

640

Benign neoplasm: Conjunctiva

198

1.22

0.36

1.1

1.0

0.69

4.64

u/ml

2.73

100

Inguinal hernia, bilateral

459

1.13

0.36

1.1

4.56

4.99

u/ml

0.06

241

Explicit bacterial Sepsis

745

0.90

0.36

1.0

1.1

5.55

5.19

u/ml

0.06

412

Benign neoplasm of other and unspecified sites

189

1.22

0.36

1.1

1.0

4.46

5.78

u/ml

—

Other assisted single delivery

277

0.82

0.36

1.0

1.1

3.56

5.33

u/ml

0.24

146

Nail disorders

793

1.10

0.36

1.1

4.31

4.97

u/ml

0.20

439

Contusion of ankle

517

1.13

0.35

1.2

1.1

5.68

5.66

u/ml

0.00

292

UC patients in KELA-register (code 208), prior to 1994

223

0.81

0.35

1.0

1.1

2.36

3.54

u/ml

—

Isolated patent ductus arteriosus

283

0.83

0.35

1.0

1.3

4.68

4.91

u/ml

0.05

217

Malignant melanoma of skin

576

0.88

0.35

1.1

4.11

3.30

u/ml

0.16

275

Other benign neoplasms of uterus

171

1.23

0.35

1.1

1.0

2.34

1.57

u/ml

—

Viral agents as the cause of diseases classified to other chapters

208

1.21

0.35

1.0

1.1

2.99

4.69

u/ml

0.33

122

SLE (Finngen)

277

0.83

0.35

1.1

5.32

4.30

u/ml

0.12

147

Hereditary corneal dystrophies

144

1.25

0.35

1.1

1.0

1.31

2.88

u/ml

—

Distal bite

884

1.09

0.35

1.1

1.2

8.95

7.41

u/ml

0.32

596

Otosclerosis

385

1.14

0.35

1.0

0.97

3.26

u/ml

2.69

186

Diabetic maculopathy

682

0.90

0.35

1.0

1.1

5.60

4.67

u/ml

0.14

348

Necrosis of pulp, including avohilmo

721

7338

0.97

0.35

1.1

4.31

5.12

u/ml

0.83

379

3855

Benign neoplasm: Descending colon

264

1.18

0.34

1.1

1.0

2.83

3.35

u/ml

0.09

124

Peripheral retinal degeneration

181

1.22

0.34

1.0

2.80

3.16

u/ml

—

Other congenital malformations of peripheral vascular system

163

1.24

0.34

1.1

1.74

5.74

u/ml

2.10

103

Reduction defects of upper limb, including avohilmo

1.35

0.34

1.2

1.1

1.30

4.52

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

490

1.12

0.34

1.1

2.38

3.77

u/ml

0.73

251

Type of accident

322

3079

1.05

0.34

1.1

6.40

5.82

u/ml

0.17

176

1717

Dissociative [conversion] disorders

500

1.12

0.34

1.1

2.85

5.50

u/ml

1.52

276

Myocardial infarction, with ST-elevation

521

0.88

0.34

1.0

1.1

1.71

3.64

u/ml

1.44

249

Osteoporosis with pathological fracture (FG)

209

1.20

0.34

1.0

1.1

0.66

2.11

u/ml

—

Nephrotic syndrome

286

0.84

0.34

1.3

1.2

0.56

6.68

u/ml

7.78

192

Anterior Iridocyclitis

163

1736

0.94

0.34

1.1

7.54

5.17

u/ml

0.71

918

Reactive arthropathies, FINNGEN

643

1.11

0.34

1.0

1.1

7.87

4.64

u/ml

0.59

332

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

814

0.91

0.34

1.1

4.34

4.56

u/ml

0.05

420

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

387

1.14

0.33

1.0

1.1

6.29

4.43

u/ml

0.33

200

Adjustment and management of implanted device

678

0.90

0.33

1.1

5.21

3.45

u/ml

0.31

341

Other and unspecified corneal deformities and disorders

228

1.19

0.33

1.1

6.16

3.98

u/ml

0.26

128

Viral conjunctivitis

219

1.19

0.33

1.0

1.1

5.50

6.32

u/ml

0.09

124

Other Crohn's disease

826

1.09

0.33

1.1

7.12

5.89

u/ml

0.24

456

Calculus of lower urinary tract

177

0.79

0.33

1.1

1.0

2.38

4.44

u/ml

—

Cystic kidney disease, including avohilmo

296

0.84

0.33

1.0

1.1

3.85

6.73

u/ml

0.63

176

Malignant melanoma

771

0.91

0.33

1.1

3.43

3.29

u/ml

0.03

366

Other benign neoplasms of connective and other soft tissue

739

0.91

0.32

1.1

4.01

4.70

u/ml

0.23

387

Systemic lupus erythematosus

274

0.84

0.32

1.1

5.32

4.27

u/ml

0.13

147

Inflammatory bowel disease, strict (require KELA)

268

2809

0.95

0.32

1.1

6.88

5.96

u/ml

0.37

130

1581

Osteomalacia

1.28

0.32

1.2

1.0

1.03

4.17

u/ml

—

Osteochondrosis of ankle, juvenile

1.32

0.32

1.1

2.60

6.45

u/ml

—

Other specific arthropathies, wide

137

1.25

0.32

1.1

1.92

4.25

u/ml

—

Superficial injuries involving multiple body regions

241

0.83

0.32

1.1

12.35

7.22

u/ml

—

138

Glaucoma suspect

213

2019

1.05

0.32

1.1

3.28

3.54

u/ml

0.11

1012

Intestinal stricture

173

1834

0.94

0.32

1.1

1.56

4.02

u/ml

6.21

938

Unspecified nephritic syndrome

110

1.28

0.32

1.0

0.37

5.78

u/ml

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

704

1.10

0.32

1.2

5.33

5.72

u/ml

0.07

462

Carcinoma in situ of other and unspecified sites

1.31

0.32

1.0

1.1

4.73

3.16

u/ml

—

Arthropathies in other diseases classified elsewhere

211

1.19

0.31

1.1

3.00

3.99

u/ml

0.18

103

Polycystic kidney disease

197

0.81

0.31

1.1

5.61

5.58

u/ml

—

117

Anisometropia and aniseikonia

305

1.15

0.31

1.0

1.1

3.77

5.60

u/ml

0.43

180

Post-traumatic wound infection, not elsewhere classified

193

1.20

0.31

1.1

1.94

5.54

u/ml

1.91

111

Disorders of mineral metabolism

561

1.11

0.31

1.1

2.08

3.94

u/ml

1.13

313

Streptococcal septicaemia, including avohilmo

579

0.90

0.30

1.0

1.1

4.38

5.26

u/ml

0.20

333

Perioral dermatitis

268

1.16

0.30

1.1

7.02

4.50

u/ml

0.38

142

Inguinal or femoral hernia, bilateral

466

1.12

0.30

1.1

4.56

4.95

u/ml

0.05

243

Migraine with aura, drug-induced

1.34

0.30

1.2

1.1

3.00

3.22

u/ml

—

Hypertrophic scar

629

1.10

0.30

1.1

7.89

5.62

u/ml

0.37

352

Benign neoplasm: Skin, unspecified

268

1.16

0.30

1.0

1.1

1.40

3.25

u/ml

1.58

143

Tularaemia, including avohilmo

120

1.25

0.30

1.2

1.1

0.88

6.34

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

115

1073

1.07

0.30

1.1

3.35

5.14

u/ml

0.82

568

Fitting and adjustment of other devices

198

1654

1.05

0.29

1.1

1.77

3.37

u/ml

2.92

804

Long labour

387

3161

1.04

0.29

1.1

4.12

4.98

u/ml

0.66

200

1642

Other embolism and thrombosis

793

1.09

0.29

1.1

3.87

3.99

u/ml

0.02

400

HSIL lesion of the cervix uteri

289

2772

1.04

0.29

1.0

1.1

5.53

4.81

u/ml

0.34

145

1477

Malignant neoplasm of other connective and soft tissue, including Hilmo

206

0.82

0.29

1.1

1.0

4.32

5.60

u/ml

—

114

Congenital malformations of heart and great arteries

170

1741

0.95

0.29

1.1

6.23

6.04

u/ml

0.05

100

1096

Non-invasive ventilation

272

2247

1.05

0.29

1.1

2.70

5.05

u/ml

3.37

145

1195

Other diseases of spinal cord

195

0.82

0.29

1.0

1.1

2.47

5.58

u/ml

—

106

Other disorders of kidney and ureter

733

0.91

0.29

1.1

2.95

4.02

u/ml

0.35

382

Spontaneous rupture of synovium and tendon

411

1.12

0.29

1.1

1.60

4.18

u/ml

2.34

193

Diabetic neuropathy

469

0.89

0.28

1.1

10.65

3.74

u/ml

1.13

227

Use of teriflunomide

112

1.26

0.28

1.1

1.0

6.54

4.55

u/ml

—

Protozoal diseases, including avohilmo

173

0.81

0.28

1.1

2.06

5.36

u/ml

—

Parkinson's disease, excluding more controls

356

0.88

0.28

1.0

0.78

2.25

u/ml

2.03

181

Ulcerative colitis, NAS

140

1486

0.94

0.28

1.1

5.37

6.28

u/ml

0.30

810

Precocious puberty

117

0.76

0.28

1.1

7.93

6.83

u/ml

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

323

0.87

0.28

1.1

3.09

4.38

u/ml

0.31

169

Seropositive rheumatoid arthritis

160

1682

0.95

0.28

1.0

1.1

2.65

4.10

u/ml

1.02

814

Car occupant injured in noncollision transport accident

386

0.88

0.28

1.1

6.88

6.54

u/ml

0.03

215

Gestational diabetes (for exclusion)

683

4574

1.03

0.28

1.1

4.87

5.10

u/ml

0.16

365

2396

Spasmodic torticollis

242

1.16

0.28

1.1

1.49

4.55

u/ml

1.93

129

LSIL lesion of the cervix uteri

153

1618

0.94

0.28

1.1

4.78

5.02

u/ml

0.09

859

Maternal care for known or suspected fetal abnormality and damage

295

2400

1.04

0.27

1.1

4.26

5.20

u/ml

0.63

162

1285

Gout, strict definition

606

0.91

0.27

1.1

2.07

3.97

u/ml

1.41

284

Cytomegalovirus infection, IBD co-morbidity

172

0.81

0.27

1.1

1.0

7.02

6.82

u/ml

—

Colectomy operation

824

0.92

0.27

1.1

3.21

4.15

u/ml

0.33

414

Presbycusis

230

1.16

0.27

1.1

1.0

0.24

1.55

u/ml

2.91

Gonococcal infection

252

1.15

0.27

1.1

4.55

6.38

u/ml

0.31

142

Other and unspecified injuries of head

626

0.91

0.27

1.1

5.36

4.59

u/ml

0.16

346

Enteropathic arthropathies

196

1.18

0.27

1.0

1.1

4.11

6.64

u/ml

—

100

Chronic pancreatitis

678

0.91

0.27

1.1

2.92

3.78

u/ml

0.34

352

Congenital deformities of feet, including avohilmo

538

1.10

0.27

1.1

5.58

6.21

u/ml

0.12

321

Other obstetric trauma

798

1.08

0.27

1.1

5.27

5.22

u/ml

0.01

419

Acute nephritic syndrome

128

0.78

0.27

1.1

2.00

4.09

u/ml

—

Conductive and sensorineural hearing loss

634

4320

0.97

0.27

1.1

4.18

4.21

u/ml

0.01

306

2188

Other abnormal auditory perceptions

104

1.26

0.26

1.2

1.1

7.13

6.21

u/ml

—

Overjet

622

1.09

0.26

1.2

8.26

7.26

u/ml

0.18

430

Congenital malformations of genital organs

165

1556

1.06

0.26

1.1

6.49

6.17

u/ml

0.08

941

Autism spe

558

1.10

0.26

1.1

4.07

6.84

u/ml

0.83

359

Social phobias

148

1400

1.06

0.26

1.1

4.76

7.28

u/ml

1.47

795

Pneumonia, organism unspecified

1147

7708

1.02

0.26

1.1

5.08

5.09

u/ml

0.00

690

4117

L04AC Interleukin inhibitors

718

0.92

0.26

1.0

1.1

2.81

5.33

u/ml

1.97

398

All pneumoniae

1354

8634

1.02

0.26

1.1

5.20

5.34

u/ml

0.12

823

4600

Acute mastoiditis

0.70

0.26

1.0

—

6.92

—

Pneumothorax

338

1.13

0.26

1.1

7.12

4.46

u/ml

0.23

194

Monoplegia

1.28

0.26

1.2

1.0

1.04

3.41

u/ml

—

Seropositive rheumatoid arthritis, wide

159

1676

0.95

0.26

1.0

1.1

2.67

3.92

u/ml

0.81

835

Other specified disorders of kidney and ureter

171

0.82

0.26

1.1

2.88

6.44

u/ml

—

Contusion of toe(s) without damage to nail

348

1.12

0.26

1.2

1.1

5.31

4.75

u/ml

0.07

196

Hypertensive heart and/or renal disease

759

0.93

0.26

1.0

1.1

1.88

2.88

u/ml

0.64

370

Other necrotizing vasculopathies (FG)

246

0.85

0.26

1.0

1.1

1.25

4.59

u/ml

—

124

Other/unspecified cytomegaloviral diseases

149

0.80

0.26

1.0

8.19

6.53

u/ml

—

Von Willebrand disease

138

0.79

0.26

1.3

1.0

0.48

5.30

u/ml

—

Vitamin B12 deficiency anaemia

394

0.89

0.26

1.1

1.67

4.06

u/ml

1.74

189

Coagulation defects, purpura and other haemorrhagic conditions

188

1792

1.05

0.26

1.1

5.37

5.54

u/ml

0.03

115

986

Other coagulation defects

732

1.08

0.26

1.2

1.1

3.89

5.22

u/ml

0.45

406

Malignant neoplasm of thyroid gland, including Hilmo

549

1.09

0.25

1.1

3.56

4.33

u/ml

0.32

287

Neoplasms

1306

6726

1.02

0.25

1.1

5.42

6.05

u/ml

0.71

733

3793

Bacterial, viral and other infectious agents

858

1.07

0.25

1.1

3.50

5.16

u/ml

0.87

475

Constitutional tall stature

142

1.22

0.25

1.3

1.2

2.55

5.71

u/ml

1.03

112

Scarlet fever, including avohilmo

151

1.20

0.25

1.0

1.1

1.35

5.72

u/ml

2.86

104

Other and unspecified injuries of thorax

123

1.22

0.25

1.1

1.0

7.63

7.07

u/ml

—

Iridocyclitis in diseases classified elsewhere

123

1.22

0.25

1.1

1.0

9.11

4.83

u/ml

—

Other mental disorders due to brain damage and dysfunction and to physical disease

446

0.90

0.25

1.0

1.1

6.12

3.49

u/ml

0.39

218

Other cataract

265

2048

0.96

0.25

1.1

5.46

3.63

u/ml

0.47

131

1014

Disorders resulting from impaired renal tubular function

213

0.84

0.25

1.0

1.1

3.99

5.50

u/ml

—

128

Pedestrian injured in collision with car, pick-up truck or van

170

0.82

0.25

1.0

1.1

11.72

6.37

u/ml

—

Malignant neoplasm of mesothelium and soft tissue

170

0.82

0.25

1.1

1.0

3.85

4.15

u/ml

—

AV-block

594

0.92

0.25

1.1

3.05

4.27

u/ml

0.43

314

Complications of internal orthopaedic prosthetic devices, implants and grafts

105

985

1.07

0.25

1.0

1.1

6.97

3.70

u/ml

0.71

477

Other disorders of binocular vision

142

1.20

0.25

1.1

1.0

0.47

5.71

u/ml

3.07

Injury of nerves and spinal cord at neck level

105

1.24

0.25

1.2

1.0

5.50

5.86

u/ml

—

Congenital malformations of the circulatory system

206

1914

1.05

0.25

1.1

5.95

5.98

u/ml

0.01

126

1187

Dislocation, sprain and strain of joints and ligaments of elbow

821

1.07

0.24

1.2

1.1

6.36

5.75

u/ml

0.10

483

Motor disorders, excluding more controls

454

1.10

0.24

1.1

1.2

4.40

6.24

u/ml

0.52

346

Mixed disorders of conduct and emotions

517

0.90

0.24

1.0

1.1

4.58

7.43

u/ml

0.89

328

Carbimazole or st.post thyroidectomy, condition for graves disease

205

1963

1.05

0.24

1.1

3.79

4.52

u/ml

0.33

123

1011

Psoriasis

257

2473

1.04

0.24

1.1

3.10

5.03

u/ml

1.59

122

1303

Chronic respiratory disease originating in the perinatal period

0.74

0.24

1.1

1.2

6.49

6.00

u/ml

—

Thyrotoxicosis with diffuse goitre

144

1367

1.05

0.24

1.0

1.1

3.44

4.92

u/ml

0.94

720

Other diseases of blood and blood-forming organs

398

1.11

0.24

1.1

2.62

4.77

u/ml

0.78

208

Foreign body or object entering through skin

600

1.09

0.24

1.1

2.75

5.64

u/ml

2.64

338

Symptoms and signs involving cognition, perception, emotional state and behaviour

1164

7636

1.02

0.23

1.1

4.68

4.97

u/ml

0.27

622

4031

Other pulmonary heart/vessel disease

180

1.17

0.23

1.0

1.1

1.17

4.09

u/ml

2.10

105

Gout

109

993

0.94

0.23

1.1

2.16

3.80

u/ml

1.38

482

Cyst of kidney

284

1.13

0.23

1.2

1.0

2.42

4.06

u/ml

0.39

133

Other psoriatic arthropathies

806

0.93

0.23

1.1

3.37

4.19

u/ml

0.15

416

Corns and callosities

401

0.90

0.23

1.1

6.99

4.31

u/ml

0.31

205

Cytomegaloviral disease

179

0.84

0.23

1.1

6.15

6.71

u/ml

—

102

Other infectious diseases

447

1.10

0.23

1.0

1.1

5.40

4.88

u/ml

0.09

243

Congenital deformities of feet

342

1.12

0.23

1.1

7.59

5.93

u/ml

0.22

212

Lack of expected normal physiological development

577

0.92

0.23

1.1

1.2

7.90

6.60

u/ml

0.22

431

Optic neuritis

463

0.90

0.23

1.0

1.1

4.60

5.37

u/ml

0.15

256

Hypoplasia of dental enamel , including avohilmo

950

0.94

0.22

1.2

4.56

6.76

u/ml

0.60

668

Embedded teeth, including avohilmo

165

1576

1.05

0.22

1.1

7.23

7.03

u/ml

0.05

101

930

Emotionally unstable personality disorder

199

1909

1.04

0.22

1.1

3.68

6.34

u/ml

2.44

123

1053

Epilepsy

296

2852

1.04

0.22

1.1

3.67

5.66

u/ml

2.08

153

1660

Ectopic pregnancy

193

1850

1.04

0.22

1.1

4.96

4.53

u/ml

0.14

947

Effects of heat and light

1.25

0.22

1.0

0.85

4.10

u/ml

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Timothy IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS